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Summary 
National reports on the drug situation in Austria are drawn up annually for the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the federal ministry respon-
sible for health affairs, and deal with the subject of illicit drugs. This report gives an overview 
of current developments regarding the political and legal framework, the epidemiological 
situation and demand reduction interventions in the reporting period 2005/6. Every year spe-
cific issues are also highlighted; in this report, the themes of drug use among very young 
people, cocaine and crack as well as drugs and driving have been selected for detailed pres-
entation. 
Summary and discussion of the most important trends 
As in the previous year, substitution treatment was a central issue of drug-related discus-
sions and measures. In the context of the plans to modify the legal framework, after exten-
sive consideration and discussion, two Decrees were prepared in the reporting period but 
their implementation had not yet started when this report was drawn up (summer2006). The 
central objective here was to define specific legally binding provisions for attending physi-
cians, which have been absent so far. The central pillars of the new regulations under prepa-
ration include obligatory further training for doctors practising substitution treatment, stricter 
regulations for dispensing substitution substances to patients to take away, a stronger role of 
the health authorities and the establishment of commissions and committees at federal and 
provincial levels for the purpose of continuing quality assurance. In future, buprenorphine, 
apart from methadone, will have to be primarily prescribed. Slow-release morphines will not 
be generally prohibited for the time being so as not to restrict the range of treatment options, 
however, this issue will be reviewed when further scientific studies are available. Parallel to 
this, a number of provinces have also taken steps to improve the quality of substitution 
treatment and to further expand the existing services. 
Another important focus of drug-related activities at federal level resulted from Austria’s 
Presidency of the EU Council in the first half of 2006. In addition to a number of current is-
sues, Austria brought up in particular the focal themes of cocaine, addiction treatment in 
prisons, social reintegration, cannabis and heroin trafficking via the Balkan route. In addition, 
Austria played a leading role in adopting the amendment to the EMCDDA founding regula-
tion. 
The present drug situation may be assessed on the basis of a number of recent data. The 
available surveys confirm the rates of drug use that have also shown in past years. The 
prevalence rates of experience of illicit psychoactive substances among both adults and 
young people have slightly risen in the past decade, but have now stabilised at a higher 
level. Approximately one out of five persons have already used cannabis, with peak shares 
of up to 35% among young adults. For all other substances, the corresponding shares are 
considerably lower and range between a maximum of 1% (heroin) and 3% (ecstasy, am-
phetamines, cocaine) among the general public, and current consumption rates (past 12 
months) are again lower to a significant degree. This confirms the assumption that use of il-
licit substances is mostly limited to experimental consumption or use during a specific stage 
in life. 
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The extent of problem drug use may be estimated on the basis of updated prevalence esti-
mates, the development of drug-related deaths as well as reports and data from the drug 
help sector. The first data from DOKLI, the nationwide documentation system of clients of 
Austrian drug help centres, will not be available before 2007. However, the implementation of 
DOKLI was complete by the end of 2005 and as of January 2006, routine data have been 
gathered. Thus, a central gap in Austria’s drug-related monitoring has been closed, therefore 
a more reliable assessment of the drug situation will be possible in future. 
On the basis of an analysis of available data and information on problem drug use in Austria 
over several years, it may be concluded that this problem has worsened in recent years. Ac-
cording to updated prevalence estimates of problem drug use – primarily poly-drug use with 
opiates, in 2004, approximately 25 000 to 32 000 persons in Austria were problem drug con-
sumers. Compared to an estimate for 2001 undertaken according to a similar methodological 
procedure, this is a rise by around 10 000 persons. In this regard, a particular increase has 
been noticed among the age group from 15 to 24. In addition, the number of directly drug-
related deaths has risen for the third time in a row since 2002, to 191 cases in 2005. Al-
though the corresponding data have to be interpreted with caution because of the small 
number of cases involved, the fact that the average age of persons who died because of 
drug intoxication has gone down also points to changes in the drug situation to some degree. 
This is also reflected in recent reports from various provinces, according to which several re-
gional drug help centres and experts have registered rising numbers of young people show-
ing patterns of massive, and often very risky, drug use. This development has been observed 
for several years already (see reports of past years) and appears to be further corroborated 
by the new data available. 
Regarding health-care measures, a great variety of new services have been provided or ex-
isting ones have been modified in almost all provinces. After, or parallel to, the establishment 
and expansion of diversified basic services, a number of highly specialised interventions 
have been planned and implemented, in order to meet the goal to build a tight network of 
care measures that are oriented towards the individual needs and requirements of the rele-
vant groups of clients. These developments have often been triggered by deficits and gaps 
or need for modifications that showed in the context of practical work or were identified in 
analyses of demand as well as evaluations. Apart from a great variety of activities in the 
fields of primary and secondary prevention as well as harm reduction and treatment, numer-
ous new or expanded services that focus on social integration deserve mention. Occupa-
tional reintegration of (former) drug addicts continues to play a central role. In addition, in-
creasing attention is also paid to demand for housing (temporary sleeping facilities as well as 
long-term housing) and sparetime activities or social networks. 
Selected issue: Drug Use and Related Problems among 
Very Young People 
In Austria, drug use among very young people is not a massive problem with regard to quan-
tity. Only a few young people has first (experimental) experience of illicit drugs before the 
age of 15. The average age at the time of first use is clearly above 15 years for all psychoac-
tive substances but not for alcohol and nicotine (around 14 years), inhalants and cannabis 
(around 15 years).  
VThe group of young people who show massive use or misuse of illicit substances or high-risk 
patterns of use at this age is very small. Furthermore, for most of the children and young 
people concerned severe psychosocial problems are the main issue. Drug misuse is one as-
pect and sometimes a consequence of the accumulation of problems and stress, which, 
however, usually aggravates the situation. The life situation of the young people concerned is 
often characterised by cutting social ties such as family and school, lack of social security, 
psychological and psychiatric problems and, in some cases, sex work or committing petty 
crimes.  
Children and very young people are hardly found as clients of drug or addiction related ser-
vices, but rather of youth welfare agencies and child or youth psychiatry services. The re-
sponse to this situation over the past few years has been to intensify cooperation between 
the drug help services and youth (welfare) agencies in order to ensure the necessary net-
working and the exchange of competence and expertise. As a complementary measure, in 
the field of drug help specific services for young people (beginning) with problem or high-risk 
patterns of use were created which are also available for people younger than 15.. 
Selected issue: Cocaine and Crack – Situation and Responses 
Over the past few years, cocaine as a fashion drug has been a recurring issue in the media. 
While it is true that in a long-term comparison, figures for use of stimulating substances such 
as cocaine have slightly risen, they have remained stable for some years at low levels of a 
maximum of 3%. Crack continues to play an insignificant role in Austria. 
Regarding regular use, a distinction must be drawn between recreational users in defined 
scenes and problem poly-drug use patterns. While the first group of users has been noticed 
for a longer period, especially over the past few years cocaine has been established as a 
relevant substance in poly-drug use patterns in the street drug scene, sometimes with co-
caine, but frequently with opiates as the main drug. Low-threshold services have reported 
that the use of cocaine in the street scene is often connected with high-risk behaviour and 
the neglect of safer-use rules. In recent years, cocaine also has played a major role with re-
gard to drug-related deaths. Cases of intoxication with cocaine as the sole drug involved are 
rare, but cocaine has often been found in connection with poly-drug intoxication with opiates. 
In drug help centres clients whose main drug problem is cocaine are still a small group, 
which indicates that the persons concerned have not yet been reached to a satisfactory de-
gree. Drug help services in Austria are not diversified to primarily focus on individual sub-
stances, but in recent years specific interventions such as inpatient therapy, cocaine consul-
tation hours, a low-threshold restroom for cocaine users and a cocaine telephone hotline 
were established in order to better accommodate the specific needs and requirements.  
Selected issue: drugs and driving 
In Austria, problems and required measures in the context of drugs used in road traffic have 
been discussed controversially for many years, which shows in related surveys, hearings, 
working groups and symposiums, among other initiatives. In 2002 an amendment to the 
Road Traffic Regulations (StVO) was passed by parliament, containing the introduction of 
mandatory blood tests if an impairment of the ability to drive due to drugs is suspected. In the 
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amendment, substances are not further specified, but the regulations are similar to the exist-
ing legislation for alcohol. 
For assessing impairment due to drug use, a model in several steps has been devised: in a 
first steps, traffic officers determine that there is a suspected impairment of the ability to 
drive. The next step is a clinical examination by a public health officer to confirm the suspi-
cion and determine the degree of impairment. If suspected impairment is confirmed, there is 
a blood test by an authorised physician. According to another amendment in 2005, a saliva 
test is provided between the first and the second step, but as yet no suitable testing devices 
are available.  
If the test result is positive, the driving licence is (provisionally) revoked, the driver punished 
with and administrative fine and potentially, accompanying measures such as after-training 
are prescribed. A positive blood test according to the StVO does not lead to a report to the 
police under the Narcotic Substances Act (SMG), but to notification of the health authority in 
charge. In 2005, 913 persons were registered on account impairment of the ability to drive 
due to clinically detected narcotic substances which were confirmed in blood tests, which is a 
small fraction compared to the reports for impairment of the driving ability because of alcohol 
(40 000). 
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1Introduction 
This is the 11th time the REITOX Focal Point at the Austrian Health Institute (ÖBIG) presents 
its annual Report to the EMCDDA (European Monitoring Agency for Drugs and Drug Addic-
tion) and the Austrian Federal Ministry that is responsible for health affairs. The REITOX Fo-
cal Point is a central link in Austria’s data and information network of drug-related matters 
and closely cooperates with the relevant federal and provincial agencies in this field as well 
as addiction and drug help centres. 
This report deals with illicit drugs and serves both as a national report on the situation in Aus-
tria and as Austria’s contribution to describing the drug situation in the European Union (EU). 
Similar reports are submitted by the REITOX Focal Points in all EU member states and by 
the EU candidates, according to guidelines issued by the EMCDDA. These reports are es-
sential as a basis of the EMCDDA’s Annual report on the state of the drugs problem in the 
European Union (latest publication: EMCDDA 2005). 
Part A of this report deals with new developments and trends with regard to the drug policy 
framework, the epidemiological situation and health-policy interventions aiming at demand 
reduction. It is based on previous reports (latest report: ÖBIG 2005a) and refers to the report-
ing period from summer 2005 to summer 2006, while routine statistics refer to the year 2005. 
In Part B of the report selected issues are presented in more detail. In the present report the 
corresponding chapters are: Drug use and related problems among very young people (<15 
years); Cocaine and crack; and Drugs and driving. The Annex includes a number of addi-
tional tables with detailed information and data. 
Every year the REITOX Focal Points also submit to the EMCDDA annual standard tables 
and structured questionnaires. These data and information have also been integrated in this 
report. For an overview of all standard tables and structured questionnaires please consult 
Annex C. Upon request, the individual tables and questionnaires may be made available to 
any interested parties. 
This report is based on many different data and information communicated to ÖBIG by vari-
ous experts in the field of drugs. In this respect, the reports on the drug situation in the indi-
vidual Austrian provinces drawn up by the Drug Coordinators and Addiction Coordinators 
have been especially significant. In addition, a number of experts provided background in-
formation and specific data for individual chapters of this report (see Selected Issues). We 
would like to express our gratitude for their cooperation. 
We are especially indebted to the members of the advisory working group of the REITOX 
Focal Point Austria, Mr Michael Dressel (Drug Coordinator of the City of Vienna and Provin-
cial Representative), Mr Thomas Neubacher (Addiction Coordinator of Vorarlberg and Pro-
vincial Representative), Mr Franz Pietsch (Federal Drug Coordinator and head of the Federal 
Drug Coordination), Mr Robert Scharinger (BMGF), Ms Johanna Schopper (head of the De-
partment of Drugs and Narcotic Substances at the BMGF) and Mr Wolfgang Werdenich 
(BMJ) for their helpful comments and invaluable input. 

PART A 
New Developments  
and Trends  

51 National Policies and Context 
The Narcotic Substances Act (SMG), which has been in force since 1998, constitutes the 
main framework of Austria’s drug policy. The SMG focuses on quantities and not on kind of 
substance, with the exception of a special provision concerning cannabis, and provides a 
wide range of alternatives to punishment. At the federal level the central actors in the field of 
drug policy include the Federal Drug Coordination and the Federal Drug Forum, which 
serves as a coordinating body with the provinces (see Figure 1.2). Due to the federal struc-
ture of Austria’s health and social care system, the provinces play important roles with regard 
to the adoption and implementation of drug policy measures. All nine provinces have drawn 
up drug strategies or addiction plans and nominated Drug or Addiction Coordinators. In addi-
tion to the provincial strategies and plans, a federal drug strategy paper is under preparation. 
Drug policy measures are financed primarily by the Provincial Governments, the social insur-
ance funds and the Federal Government. The public discussion of drug issues primarily con-
centrates on questions related to public safety and delinquency. Although Austria’s political 
parties take differing stands with regard to drug policy, they unanimously endorse the princi-
ple of therapy instead of punishment, which is also widely accepted by the general public. 
1.1 Legal framework  
The reporting period did not see any amendments to the National Substances Act (SMG). 
However, the synthetic substances 2C-B, 2C-I, 2C-T-2, 2C-T-7 and TMA-2 were incorpo-
rated in the provisions of the SMG in accordance with the corresponding decisions at interna-
tional level. In addition, preparations were started for implementing the European Framework 
Decision laying down minimum provisions on the constituents of criminal acts and penalties 
in the field of illicit drug trafficking (Council of the European Union 2003), which will require 
an amendment to the SMG. 
In the context of the plans described last year to modify the legal framework of substitution 
treatment (see ÖBIG 2005a), after extensive consideration and discussion by experts, two 
Decrees were prepared in the reporting period. The central objective here was to define spe-
cific legally binding provisions for attending physicians, which have been absent so far. The 
central pillars of the new regulations under preparation (see also Chapter 5.3) include obliga-
tory further training for doctors practising substitution treatment, a stronger role of the health 
authorities and the establishment of expert commissions for the regional coordination of sub-
stitution treatment at provincial level, as well as a federal committee responsible for the qual-
ity and safety of substitution treatment. Slow-release morphines will not be generally prohib-
ited for the time being so as not to restrict the range of treatment options, however, this issue 
will be reviewed when further scientific studies are available. 
With regard to the implementation of the relevant provisions, information is available on 
statutory alternatives to punishment (for more detail see ÖBIG 2004 and Structured Ques-
tionnaire 31). 2005 saw a rise in the corresponding measures from 9 666 to 11 660 cases. 
Chapter 1: National Policies and Context 
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This increase, as in the previous year, exclusively results from waiving of reports to the 
police, while the number of suspended proceedings has slightly declined (see also Table A 
16 in Annex A). Simultaneously, the number of reports to the police went up (from 25 215 to 
25 892), as did the number of convictions under the SMG – to an even more pronounced 
degree, i.e., from 5 706 to 6 128 (see Chapter 8.2). 
Figure 1.1: Development of the implementation of statutory alternatives to punishment in Austria, 
from 1996 to 2005 
 
Section 35 SMG = provisional waiving or reports by the public prosecutor's office 
Section 35 (4) SMG = provisional waiving of reports in the case of small amounts of cannabis for personal use 
Section 37 SMG = provisional suspension of proceedings by the court 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. A specification as to which al-
ternative to punishment was applied is possible for the period since 1998 only. Regarding Section 39 of the SMG (stay of 
execution of prison sentences based on the principle of therapy instead of punishment) no reliable data are currently 
available.  
Source: BMGF; calculations by ÖBIG 
Salzburg again provided complementing analyses of the results of examinations according to 
Section 12 of the SMG, which give insight into the implementation practice of the health au-
thorities. In 2005, one health-related measure was recommended for 26% of the patients ex-
amined, and in 60% of the cases, two or more measures were regarded as necessary. For 
14% no health-related measure was recommended. Thus, the situation has been reverted 
compared to the year 2004, when one measures was deemed necessary for 58% of the pa-
tients and two or more measures for 28%. In addition, medical supervision of the patients’ 
state of health was recommended significantly more often (75% in 2005 v. 33% in 2004), 
while psychosocial counselling and care were deemed necessary in fewer cases (62% v. 
71%). The drastic changes in this regard cannot easily be explained and require further ob-
servation. However, the results provided indicate that considerable differences in the exami-
nation practices of the individual district health authorities still exist (Drogenkoordination des 
Landes Salzburg 2005). Thus it would be necessary to define and implement uniform stan-
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dards and quality assurance measures, preferably at federal level, because this problem has 
occurred not only in the province of Salzburg (see ÖBIG 2005a). 
 
1.2 Institutional framework, strategies and policies 
No major changes in the political and administrative framework took place in the reporting 
period (see also Structured Questionnaire 32). The Federal Drug Forum (see Figure 1.2 on 
the following page) met twice, in November 2005 and in April 2006, to discuss, among other 
issues, a modification of the regulations for substitution treatment (see Chapters 1.1 and 
5.3), drug-related legal questions (including the implementation of the European Framework 
Decision; see Chapter 1.1), the further advancement of drug monitoring, the Austrian Presi-
dency of the Council of the European Union and future international cooperation. 
An important focus of drug-related activities at the federal level resulted from Austria’s Presi-
dency in the first half of 2006. In the context of chairing the Horizontal Drugs Group (HDG), in 
addition to discussing a number of current issues (such as international cooperation and 
amended EMCDDA regulation), Austria brought up the themes of cocaine, addiction treat-
ment in prisons as well as social integration. Furthermore, Austria was in charge of the 
preparation for, coordination of and follow-up activities after Europe’s participation in the 
Commission on Narcotic Drugs (CND) at UN level, and a number of other international meet-
ings took place as well. On 16 and 17 February, the national Drug Coordinators met in Inns-
bruck for a more detailed discussion of the subjects of cannabis problems, heroin trafficking 
via the Balkan route as well as cocaine. 
Furthermore, based on a compromise proposed by Austria, the amendment to EMCDDA 
founding regulation was adopted. What is particularly relevant in this context is that in future, 
the EMCDDA will explicitly take over the task to analyse new trends regarding the combined 
use of legal and illicit psychoactive substances. 
A number of other activities and trends at national level worth mentioning include the imple-
mentation at the end of 2005 of DOKLI, the uniform documentation and reporting system of 
clients of Austrian drug help centres (see ÖBIG 2005a and ÖBIG 2005b). Since January 
2006 DOKLI has been used as a standard instrument, which is a milestone for the expansion 
and improvement of drug-related monitoring in Austria. In the context of the gender main-
streaming initiative of the Federal Ministry of Health and Women (BMGF), the study on gen-
der budgeting already mentioned last year (see ÖBIG 2005a) was concluded and a gender 
budgeting programme for the field of drugs and addiction was drawn up, which is now being 
implemented. 
Figure 1.2: Overview of the organisational structure of the drug sector in Austria
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Also at provincial level, only a small number of relevant changes are worth mentioning. In 
Lower Austria, the Addiction Coordination, which had been part of the Federal Government, 
was outsourced and is now run by a private association: the Addiction Prevention Coordina-
tion and Counselling Unit. Apart from addiction coordination and the implementation of Lower 
Austria’s Addiction Plan, the Association’s activities also include prevention and treatment 
(Hörhan, personal communication). In Vienna, drug issues no longer fall within the remit of 
the Vienna Social Fund (FSW) but were moved to the newly established non-profit company 
Sucht- und Drogenkoordination Wien [Addiction and Drug Coordination Vienna]. Styria ex-
panded the Provincial Addiction Advisory Board; its members now also include representa-
tives of the judicial system, the Medical Association and pharmacies. Thus the trend of Pro-
vincial Governments to outsource coordination tasks and to integrate the theme of drug af-
fairs in a more general context of addiction has continued. Central drug policy measures un-
dertaken in all provinces include the implementation of regional drug or addiction strategies 
as well as responses to new developments and problems. 
1.3 Budget and public expenditure 
The financial regulations in the field of drugs did not undergo relevant changes in the report-
ing period. With regard to budget, the available information is limited and no general over-
view can thus be given. 
1.4 Social and cultural context 
There are a number of new studies that provide data on opinions with regard to drug issues 
among the general public. The drug surveys of Vienna permit an analysis of long-term trends 
as they have been conducted every two years since 1993. For the most recent survey car-
ried out in autumn 2005, 600 persons aged 15 or older were interviewed (IFES 2005a, see 
also Chapters 2.1 and 12.1). The results again reflect a strong acceptance of the approach to 
give priority to health-policy interventions (treatment) and decriminalisation over repressive 
measures (imprisonment) for drug users and addicts, paralleled by massive opposition to a 
far-reaching liberalisation of drugs. Substitution treatment is regarded as sensible by a major-
ity of respondents (approval: 63%), while medical prescriptions of heroin tend to be rejected 
(approval: 9%). 
A long-term comparison shows a trend away from more liberal attitudes. While between 1995 
and 2001, approval, for instance, of a liberalisation or legalisation of cannabis but no other il-
licit drug was growing, the relevant percentages went down again in the years to follow. This 
was accompanied by stronger acceptance of more repressive positions such as prison sen-
tences for drug use (see Figure 1.3 on the following page). 
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Figure 1.3: Attitudes towards drug policy measures among the population of Vienna 
from 1995 to 2005 (percentages show approval of the measure in question) 
Source: IFES 2005a 
A representative study on prevalence and patterns of use of legal and illicit narcotic sub-
stances (see also Chapters 2.1, 10.1 and 12.1 as well as ÖBIG 2005a) that was drawn up for 
the Federal Ministry of Health and Women (BMGF) surveyed attitudes towards drug policy 
issues largely following the model of the drug survey of Vienna so as to permit comparisons. 
For this purpose, all over Austria approximately 4 500 persons aged 14 or older were inter-
viewed (Uhl et al. 2005a). The resulting nationwide attitudes to drug issues are comparable 
to the results obtained for Vienna (see Figure 1.3): 60% are in favour of retaining the general 
prohibition of drugs, paralleled by a decriminalisation of drug addicts. 80% support the estab-
lishment of additional treatment centres for drug addicts, 58% advocate the distribution of 
sterile injection equipment to addicts, and 20% would welcome the establishment of con-
sumption rooms. At national level, prison sentences because of drug use are slightly better 
accepted (by 37% of respondents) than in Vienna. On the other hand, the nationwide ap-
proval of positions favouring a liberalisation/legalisation for hashish but no other illicit drug 
(20%) and general liberalisation (6%) is also slightly higher compared to the survey of Vi-
enna. 
The nationwide study also surveyed what respondents thought of the risk potential of individ-
ual substances. Here the opinions regarding the danger of heroin [94% said that it was (very) 
dangerous to try it once or twice and 100% regarded regular use as (very) dangerous)], co-
caine (87% and 99%) and ecstasy (80% and 98%) were similar in all age groups. Alcohol 
(15% and 84%) and nicotine (18% and 78%) are regarded as more dangerous with rising 
age. The danger of cannabis (60% and 87%) is regarded as comparable to the rest of illicit 
drugs among the youngest respondents, but assessed to be less risky with rising age up to 
approx. 23 years. After 23, it is again judged to be more risky by constantly rising shares, up 
to the oldest age groups (Uhl et al. 2005a). 
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Styria provided information on the views trainees have of the risk of drugs and drug policy 
positions, obtained in the context of interviews of a total of 3 919 trainees attending voca-
tional school aged between approx. 15 and 20 (Hutsteiner et al. 2005; see also Chapters 2.2, 
3.1 and 12.1). On a scale from 1 (very dangerous/very high risk of addiction) to 4 (not dan-
gerous at all/no risk of addiction) tobacco (2.09) and alcohol (2.40) as well as natural drugs 
(2.22) and poppers (2.00) were regarded as the substances with the lowest addiction poten-
tials, while illegal substances such as cannabis (1.76), party drugs (1.31), amphetamines 
(1.28), opiates (1.18), cocaine (1.17) and crack (1.27) were thought to be significantly more 
dangerous. Regarding attitudes towards drug policy measures, rather rigid opinions pre-
dominated. For instance, approx. 70% of respondents were against a legalisation of canna-
bis for users over 18 – which is a high percentage compared to other surveys among young 
people. It also showed that a rather large share of the trainees held views that have scientifi-
cally proven to be wrong (e.g., cannabis as a gateway/starter drug or fatal overdoses of 
hashish). 
The political and media discussions of the theme of substitution treatment (see ÖBIG 2005a) 
were continued in the reporting period, but with the focus shifting towards the controversial 
issue of slow-release morphine prescriptions on the one hand and the pros and cons of the 
planned changes in the relevant legal framework on the other (see Chapters 1.1 and 5.3). 
As briefly mentioned in the report of last year (see ÖBIG 2005a), a project to reduce public 
disturbance was started in Vienna. Initiated by the City of Vienna and implemented in coop-
eration with the public transport system of Vienna, the Help U pilot project in Karlsplatz 
square, a major public transport junction and traditional meeting place of the drug scene, 
aims to promote peaceful coexistence and further enhance safety in sensitive urban areas. 
The Help U team is present on the spot for contacts with passers-by, public transport users, 
tourists, shop owners, etc., in order to prevent conflicts and to be able to intervene quickly in 
cases of crisis and emergency. The project was started in September 2005 and will be con-
tinued until December 2006. It may be extended and possibly also established in other areas 
(see www.wien.gv.at). 
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2 Drug Use in the Population 
In Austria, experience of illicit drug use primarily concerns cannabis, with prevalence rates of 
approximately 30% among young adults. According to representative studies, about 2% to 
4% of the population has experience of ecstasy, cocaine and amphetamines, and between 
around 1% and a maximum of 2% also of opiates. In recent years, the range of substances 
consumed in the context of experimental use has been found to have widened. In certain 
scenes and groups of young people, high prevalence rates for a variety of substances are 
found, including biogenic drugs and poppers. New results of representative studies indicate 
that this has led to a general increase in prevalence rates in particular among adolescents 
and young adults. 
2.1 Drug use in the general population 
Since 1993 Vienna has conducted drug surveys in comparable settings every two years, 
which permits an analysis of long-term trends. The latest survey took place in autumn 2005 
and included interviews with 600 persons aged 15 or older (IFES 2005a; see also Chapters 
1.4 and 12.1 as well as Table A1 in Annex A).  
Figure 2.1: Lifetime experience of illicit drugs among the population of Vienna, comparison 
from 1993 to 2005 (percentages) 
 
Source: IFES 2005a 
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group under 30 to 7% among people aged between 50 and 60. In addition, lifetime 
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prevalence rates are significantly higher for men than for women in all age groups. The study 
does not confirm reports stating an increased use of cocaine (see also Chapter 12). It also 
surveyed drug use during the past three years and in the past 30 days. Here, relevant levels 
of use were only found for cannabis (7% and 3%, respectively), while the prevalence rates 
for the rest of substances were never above 1% and often lower. Approximately one out of 
four persons who reported lifetime experience of cannabis had taken this substance more of-
ten than only once or twice in the past three years. The average age of first use of cannabis 
is 18 years (IFES 2005a). 
Now the final report on the nationwide representative study mentioned in the report of last 
year (ÖBIG 2005a; see also Chapters 1.4 and 12.1 as well as Table A1 in Annex A) has 
been concluded (Uhl et al. 2005a). This study again shows that a majority of drug users tend 
to try illicit drugs a few times but soon stop using these substances (experimental use). De-
pending on the substance in question, differences according to gender show to varying de-
grees (e.g., share of women of 27% in LSD users, 33% regarding cocaine and 42% for can-
nabis). A closer description of the group of drug users can safely be given for cannabis only, 
because in the case of the other illicit drugs studied, the prevalence rates are too low to per-
mit more detailed statements. Typically, today’s cannabis users are between 20 and 49 
years old, they have rather high educational levels and are psychologically imbalanced to 
some extent, they live in urban areas and tend to be unmarried, single persons without chil-
dren. However, the socio-demographic differences to non-users are becoming less pro-
nounced than in the past, as cannabis use has turned into a more common occurrence. 
In Salzburg, based on a long-term comparison of the results of examinations by the district 
health authorities (see Chapter 1.1) it was concluded that there has been a slight, continuous 
upwards trend regarding shares accounted for by party drugs (ecstasy, speed, cocaine), 
while the shares of cannabis and hallucinogens have remained stable and opiate use has 
gone down (Drogenkoordination des Landes Salzburg 2005). 
2.2 Drug use in the school and youth population 
In Styria, a total of 3 919 trainees at vocational school aged between approx. 15 and 20 were 
interviewed in 2005 in the context of the aforementioned vocational school survey (see 
Chapter 1.4), which also included questions concerning experience of drug use (Hutsteiner 
et al. 2005; see also Chapters 3.1 and 12.1). Obviously, this survey also shows significantly 
lower prevalence rates of use during the past 12 months compared to lifetime experience 
(see Chapter 2.2). The general results regarding prevalence are in accordance with similar 
surveys and analyses carried out in recent years (see Klopf and Weinlich 2004, Uhl et al. 
2005b as well as Table A2 in Annex A) that also refer to vocational schools. 
The lifetime prevalence rates for illicit substances indicated by the trainees at vocational 
school surveyed tend to rise with age (e.g., cannabis: from 15.5% among 15-year old train-
ees to 35.4% for trainees over 18; party drugs: from 3.4% to 6.2%) and they are higher in ur-
ban areas compared to rural areas (e.g., cannabis: 42.7% in the provincial capital of Graz 
and 20.6% in peripheral districts). The same pattern also shows for drug use in the past 12 
months, and here the prevalence rates found are considerably higher among male trainees 
(Hutsteiner et al. 2005). The young people interviewed mostly indicated that they used can-
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nabis at their friends’ homes (71%) and used party drugs and amphetamines primarily when  
going out (85.7% and 80.5%). 
Figure 2.2: Experience of use of psychoactive substances among trainees at vocational schools 
in Styria with regard to lifetime and 12-month prevalence, in 2005 (percentages) 
 
Source: Hutsteiner et al. 2005 
The vocational school survey of Styria also studied the trainees’ motives for drug use. The 
majority of respondents rejected the statement that drugs were used as a way to escape 
from everyday life (rating of 2.94 on a scale from 1=fully agree to 4=don’t agree at all) as well 
as the statement that they felt excluded to some extent if they did not smoke hashish in a 
group of spliff smokers (rating of 3.36). The relevant results are even lower for cannabis-
using groups: only 18.8% (v. 25.6% in general) said they felt excluded if they did not join the 
spliff smokers. As far as views of the drug situation at vocational school are concerned 
(statement: extent of use is much too high), the respondents said that alcohol use (2.32 on a 
scale of 1=fully agree to 4=don’t agree at all) and tobacco use (1.85) was much more prob-
lematic compared to illicit drug consumption (2.99). 
In addition to these studies, information by drug centres and experts from a number of prov-
inces are available, so that the data obtained may be qualitatively complemented. Bur-
genland reports rising numbers of young at-risk drug users among the clients of care centres, 
for whom assistance cannot easily be provided (Dantendorfer 2005). According to drug help 
centres of Lower Austria, excessive use of cannabis by young people is rising (Hörhan, per-
sonal communication; see also Chapter 11.1). 
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2.3 Drug use among specific groups 
So far, all data on drug use among specific groups in Austria (e.g., conscripts, ethnic minori-
ties, immigrants etc.)  come from projects that focus on specific youth scenes. Some of the 
results from these sources have been included in Chapter 12 on cocaine and crack. More re-
cent data are not available.  
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3 Prevention 
In Austria prevention measures are primarily taken at local and regional levels, in accordance 
with expert consensus. The Addiction Prevention Units at provincial level are central in this 
field. Generally, the distinction between primary1 and secondary2 prevention is regarded as 
fundamental. Since the early 1990s, when the Addiction Prevention Units were established, 
primary prevention has been pursued at a professional level. In recent years the focus has 
been placed on intensified primary prevention and an expansion of secondary prevention. 
Furthermore, prevention measures were initiated and coordinated increasingly often at re-
gional levels as well. 
Generally, the prevention measures taken in Austria are aimed at long-term effectiveness 
and sustainability. Therefore, a number of standard programmes, such as Eigenständig wer-
den (Becoming Independent) and Step by Step, are routinely carried out at a nationwide 
level (Tables A23 and A24 in Annex A). In addition, several regional projects have also been 
implemented for longer periods and shown good results (e.g., the Peer Education pro-
gramme of Upper Austria). The following chapter will primarily present innovative measures 
and new developments. The wide range of prevention measures taken in Austria, including 
the activities mentioned in this report, are described in more detail on the individual websites 
and in the annual reports and newsletters of the Addiction Prevention Units and other rele-
vant actors, as well as in previous reports by ÖBIG (see Bibliography). 
3.1 Universal prevention 
Universal prevention plays a central role in Austria, with schools as important settings in this 
context. Apart from proven forms of cooperation and activities, a number of new develop-
ments deserve mention. For instance, Salzburg plans to build district-based networks of liai-
son teachers in order to facilitate their integration in regional coordination bodies (Dro-
genkoordination des Landes Salzburg 2006). In Burgenland, a course in prevention strate-
gies in schools was held in 2005 for the target group of school medical officers. An evalua-
tion of the Tyrol’s project on expert-aided addiction information in schools, a uniform model 
for well-founded information work in the field of addiction (see EDDRA), showed positive re-
sponses to the pertinent events, however, a more intensive participation by teachers as well 
as more flexibility on the part of the schools with regard to organising events within the nor-
mal curriculum would be desirable. Upper Austria’s successful Peer Education project was 
further developed and is now continued under the name Peers for Peers. Its objective is to 
consolidate the peer approach in schools in the long run as experienced peers assist newly- 
1 Primary prevention (universal prevention) aims at avoiding the development of addiction among persons who do not belong to 
a specific at-risk group and who have not had addiction problems so far. The corresponding measures are often based on the 
principle of health promotion or life skills approaches and use a variety of methods (e.g. educational theatre play and peer 
education). 
2 Secondary prevention (selective prevention) addresses defined at-risk groups and persons with problems which have not yet 
become manifest to their full extent. The measures taken are oriented towards the specific needs of the respective groups. 
The main target group is young people.
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trained young peers.The possibilities and limits of peer education in the field of prevention 
were on the agenda of a conference of the Addiction Prevention Institute of Upper Austria 
held in June 2006. In Vienna the teaching material Zeitung in der Schule (Newspaper at 
School) provides information on addiction and media competence in this respect. The meas-
ures taken for vocational schools focus on improving the ways of dealing with drug cases. 
For instance, the Step by Step programme of Salzburg was modified for this specific purpose 
(Drogenkoordination des Landes Salzburg 2006), and in Vorarlberg several initiatives have 
drawn up their own prevention regulations. 
In Lower Austria the new join-in theatre play Traust du dich? (Do You Dare?), which is the 
first of its kind to include gender aspects, has been available for booking, combined with a 
parent meeting or an educational conference, since the school year 2005/6. The Station 
Model (see EDDRA), which aims to integrate in the school system modern educational 
methods and prevention aspects, was evaluated and expanded in the reporting period. It fo-
cuses on further training for teachers, who, in cooperation with experts, organise a modular 
action day at their schools. Experience has shown that this model is very helpful as an intro-
duction to prevention and may easily be adapted to specific situations. What is central for 
good results is a teacher who manages the project, as well as support on the part of the 
head of the school. In order to promote the long-term integration in school routines of the 
themes and methods of prevention, an enhanced version of the station model was devel-
oped. The project is often implemented as a response to concrete drug incidents, therefore a 
specific brief intervention programme was also prepared, which focuses on help instead of 
punishment. It makes it possible to provide appropriate assistance quickly in cases of sus-
pected drug abuse at school and serves as a link between the Station Model and Step by 
Step programmes. 
In the field of kindergartens, no relevant developments have taken place. Vienna is analys-
ing demand in this field in order to get an overview of the current situation regarding preven-
tion in the kindergartens of Vienna as a basis for measures to be taken (Kolar, personal 
communication). It has been planned to establish a system for training multipliers all over Vi-
enna. 
The prevention measures for the target group of parents primarily focus on information on 
addiction and prevention. For instance, Drogen – Angst ist ein schlechter Ratgeber (Drugs: 
Fear is no Good Guidance) is an information and discussion event for parents of youths in 
rural Salzburg, which aims to reduce feelings of insecurity with regard to drug use among 
young people (Schabus-Eder, personal communication). In the district of Dornbirn, Vorarl-
berg, the booklet Kindersorgen – Sorgenkinder (Children’s Problems – Problem Children) 
has been prepared as a low-threshold approach to the relevant programmes and services for 
parents in the district. The campaign Leichter Leben (Easy Living) of the drugstore chain dm 
also deserves mention: its booklet includes advice for parents on how to promote responsible 
attitudes by children towards addictive substances. VIVID, the Addiction Prevention Unit of 
Styria, prepared a special supplement to the Kleine Zeitung daily under the title Wissen 
schützt! (Knowledge Will Protect You), 205 700 copies of which were distributed in Septem-
ber 2005. It aimed at informing the public on addiction and prevention as well the services 
provided by the Addiction Prevention Unit. Because of the resulting great demand shown by 
parents, the project will be repeated in 2006. 
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Prevention in the workplace is another focal theme in Austria. In this field, trainees are an 
important target group. Again, further training schemes for teachers and instructors of train-
ees form an essential part, but courses for managerial staff are also organised. The corre-
sponding courses, for instance, Sunplus of Upper Austria, aim to raise the awareness of and 
understanding for prevention activities and to provide basic know-how. The services include 
communication training for talks in the case of drug incidents. The Addiction Prevention  In-
stitute of Vienna is building a prevention network with the aim to establish quality standards 
for prevention in the workplace and to coordinate the corresponding projects (FSW 2006a). 
In addition, a conference on addiction in the workplace will be organised. In Styria, theatre 
education approaches will now also be used for health promotion and prevention in the 
workplace. The objective of the project blauPAUSE (Habit Break) is to develop interactive 
theatre plays in order to raise awareness and to introduce this theme in enterprises and also 
non-profit organisations. 
A survey at vocational schools and residence halls for trainees in Styria (Hutsteiner et al. 
2005, see Chapters 1.4, 2.2 and 12.1) has shown that many forms of cooperation exist in the 
field of prevention. Section 13 of the SMG is mostly regarded as helpful, but as the trainees 
stay at vocational school for short periods only, it is difficult to detect substance abuse at an 
early stage (see Structured Questionnaire 22). What is recommended is measures that raise 
the trainees’ self-esteem and help them to resist peer group pressure, as well as a wider 
range of attractive spare time activities at the residence halls, objective, well-founded infor-
mation on substances and their effects and risks, and eventually counselling services at 
schools provided by external experts. Regarding Section 13 of the SMG, modifications so as 
to take into account problem alcohol use would be desirable, as would be a stronger partici-
pation of parents with regard to decisions about psychosocial interventions. In addition, bet-
ter communication between the residence halls and the vocational schools would be advis-
able and a formal structure for pertinent actions should be created. Eventually, demand has 
been identified for further training schemes for vocational school teachers and residence hall 
tutors as well as measures for burnout prevention among advisory teachers, who play key 
roles and face great stress. 
The prevention measures in recreational settings addressing young people (both students 
and trainees) often combine primary and secondary approaches (see Chapter 3.2), because 
at that age, young people are likely to experiment with drugs (ÖBIG 2001b). In the reporting 
period, the existing further training schemes for multipliers were expanded. For instance, in  
Vienna a module on prevention was integrated in the youth social work training programme 
(FSW 2006a). VIVID, the Addiction Prevention Unit of Styria, offers further training pro-
grammes complementing the High genug? (High Enough?) methodological prevention set 
(ÖBIG 2005a), which had been revised and evaluated. By spring 2006, around 200 sets had 
been distributed, in particular to organisations specialising in youth social work, and their 
feedback with regard to subjects covered and practical use has been very positive (see 
EDDRA). However, the reference booklets tend to be consulted more often than the materi-
als that require more intensive study. 
In recent years Austria has seen a significant increase in community-located prevention ac-
tivities, which, apart from awareness-raising among the public, have also triggered the de-
mand for training courses, workshops and outpatient services of drug care centres (Ederer, 
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personal communication). VIVID of Styria issued guidelines for community-based prevention, 
which aim to provide assistance to decision-makers and private persons in communities who 
want to plan and carry out prevention projects. The guidelines include information on and 
suggestions for possible interventions, practical examples as well as check-lists for imple-
mentation. In addition, information lectures for communities are offered. In the city of Salz-
burg, three working groups for the fields of infancy, schools and youth social work outside 
school will be established in order to ensure an effective implementation of a set of preven-
tion measures that have already been adopted (Drogenkoordination des Landes Salzburg 
2006). 
Styria’s project Jugend ohne Grenzen?! Mladi brez meja?! (Youth Unlimited?!; see ÖBIG 
2005a) has meanwhile been evaluated (see EDDRA). In addition to further training courses 
and events on the issue of addiction, a public relations initiative for financing small projects 
was carried out, and the soft drinks bar soft:bar was offered to these projects free of cost. 
The initiative got high publicity in the towns where it was implemented, and it was generally 
regarded as important. However, the respondents from the Slovenian towns turned out to 
know significantly more about available assistance services in the case of addiction problems 
than the respondents from the Styrian towns participating in the project. 
The Guat beinand (Feeling Good) Interreg project of Salzburg was concluded in 2005 (see 
EDDRA). In most towns, well-functioning local project groups were established, and a wide 
range of health promotion and prevention measures were carried out. The evaluation has 
shown that the communities’ motivation as well as the makeup of the local project groups 
were essential for the implementation and sustainable results of the project. In particular at 
the initial stage of the project, assistance by prevention experts is essential so that a com-
mon understanding of what addiction is may be achieved. Based on the experience made, a 
follow-up project was started: FeierFest! (Party Proof!) focuses on protection of young people 
and the promotion of a new awareness of and approach to party culture (Rögl, personal 
communication). Young party peers will take part in the project order to ensure its attractive-
ness for young people. 
Further activities in the field of prevention include the newly established network for gradu-
ates of the academic course in addiction prevention in Upper Austria and federal initiatives to 
improve the coordination of prevention activities in Austria so as to create synergy. For this 
purpose, a coordination meeting with relevant institutions was held early in 2006. 
3.2 Selective/indicated prevention 
In Austria, addiction prevention activities addressing specific target groups are primarily 
found in recreational settings and aim at communicating a critical attitude to psychoactive 
substances (risk competence). What plays a central role in this context is youth social work 
outside school, a field where primary and secondary prevention overlap (see Chapter 3.1). In 
Vorarlberg, the third round of district conferences was started in the second half of 2005 
(ÖBIG 2004, ÖBIG 2005a). In 2005 more than 200 system partners from the fields of drug 
social work, youth social work, care and treatment, schools, sports associations, administra-
tion and politics took part in the district conferences. In summer 2006 Supromobil started the 
new Interreg project Reflect and Act – Jugendkultur in bewegenden Bildern (Youth Culture in 
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Moving Pictures). In this project, young people between 14 and 26 are encouraged to tell 
their own digital stories and reflect on their personal environment and their own youth-cultural 
background. Since 2005 MDA basecamp, under the heading of mobile drug work in everyday 
life, has organised several activities, which take place in traditional meeting spots of young 
people such as large cinemas, shopping centres, pedestrian areas and also youth centres. 
Experience has shown that although this approach does not typically lead to a great number 
of confidential talks with at-risk youths, it helps to expand the target group of prevention 
workers. 
The members of the club and party scene have been identified as a specific at-risk group. 
In Vorarlberg, the working group on event actions drew up a programme of activities for the 
year 2006 which, in addition to positive experience of recent years, also integrates other 
measures such as consulting for organisers of events, qualified further training of staff as 
well as innovative products aimed at harm reduction. The presence of ChEck iT! at a large 
techno event in Lower Austria underlined the importance of public relations work and infor-
mation on the work of this service and it has shown that activities also at other large techno 
events were important so as to approach new techno fans and to find access to and accep-
tance of this scene. In summer 2005, MDA basecamp organised a networking meeting for 
organisations that provide event-related services. The common trends identified in this field 
are regionalisation and integration in larger networks as well as a stronger focus on the sub-
jects of alcohol and cannabis. 
Another important task of secondary prevention work of outpatient centres includes counsel-
ling for at-risk families. MDA basecamp and the drug counselling unit of Tyrol’s youth centre 
Z6 opened a cannabis phone hotline for parents. In Lower Austria, a hotline for relatives of 
drug addicts was established where anonymous, cost-free initial counselling may be ob-
tained (Hörhan, personal communication). In cooperation with Grüner Kreis, a booklet was 
published to support parents, families and young people with regard to early detection 
(Grüner Kreis 2006a). 
Socially disadvantaged persons as a specific target group are addressed by projects such 
as aXXept of Streetwork Vienna: this is a counselling and care project for members of the 
punk scene and other “socially deviant” groups that was established in the middle of 2005  
(FSW 2006a). Its objective is to reduce conflicts in public areas on the one hand and to im-
prove the social situation of the young people on the other. In Lower Austria, Streetwork 
Rumtrieb, in the context of its outreach work in socially disadvantaged neighbourhoods of 
Wiener Neustadt, particularly focused on girls in 2005. In the Streetwork centre, a regular 
girls’ afternoon was established, which serves as a basis for confidence-building and pro-
vides opportunities for intensive counselling talks and support in the case of specific prob-
lems. 
As far as prevention activities addressing immigrants are concerned, Supromobil of Vorarl-
berg cooperated with okay.zusammen leben (okay. living together) to prepare an information 
leaflet in Turkish and German about counselling services. The existing German language 
and orientation courses for immigrants, in the context of treating child-related questions, also 
offer counselling with regard to education problems and addiction behaviour. 
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Children in families with addiction problems are becoming more and more important as a 
focus of activity; however, many measures, e.g., the European network ENCARE, concen-
trate on children of alcohol-abusing parents. In June 2006 an expert meeting on this subject 
took place in Salzburg, which included information on and discussions of the theory and 
practice of prevention, also with regard to illicit drugs. In 2005 Supromobil, in cooperation 
with the outpatient family services, drew up the Kasulino programme for children in families 
with addiction problems. The children are supported in a closed group, where they may ex-
perience alternatives to the influence coming from their families and develop new perspec-
tives. Because of its good results the programme will be expanded. 
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4 Problem Drug Use 
Problem drug use here means the frequent use of hard drugs (in particular opiates and co-
caine), which is often accompanied by dependence and consequences for the health, social 
and legal situation of the consumers (see also Chapters 6 and 8). One has to bear in mind, 
however, that it is primarily patterns of use and not substances as such that are risky or safe. 
In addition, it is difficult to distinguish between experimental use and problem drug use 
(ÖBIG 2004). This problem is further aggravated by the fact that hardly any scientific analy-
ses of this aspect are available. 
In Austria, poly-drug use with opiates, often administered intravenously, has traditionally 
played a central role. In the past decade the range of substances consumed in the context of 
poly-drug use has widened. Intravenous use of cocaine has also become more relevant in 
the street scene (Chapter 12, ÖBIG 2001a). 
According to recent estimates, a prevalence rate of 25 000 up to a maximum of 32 000 prob-
lem opiate users, probably in the context of multiple drug use in the majority of cases, seems 
realistic for Austria. However, prevalence estimates of poly-drug use are difficult to give as 
methodological problems arise due to the complexity of the subject. Therefore the figures ob-
tained are conclusive to a limited extent only (ÖBIG 2003). Thus any results given are rough 
approximations and have to be interpreted with caution.  
4.1 Prevalence and incidence estimates 
In Austria scientific estimates regarding the prevalence of problem drug use are only avail-
able for opiates or poly-drug use with opiates. In the context of Austria’s monitoring project, 
the estimates that had so far been available until the year 2002 (ÖBIG 2003) were updated 
to include the years 2003 and 2004 (ÖBIG, under preparation). For the capture-recapture 
method, on which the prevalence estimate is based, data on substitution treatment and re-
ports to the police relating to opiates were used. The results of a complementing survey 
among physicians providing medically assisted treatment (see Chapter 4.2) were used to in-
clude a correction factor in the estimates in order to account for the share of ghost cases in 
the total of substitution patients registered. For the year 2004, a total number of 29 597 per-
sons is thus estimated (95% confidence interval: 27 763, 31 431), while, for instance, the cor-
rected estimate for 2001 is 17 750 (95% confidence interval: 16 620, 18 880). Figure 4.1 
gives the relevant age stratified estimates. An increase in prevalence rates of problem drug 
use with opiates is found especially in the age group between 15 and 24 years.  
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Figure 4.1: Results of prevalence estimates of problem drug use with opiates by means of  
2-sample CRC method, age-stratified, from 2001 to 2004 
 
Source: ÖBIG, under preparation 
The results of the 2-sample CRC estimates could mostly be verified for the years 2001 and 
2002 by means of 3-sample CRC estimates, which also included drug-related deaths (for 
2004 and 2005, the data on drug-related deaths, which are needed for the 3-sample CRC 
estimates of 2003 and 2004, have not yet been available). 
Because of methodological restrictions, all results based on the CRC method give approxi-
mate figures only. For instance, the estimated number of problem drug users may be biased 
as, for instance, not all persons reported to the police because of opiate offences are likely to 
be problem drug users, or because substitution treatment has become available to new 
groups of clients. Another uncertainty is accounted for by interactions between data sources 
(e.g., the fact that a person has been reported to the police may have an influence on the 
probability of substitution treatment). However, this bias cannot fully be taken into account in 
the context of 3-sample CRC estimates. According to Uhl and Seidler (2001), in the case of 
CRC estimates it is realistic to assume that the true figures lie somewhere between 50% and 
200% of the estimate. 
In addition, trends that have been observed with regard to the number of persons estimated 
may also be influenced by systematic changes in the sources of error. Assuming that the 
sources of error have not strongly changed in the period from 2001 to 2004, one may con-
clude that the number of problem drug users has risen. This conclusion is corroborated by 
the fact that the corresponding increase in the age group between 15 and 24 is significantly 
greater than in the other age groups, as Figure 4.1 shows. Another indication of a rise in 
problem drug use is that in recent years the number of drug-related deaths has been found 
to go up while the average age has fallen (see Chapter 6.1). At present, data from the treat-
ment sector, which are important for an assessment of the overall situation, are still lacking. 
The single fact that the number of persons undergoing substitution treatment has risen (see 
Chapter 4.2) does not tell whether this rise is due to growing numbers of problem users of 
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opiates or better availability of this type of treatment. Apart from the routine data sources 
mentioned, qualitative estimates at local level have repeatedly been made and also indicate 
a rise in problem drug use. For 2005, such estimates have been communicated by Upper 
Austria (Pro mente Oberösterreich 2006) and Burgenland (Dantendorfer 2005). 
Taking into account the data sources mentioned and based on the available data, it is fairly 
safe to assume a quantitative rise in persons showing problem patterns of drug use with opi-
ates. This trend should also be regarded in connection with the fact that a distinction be-
tween experimental use and problem drug use is becoming increasingly difficult. Further 
analyses (e.g., studies of the relevant scenes) are imperative for identifying causes and 
backgrounds on the one hand and for confirming the current trend estimates on the other. 
4.2 Main characteristics and patterns of use  
By the end of 2005 DOKLI, Austria’s nationwide treatment documentation system, was fully 
established. In the context of this documentation system, which has been established on be-
half of and financed by the BMGF, nationwide data on clients of drug help centres are cen-
trally collected in accordance with the documentation standards of the EMCDDA and ana-
lysed at the ÖBIG Institute. For further details see http://tdi.oebig.at. At present (August 
2006) a total of 179 drug help centres have contributed data to the DOKLI system. In 2007 
the first annual analysis of the data for 2006 will be made. As Austria has no uniform data 
collection system for the field of treatment, so far only few data of limited interpretative value 
are available.  
Recent data for Vienna coming from the BADO Basic Documentation compiled by the Vien-
nese working group on documentation are available for the year 2004 (IFES 2005b). The 
data that could be evaluated relate to a total of 3 614 clients who received counselling in one 
of the 27 drug help centres in Vienna in 2004. In this context, counselling is defined as a 
minimum of three contacts at intervals of no more than three months, or as inpatient treat-
ment. Regarding data quality, it should be mentioned that 2 892 sets of data had to be ex-
cluded as they were incomplete to an extent that made analysis impossible. Furthermore, the 
data sets that were actually used for analysis were also incomplete to varying degrees, 
therefore the total numbers to which the individual percentages relate are given in brackets in 
each case. The figures below only refer to clients of drug help centres, therefore they are 
valid only with regard to those persons with drug problems who have actually turned to the 
drug help system. 
28% of the clients receiving counselling were women (n = 3 477). 48% were between 21 and 
30 years old, 18% were under 21, 24% were between 31 and 40, and 10% were over 40 
(n = 3 488). While 24% of the female clients were under 21, the share of men in this age 
group was only 14%. 26% of the clients had one or more children (n = 1 682).  
The data on patterns of use confirm the indication that multi-drug use with opiates dominates 
among those persons with drug problems that have been registered in the treatment system 
of Vienna. The analyses on the current form of application have yielded interesting results: 
according to the data from 2003, surprisingly, the most frequent application route of heroin 
was indicated to be nasal, which was found again in the data from 2004. 53% out of 625 her-
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oin users indicated nasal use in the past 30 days before the start of counselling. 42% said 
they had injected heroin and 5% had smoked heroin, while indications of oral use were not 
found. In this regard, further analyses would be necessary in order to find out whether snort-
ing is typical of the initial stage of heroin use and if the respective persons will turn to i.v. use 
later, or whether there are exclusive heroin snorters. Other opiates and substitution sub-
stances were injected by 33% of users, snorted by 1%, and used orally by 65% (n = 551). In 
the case of cocaine, the share of i.v. users was 47% (nasal use: 51%; smoking: 2%; n = 
509). Amphetamines were used intravenously by 7%, nasally by 53%, and 40% indicated 
oral use (n = 58). 
44% of the clients had turned to a drug help centre for the first time, and 56% of them had al-
ready received drug treatment and care at such a centre at least once in the past (n = 1 826). 
40% were undergoing substitution treatment (n = 2 264). The figures given approximately 
correspond to the results of the BADO evaluations of 2002 and 2003 (IFES 2003, IFES 
2004b).  
National monitoring of substitution treatment is performed by the BMGF and based on the 
reports of attending doctors. Although these reports are not always complete and frequently 
not provided in due time (see ÖBIG 2003), they still give a general impression of both quanti-
tative developments and characteristics of clients. Currently efforts are being made by the 
BMGF to improve the monitoring system. 
A central problem of the current monitoring of substitution treatment is that physicians often 
do not report the end of treatment. As a consequence the corresponding clients are still reg-
istered in the statistics as persons undergoing substitution treatment several years after the 
actual end of treatment (ghost cases). This error, which accumulates over the years, consti-
tutes a massive problem in particular for estimates of prevalence rates. In order to assess 
the magnitude of this error (and to permit a statistical correction of the prevalence estimates), 
in 2005 the physicians registered as currently providing substitution treatment to a random 
sample of 600 clients were interviewed with regard to the actual treatment status of those cli-
ents. The share of ghost cases identified in this way amounted to approximately 35%, and a 
strong correlation between duration of treatment and share of ghost cases was found. For in-
stance, the share of ghost patients in persons registered as undergoing treatment for no 
longer than two years was only 3%, compared to 55% in the case of persons for whom sub-
stitution treatment for 6 to 10 years was reported, and 70% for persons registered as under 
treatment for over 10 years (ÖBIG, under preparation). 
The increasing acceptance of, and resort to, substitution treatment is reflected in the annually 
rising number of persons reported as currently undergoing substitution treatment. The num-
ber of first treatments (number of clients reported as undergoing substitution treatment for 
the first time in life) slightly rose in 2005 compared to the year before (see Figure 4.2). 
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Figure 4.2: Development of annual registrations of persons currently undergoing substitution treatment 
in Austria by first treatment and continued treatment, from 1996 to 2005 
 
Note: Continued treatment means treatment started before the respective year or repeated treatment of persons having un-
dergone substitution treatment in the past. First treatment means treatment of persons who have never been in substitu-
tion treatment before. 
Sources: BMGF, calculations by ÖBIG 
 
Figure 4.3 (see following page) shows that the rise in first treatments in recent years has 
primarily been accounted for by the age group up to 19 and the group between 20 and 24. 
From 1995 to 2000 the share of these two groups was between 35% and 40%, continuously 
rising since then to 54% in 2003. In 2005 it was 51%. 
On the one hand this rise may indicate easier access to substitution treatment for young opi-
ate users. On the other, it may also point to an increase in prevalence rates of (poly-)drug 
use with opiates (see Chapter 4.2). What is also interesting in this connection is that the rise 
in first treatments considerably differs according to region. For instance, in recent years in-
creases have been registered in Carinthia and Vorarlberg, while Styria and the Tyrol report 
declines (BMGF, calculations by ÖBIG, see Table A21 in Annex A). 
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Figure 4.3: First substitution treatment in life by age, from 1996 to 2005 
 
Sources: BMGF, calculations by ÖBIG 
Gender-related analyses show that the share of women in persons undergoing substitution 
treatment for the first time has been between 25% and 35% over several years (2005: 26%). 
In 2005, as in previous years, the share of women in the group under 20 undergoing treat-
ment for the first time (40%) was markedly higher than in any other age group. In the older 
age groups men clearly predominate. The fact that the share of women undergoing substitu-
tion treatment has been found to be higher among young age groups is in line with similar 
observations reported by BADO (Vienna) and also with regard to drug-related deaths. It is 
the subject of further studies currently undertaken in the context of an EMCDDA project by 
Austria, the Czech Republic, Greece, the Netherlands and Switzerland. 
In recent years qualitative reports from a few provinces have indicated a possible abuse of 
slow-release morphines in the context of opiate use (e.g., Zeder, personal communication; 
Neubacher, personal communication). The available data do not permit a quantitative as-
sessment of this problem at present. According to reports from Graz there is a certain scene 
using Ritalin intravenously, however, this has turned out to be a local phenomenon (Zeder, 
personal communication). 
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5 Drug-Related Treatment  
Austria attributes great importance to a diversification of the available treatment options. As a 
result, in the past decade the inpatient sector saw a development from long-term to short-
term treatment and generally, to more flexibility with regard to possible kinds of therapy, for 
instance in the form of modular systems. This more flexible approach aims at taking individ-
ual needs into account to a greater extent. The trend towards diversification also shows in 
the field of substitution treatment, where a number of different substitution substances may 
be prescribed. In quantitative terms, substitution treatment has become the most important 
form of therapy in Austria, and efforts to improve it have continuously been made (see Chap-
ter 4.2). 
Drug-specific counselling, care and treatment services are provided both by specialised cen-
tres and in the context of the general health care system (e.g., psychiatric hospitals, psycho-
social services, established physicians). Established primarily in the outpatient sector but in-
creasingly often also for inpatients, they include measures oriented towards drug-free treat-
ment as well as substitution treatment, therefore they can be classified to a limited extent 
only. As the general aim is to build a comprehensive care network, most centres also provide 
a variety of preparatory and aftercare measures as well as recreational and reintegration 
services (see Chapter 9.1) and also measures for specific target groups (e.g. young people 
or persons with psychiatric comorbidity). The services mentioned in this report are described 
in more detail on the web sites as well as in the annual reports and newsletters of the indi-
vidual centres (see Bibliography). 
5.1 Treatment system 
By now Austria’s network of drug-related assistance, care and treatment centres is almost 
nationwide (see Maps 5.1 and 5.2). As already mentioned in previous reports, there are still 
waiting lists, and waiting times have to be accepted before assistance services or treatment 
can be started  (ÖBIG 2004, ÖBIG 2005a). There are provinces where the waiting time for 
the first counselling talk is even up to five weeks. One reason for this seems to be the current 
examination practice to refer persons to counselling without necessity, which is reflected in 
rather high shares of persons receiving counselling for a short time. For instance, Salzburg 
reports that the number of concluded counselling cases is continually rising compared to the 
overall number of person receiving counselling in drug help centres. In 2005, six to seven out 
of ten cases were concluded v. only between four and five out of ten cases in 2000 (Dro-
genkoordination des Landes Salzburg 2006). Another reason is that rising numbers of substi-
tution patients contact counselling centres in the context of accompanying psycho-social 
measures. This has been reported from Styria, among other provinces. In addition, the rising 
trends in drug use (see Chapter 4.1) will also show effect in this regard.  
In the reporting period, the existing services were both expanded and more specifically ori-
ented towards the respective target groups. For instance, in 2005 the association Dialog (Vi-
enna) opened the Dialog 10 counselling centre, whose services include a focus on young  
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drug users (see Chapter 11.5). On the one hand, appointments for counselling may be 
made, and on the other, open services are offered, in particular for opiate addicts whose 
situation in life makes it difficult for them to stick to fixed dates. Another new service of Dia-
log’s is acupuncture, which is especially useful for clients who want to undergo withdrawal. 
Lower Austria meanwhile has completed the expansion of seven centres as planned, i.e., in 
each district or for every 50 000 inhabitants, respectively, one full-time staff (30 hours social 
work, 5 hours medical treatment, 5 hours psychotherapy) has been employed (Hörhan, per-
sonal communication). Since July 2005, Grüner Kreis offers cost-free addiction counselling at 
the offices of Lower Austria’s Public Employment Service (Grüner Kreis 2006b). The ques-
tion to what extent young people and children may find support on a peer basis was dis-
cussed in an expert meeting initiated by Supromobil and Club Antenne, a peer support ser-
vices and contact centre in the province of Vorarlberg, and held at the therapy department 
Carina (Vorarlberg) in December 2005. Based on the results of this meeting, special services 
will be developed. Burgenland is expanding its services of home visits by medical specialists 
(Dantendorfer 2005). 
Activities to integrate gender mainstreaming in drug-related work have also been continued 
(see Chapter 12). February 2006 saw the start of the preparation of guidelines for gender-
specific drug help work, based on a survey of existing gender-sensitive and gender-related 
services and interventions in Vienna’s drug help centres. Dialog introduced a men’s group 
under the title 4men, which addresses individual male substitution patients aged 20 or older. 
Its aim is that the participants join forces to find coping strategies and ways of establishing 
daily structures. The Drug Counselling Centre of the Province of Styria organised a new 
women’s group (see Chapter 9.1). As the group members said they preferred better continu-
ity, since the beginning of 2006 regular group meetings have been held once a month. 
In order to assure the quality of addiction help services, corresponding guidelines were 
drawn up and further training courses were organised in the reporting period. For instance, a 
guide to the medical treatment of patients with substance-related addictions was issued as a 
reference book for established doctors in Styria, covering the relevant theories, substances 
and treatment options (Ederer, personal communication). Early in 2006 ChEck iT!, in coop-
eration with other drug service providers, drew up standards for online counselling that are 
available on the Internet (www.e-beratungsjournal.net) and as a booklet. They include both 
basic know-how of online counselling and motivational interviewing as a useful approach for 
this purpose as well as concrete guidelines for actions in the context of practical implementa-
tion. Lower Austria is preparing a quality assurance programme for drug help centres 
(Hörhan, personal communication). In November 2005, the Austrian Association of Experts 
in the Field of Drugs (ÖVDF) organised an event under the heading Drug-using young peo-
ple between adjustment, downfall and exclusion, which aimed to communicate approaches 
to action as well competences so as to facilitate dealing with this theme. A symposium of the 
Maria Ebene foundation of Vorarlberg, also held in November 2005, focused on addiction 
and immigration, i.e., the specific situation of young immigrants and the resulting opportuni-
ties and problems of inpatient drug treatment. An additional workshop provided an opportu-
nity for an exchange of experience regarding treatment of and care for drug-addicts from 
immigrant families. It has shown that these services have to take into account the clients’ 
special situation as immigrants. The Lukasfeld therapy department reports good results re-
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garding the integration of addicted patients whose families come from Turkey or former 
Yugoslavia. 
ASBO, a new transboundary Interreg III A project of the European Union that focuses on 
acute treatment of addiction patients in the Bodensee region (bordering Austria, Germany 
and Switzerland) is aimed at linking and comparing the treatment services in the Alpenrhein-
Bodensee-Hochrhein region in order to derive best practice models. In this context two ad-
diction dialogue events were held in the first half of 2006, in which the participating service 
providers from the Bodensee region exchanged their experience of withdrawal treatment on 
the one hand and comorbidity of addiction and other psychological diseases on the other. 
The first Austrian addiction aid fair held in autumn 2005 also focused on networking. Here, 
mostly inpatient treatment centres presented their services. 
5.2 Drug-free treatment 
No relevant changes took place in the field of drug-free treatment. In Austria withdrawal 
treatment is mostly carried out in inpatient departments, but more and more often also in 
outpatient settings. Generally, the trend towards more flexible programmes of differing dura-
tion has continued in Austria. The waiting times for admission to inpatient therapy are be-
tween 10 and 100 days (Suchthilfekompass/Austrian Addiction Help Compass). 
The Erlenhof treatment centre, in cooperation with the local and district governments, devel-
oped a programme for addicted mothers with children. However, it turned out that many 
mothers were only ready to start treatment after their children had been placed in care by the 
youth welfare departments, or did not turn to drug help centres because they feared that their 
children might be taken away from them (pro mente Oberösterreich 2006). In the context of 
the 2005 Quality Assurance Initiative, the therapy department Carina (Vorarlberg) started to 
implement a standardised clinical and psychological admission diagnosing system (see 
Chapter 7.3), which systematically records the quality of the results of treatments that are 
concluded as planned and which collects discharge diagnoses and catamnestic data on 
treatments concluded as planned in a standardised way. The stage of developing and testing 
the admission diagnosing system has been finished, and it has been integrated in the treat-
ment process as of the beginning of 2006. Analyses made so far show that 85% of the pa-
tients interviewed said that the treatment had been successful or very successful and that 
they were satisfied or highly satisfied with the treatment they had just concluded (Stiftung 
Maria Ebene 2006). 
A study on quasi-compulsory treatment carried out in Vienna showed that the corresponding 
treatment was successful both among volunteer patients and persons who had undergone 
treatment in the context of the therapy instead of punishment approach (Trinkl and Werden-
ich 2006; see Chapter 12.1). 
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Map 5.1: Specialised providing treatment, counselling and care services for drug users and drug patientscentres
2 Number of centres (to the right of the symbol) if more than
one centre of the category in question is available in one district
Inpatient centres for short-term treatment
Inpatient centres for physical withdrawal
Outpatient drug centres and departments
Low threshold centres
Counselling centres
Outpatient counselling centres (open less than 15 hours/week)
Inpatient centres for long-term treatment
Therapeutic centres in prison
(Sopron/
Hungary)
Note:
The map provides an overview of selected drug-related centres, broken down by district. The map does not specify quantitative and qualitative aspects (i.e., opening hours or number and qualification
of personnel, respectively). However, a distinction was made in the field of counselling, which is frequently provided by general centres covering a broader range of services (psychosocial counselling
centres, addiction counselling centres, etc.) though limited to a few hours a week. Specialised drug counselling centres with limited opening hours have been listed seperately (see legend). Please no-
te that in addition general services (e.g., general practitioners, hospitals) are available for drug users and addicts - they are not included in this map.
Source: ÖBIG - based on information by the Drug Coordinators and Drug Representatives as of August 2006
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Prevention of infectious diseases - testing and vaccination
Outreach work (Streetwork, bus, connection services, mobile youth work, etc.)
Housing for former drug addicts - aftercare (HalfWayHouse, housing communities, etc.)
Housing for drug addicts (temporary sleeping facilities, etc.)
Occupation projects for drug addicts (low threshold)
Occupation projects for former drug addicts (aftercare, reintegration, etc.)
Prevention of infectious diseases - syringe exchange and distribution
Outpatient psychotherapy for drug addicts
2 Number of services (to the right of the symbol) if more than
one service of the category in question is available in one district
Map 5.2: Specialised treatment, counselling and care for drug users and drug patientsservices
Note:
The map provides an overview of selected drug-related services, broken down by district. The map does not specify quantitative and qualitative aspects (i.e., opening hours or number and qualificati-
on of personnel, respectively). It distinguishes between kinds of service and not centres (see Map. 5.1), therefore a single centre can appear in several categories. Please note that general services
(e.g., the public employment service or emergency shelters) are also available for drug users and addicts - they are not included in this map.
Source: ÖBIG - based on information by the Drug Coordinators and Drug Representatives as of August 2006
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5.3 Medically assisted treatment 
Based on the results of the working groups that have met in recent years, two decrees laying 
down the future framework of medically assisted treatment were drafted in the reporting pe-
riod (ÖBIG 2004, ÖBIG 2005a; see Chapter 1.1). Their objective is to optimise substitution 
treatment, however, several of the amendments proposed have given rise to controversial 
debates among experts. What they primarily demand is that adequate transitional provisions 
be adopted and, in part, also that slow-release morphines continue to be available for substi-
tution treatment. 
The amendments to and new provisions of the Decree on Narcotic Drugs that have been 
planned include especially careful diagnosing before substitution substances are prescribed 
to young people and to patients addicted to opiates for a short time only, and in addition, 
methadone and buprenorphine are to be prescribed primarily, while other substances such 
as slow-release morphines should only be administered if the former two substances are 
contraindicated. As a rule, patients will have to take their daily doses of substitution medicine 
under supervision, and exceptions will be granted only to a very limited extent, and particular 
restrictions apply if slow-released morphines are used. In future, all prescriptions will have to 
be authorised by public health officers, who will also be in charge of checking the qualifica-
tion of attending doctors and the conformity with the Decree of indications and treatment de-
cisions. 
The draft of the Oral Substitution Further Training Decree (ÖBIG 2005a, Chapter 1.1) pro-
vides that in future only physicians with special qualifications be authorised to practice in 
substitution treatment programmes. The required further training is to be ensured by the Aus-
trian Medical Association, in cooperation with medical universities and other organisations. 
The training scheme envisaged would consist of a basic training module (40 lessons) plus 
additional further training (6 lessons per year on an average within a period of three years). 
20 lessons of the basic module may be studied via e-learning. The qualification licence would 
have to be submitted to the district authorities, which will have to maintain a list of doctors 
qualified to practise in substitution programmes. Entries in the list would be valid for three 
years, and 3 months before the end of this period, an extension would have to be applied for. 
Transitional provisions are planned for persons who have been working in the field of medi-
cally assisted treatment for a long time already. 
Styria reports insecurity among both attending doctors and addiction patients due to the de-
lays and the unclear situation regarding the planned modification of the legal framework. In 
Salzburg, the system of branch offices of established physicians in drug counselling centres 
was further developed in the reporting period (Drogenkoordination des Landes Salzburg 
2006, ÖBIG 2005a), and the Working Group on Substitution decided to retain the three-stage 
model of substitution treatment (ÖBIG 2005a). Lower Austria’s substitution model for the dis-
trict of Sankt Pölten Land is successfully being implemented and will also be introduced in 
the district of Bruck an der Leitha (Hörhan, personal communication; ÖBIG 2005a). In Bur-
genland the substitution programme was expanded in the reporting period, and regional 
quality circles were established for this field (Dantendorfer 2005). In Vorarlberg’s H.I.O.B. low 
threshold centre the Intensive Care Substitution programme was introduced in late 2005, 
which provides a wide range of enhanced assistance services (Neubacher 2006). In the cen-
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tre, substitution substances may be obtained, and care and medical treatment are also pro-
vided there so that addiction patients with above-average treatment needs (e.g., persons 
showing risky patterns of use also of other substances) may be stabilised to a degree neces-
sary for standard substitution treatment. In the majority of cases, methadone and buprenor-
phine are administered, while slow-release morphines are prescribed in justified exceptional 
cases only. The substitution substances are dispensed on a daily basis and taken under su-
pervision, which also permits interventions if acute problems show. Additional use of other 
problem substances is tolerated but this issue is regularly addressed. The treatment goal and 
the current situation of the patients are discussed in weekly team meetings, and in part also 
with the patients concerned. The services offered include controlled outpatient withdrawal 
from benzodiazepines over a period of several months. The good results of this programme 
are also reflected in the fact that around half of the patients treated have applied for further 
treatment measures or withdrawal. In a number of drug help centres such as Clean Feldkirch 
(Vorarlberg), substitution substances may be dispensed to patients to take away only after a 
written application and if authorisation by a public health officer has been obtained (Stiftung 
Maria Ebene 2006). Since this time, the pertinent requests by patients have significantly 
gone down. 
In 2005, as in the previous year, the discussion of amendments to the Substitution Decree 
(ÖBIG 2005a) have had considerable effects all over Austria on the number of new substitu-
tion patients (see Chapters 4.2 and 5.1). The share of first treatment patients who are pre-
scribed methadone has gone up to 42%, while prescriptions of slow-release morphines have 
declined to 23%. The number of patients treated with buprenorphine and codeine has hardly 
changed, or remained the same (33% and 2%, respectively). 
Figure 5.1: Development of kinds of substitution substance used for first treatment,  
from 1998 to 2005 
 
Sources: BMGF, calculations by ÖBIG 
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Data from Salzburg on the age-related distribution of substitution substances show that slow-
release morphines are primarily prescribed to older addiction patients, while buprenorphine 
and codeine are more often administered to young drug patients (Drogenkoordination des 
Landes Salzburg 2006). 
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6 Health Correlates and Consequences 
The Ministry of Health has collected data on drug-related deaths in Austria since 1989. After 
the mid-1990s (see Table 6.1 on the following page) the overall number of directly drug-
related deaths went down temporarily. In recent years, however, a rise has again been regis-
tered (see ÖBIG 2006b). 
Infectious diseases are relevant in particular with regard to the risk of transmission due to in-
travenous drug use. The available data in this context are based on a few small samples 
from treatment institutions or low-threshold centres (see ÖBIG 2000). While the HIV preva-
lence rate still was around 20% at the beginning of the 1990s, it has remained at a low level 
since then (3 to 6%). However, the prevalence rate of hepatitis C is very high: the shares re-
ported have remained between 50% and 80% in the case of hepatitis C and around 30% for 
hepatitis B. 
Psychiatric comorbidity has increasingly often been discussed in the context of drug depend-
ence in Austria. Although no routine data have been collected in this field, many data and re-
ports from the treatment sector are available. These data indicate a high prevalence of psy-
chiatric comorbidity (dual diagnoses) among problem drug users (see ÖBIG 2003).  
6.1 Drug-related deaths and mortality of drug users 
Regarding drug-related deaths, a distinction is made between deaths directly caused by drug 
use and indirectly related deaths1. In a number of countries, also Austria, the sum of directly 
and indirectly drug-related deaths was reported as the number of drug-related deaths for a 
long time. However, after intensive discussions of this issue at international level, for in-
stance, in the context of EMCDDA projects, now all countries of the European Union only re-
port directly related deaths with regard to the indicator of drug-related deaths. The reasons 
for this include that it is highly problematic to add direct and indirect deaths because this 
mixes up different indicators. In the case of indirectly related deaths, drug use has taken 
place a long time ago (for instance, in the case of persons who died of AIDS and had con-
tracted HIV because of drug use). Often, these deaths are not necessarily related to current 
drug consumption. Another reason is that in most cases, these fatalities are assumed to be 
indirectly drug-related on the basis of conclusions that cannot be corroborated by direct data, 
1 In the case of directly drug-related deaths, a direct causal relationship between death and the consumption of drugs of abuse 
may be assumed. Different to indirectly drug-related deaths, an acute intoxication with a drug of abuse is the cause of death. 
This definition corresponds to the definition of drug-related deaths by the European Monitoring Centre of Drugs and Drug Ad-
diction (EMCDDA)  
 In the case of indirectly related deaths, death has not been caused by an acute intoxication with a drug of abuse. However, 
because of the patient’s history of drug use, her/his death may be related to drug consumption. According to the definition by 
the EMCDDA, indirectly drug-related deaths include death caused by diseases that may be related to drug use such as AIDS if 
the HIV infection has been brought about by intravenous drug use, accidents under the influence of drugs or suicides of drug 
addicts (excluding overdoses), among other causes. The causal relationship between drug use and death is indirect only and 
assumed on the basis of conclusions (ÖBIG 2006b) 
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and not even indirect causal relations between drug use and death can safely be estab-
lished. In addition, the pertinent data are incomplete to large degrees because, for instance, 
if death has been caused by a secondary disease (e.g., hepatitis) that results from intrave-
nous drug consumption, this fact may be overlooked so that the case in question is not re-
ported as a possible indirectly drug-related fatality. The subject of indirectly related deaths is 
treated in more detail in Chapter 6.4. 
In 2005 the number of directly drug-related deaths rose to 191 (2004: 185 cases, see Tables 
A3 and A4 in Annex A; ÖBIG 2006a, ÖBIG 2006b). In 25% of these cases, the toxicological 
analyses revealed only illicit substances (one drug or a combination of several drugs). In ad-
dition, psychoactive substances were found in 39% of the cases, 15% had also used alcohol, 
and 20%, both substances, i.e., alcohol and psychoactive drugs (see Tables A6 and A7 in 
Annex A). As in the past, poly-drug intoxications with opiates predominate (79% of all intoxi-
cations with known substances; see Figure 6.1). The share of persons who had exclusively 
taken opiates (18%) has slightly gone down compared to the previous two years (2001 and 
2002: 12%; 2003: 25%; 2004: 22%). Patterns of multiple drug use, where the effects of dif-
ferent substances may be potentiating and thus can hardly be controlled, continue to be 
wide-spread and constitute serious health hazards. 
Figure 6.1: Number of directly drug-related deaths in Austria by cause of death, from 1996 to 2005 
 
Source: ÖBIG 2006b 
Until 2002 the average age of persons who died as a direct consequence of drug use was 
rising. Since 2003, the grouped median has become smaller1, and was 25.9 years in 2005. 
The share of persons under 20 slightly rose in 2004, but in 2005 (15%) it was at a level simi-
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lar to the preceding years (2002: 13%; 2003: 12%; 2004: 22%; see Figure 6.2). The share of 
persons between 20 and 24 years was 25%, which corresponds to the average shares in the 
past few years (2002: 14%; 2003: 23%; 2004: 22%). The share of women in directly drug-
related deaths, i.e., 23%, is in line with the long-term average. 
Figure 6.2: Age distribution of directly drug-related deaths in Austria, from 1996 to 2005 
Source: ÖBIG 2006b 
In 2005, the greatest number of acute drug-related deaths was registered in the province of 
Vienna, which is not surprising as drug problems tend to be more acute in and around larger 
cities. In Vienna, 8.2 cases of directly drug-related deaths per 100 000 inhabitants aged be-
tween 15 and 64 were counted in 2005 (see Tables A4 and A7 in Annex A). The Tyrol 
ranked second, with 3.6 deaths per 100 000 inhabitants (ÖBIG 2006b). 
In the reporting year the places where the persons concerned had died were systematically 
recorded for the first time. This provides important information on locations where fatal over-
doses typically occur. It has shown that the majority of directly drug-related deaths (i.e., 81%) 
occur in private apartments. An explanation for this is that a large part of high-risk drug use 
takes place in seemingly safe, private contexts, which, however, may mean that in the case 
of intoxication help is not available quickly enough so that the risk of fatal overdoses is ele-
vated. In addition, analyses were made of diseases other than addiction that were diagnosed 
in persons who had died as a direct consequence of drug use (see Chapter 6.4). 
Any changes in the number of directly drug-related deaths have to be interpreted with cau-
tion because their numbers are small in a statistical sense, and they must not be regarded as 
indicators of the development of the drug situation as such. However, as the number of di-
rectly related deaths has risen three years in a row, and taking into account that the average 
age has gone down, it is plausible to assume that the situation regarding directly drug-related 
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deaths has worsened. For this reason, specific health policy measures for risk minimisation 
should be considered. 
6.2 Drug-related infectious diseases 
Recent data from a number of low-threshold centres and inpatient departments (see Table 
6.1) point to hepatitis B (HBV) infection rates ranging from 0% to 28%. The prevalence rate 
of hepatitis C (HCV) infections seem to have balanced out at a level between 50 and 60%, 
as this year’s data hardly differ from the figures of the past few years. 
Table 6.1: Data on hepatitis B, hepatitis C and HIV infection rates in 2005 
Data source HBV rate HCV Ab rate1 HIV rate 
Lukasfeld therapy department  16% (5/31)2 55% (17/31)  0% (0/31) 
API long-term therapy department  0% (0/58)3 59% (34/58)  0% (0/58) 
Low-threshold centre Ganslwirt  28% (22/80)4 49% (45/92)  3% (5/163)  
Caritas Marienambulanz outpatient department  22% (21/94)5 49% (47/96)  0% (0/89) 
Drug outpatient department of General Hospital Vienna n.a.  49% (48/97)  2% (2/97) 
Drug-related deaths (intoxications) in 2004 4% (7/185) 23% (42/185)  5% (10/185)  
Drug-related deaths (intoxications) in 2005 n.a.  32% (61/191) 6
48% (61/127)6
7% (14/191)6
12% (14/118)6
1 These prevalence rates relate to persons in whom HCV antibodies were found, and not to HCV-PCR tests, which permit a di-
rect detection of the virus. 
2 This percentage relates to persons in whom antibodies to hepatitis B were found and whose medical history did not indicate a 
hepatitis B vaccination. 
3 This percentage relates to persons in whom antibodies to hepatitis B were found and for whom it was proved that they had not 
received vaccinations or been cured. 
4 This percentage relates to persons in whom hepatitis B antibodies or antigens were found and who had not yet received hepa-
titis B vaccinations (data obtained from Ganslwirt’s vaccination project). 
5 Positive test results only refer to HBV sAb positive and not to anti-HBs positive results. 
6 Only 127 and 118, respectively, out of a total number of 191 expert opinions on directly drug-related deaths explicitly men-
tioned the presence or absence of HCV and HIV infections. In the case of the remaining 64 cases it is not clear whether no 
tests for the relevant infections were carried out or whether the results were negative and thus not mentioned. The two per-
centages given thus indicate maximum and minimum levels of HCV and HIV infection prevalence rates. 
Sources: Duspara, Stolz-Gombocz, Haltmayer, Anderwald, Fischer: personal communication; ÖBIG 
2006a, ÖBIG 2006b, see also Standard Table 9 
A comparison of these prevalence data over several years shows that the figures reported by 
the individual centres tend to show smaller differences than in previous years. The centres 
continue to register low HIV prevalence rates between 0% and 5%, but the expert opinions 
on drug-related deaths have again revealed prevalence rates of more than 10% after many 
years. This is especially relevant as those findings relate to an independent sample, so one 
can be sure that incidence and prevalence rates have been kept apart. This trend confirms 
assumptions held in previous years that new HIV infections among intravenous drug users 
were rising (see ÖBIG 2004, ÖBIG 2005a). The forensic expert opinions on directly drug-
related deaths also indicate that 4 out of 14 persons with HIV infections had already had 
AIDS symptoms.  
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Again, reliable statements on developments and trends cannot be given due to the small 
number of data sources. Since January 2006, data on drug-related infectious diseases have 
been collected in the uniform documentation and reporting system of clients of Austrian drug 
help centres (DOKLI), therefore, as of 2007 additional information from the treatment sector 
will be available (see Chapter 4.2). 
In the reporting year, prevalence rates based on HCV-PCR tests were available for the first 
time, which provide better information on chronic developments than HCV antibody tests 
(HCV Ab). The corresponding data from the low-threshold settings of the Caritas Marienam-
bulanz outpatient department and the drug outpatient department of the General Hospital Vi-
enna show that more than half of HCV-Ab positive patients also had positive PCR results  
(47 out of 96 and 48 out of 97, respectively), while the corresponding percentages are lower 
in the treatment sector (Lukasfeld: 7 out of 31; Anton Proksch Institute: 10 out of 58). Re-
garding HCV genotype tests, hardly any data are available as yet. Innsbruck reports that in 
54% of HCV positive patients genotype 1 was found, and in 38%, genotype 3 (Vogel 2005). 
The data from Vienna’s BADO basic documentation system show an age-related trend re-
garding HIV and HCV infections: in the group between 16 and 20 years, 14% of patients in-
dicated HCV infections, with this share rising to 23% already in the age group between 21 
and 25, and eventually, 37% of persons aged between 26 and 35 indicated diagnoses of 
hepatitis C. Regarding HIV infections, a marked rise shows especially in patients of 30 years 
or older, namely from between 2% and 3% to between 7% and 9% (IFES 2005b, see Chap-
ter 4.2). 
According to experts, TB infections still hardly constitute a problem in Austria, as only a few 
isolated cases have been registered. The data of BADO (Vienna) give prevalence rates for 
sexually transmitted diseases among drug-using clients of less than 1% (see Table 6.2, IFES 
2005b).  
6.3 Psychiatric comorbidity 
As already described in the reports of past years (see ÖBIG 2004, ÖBIG 2005a), high preva-
lence rates of psychiatric comorbidity (dual diagnoses) show among problem drug users. Al-
though no nationwide routine data are available, the individual institutions direct more and 
more attention to this problem in the context of clinical psychology diagnosing. 
52 out of 58 persons newly admitted to the Anton Proksch Institute (API) took part in clinical 
psychology examinations. 6 of these patients were under 19 years old. In 30% of the patients 
over 19, at least one personality disorder according to DSM IV was diagnosed, and in 43%, 
two or three disorders were found. The most frequent diagnosis is antisocial personality dis-
order (34%), starting before the age of 15, followed by borderline personality disorder (24%). 
Furthermore, narcissistic, dependent, avoidant and histrionic personality disorders were di-
agnosed, while obsessive-compulsive or paranoid personality disorders play insignificant 
roles (API 2006). According to Carina (Vorarlberg), almost 54% of patients, besides addic-
tion, also suffered from an additional psychiatric disease, in particular personality disorders 
and drug-induced psychoses, and in more than 35% of patients, two or more psychiatric dis-
eases were diagnosed (Stiftung Maria Ebene 2006). These observations correspond with re-
ports from the BBZ counselling and care centre in Vienna (Dialog 2006). 
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As in past years, around 20% of clients of drug help centres in Vienna (see Chapter 4.2) in-
dicated that they had undergone psychiatric treatment within the last 12 months before the 
start of drug counselling. 56% of these clients said they had received outpatient treatment, 
and 53%, inpatient psychiatric treatment. In this regard, no gender-related or age-related dif-
ferences can be identified, with the exception that in the age group over 40, the share of psy-
chiatric patients is significantly elevated (IFES 2005b). 
6.4 Other drug-related health correlates and consequences 
In addition to psychiatric comorbidity and the health consequences of the aforementioned in-
fectious diseases, there are also other somatic diseases and problems resulting from chronic 
effects of toxicosis or from the precarious living conditions which particularly i.v. drug users 
often face. 
For the first time, the forensic expert opinions on drug-related deaths have systematically 
been analysed with regard to other health correlates and consequences. The relevant find-
ings range from mild, reversible organic diseases to acute life-threatening conditions. For 
120 out of a total of 191 directly related deaths, expert opinions that include diseases other 
than addiction are available. In 38% of the cases one organ was found to be affected; dis-
eases of two or three organs were found in 68 persons; and 14 persons had diseases of 
more than four organs. 
In the majority of expert opinions, i.e., 100 opinions, liver diseases were diagnosed. 10 per-
sons had already developed cirrhosis. In 69 cases heart problems were found, with diagno-
ses ranging from fatty or fibrous degeneration, cardiac scars, infarction scars due to coronary 
sclerosis to myocarditis and cardiovalvulitis. In 32 persons, lung diseases were found, with 
the most frequent diagnoses including pulmonary emphysema and anthracosis. 17 opinions 
mention renal problems, and 12 autopsies showed pancreas diseases. 17 persons had suf-
fered from atherosclerosis, i.e. plaque in the inner artery linings, possibly caused by chronic 
effects of toxins. Cerebral neurological problems are described in 7 expert opinions. 18 opin-
ions, in addition to organic diseases, mention life-threatening conditions such as septicae-
mia, severe pneumonia or cachexia. In the case of these diseases, the patients’ tolerance to 
narcotic drugs is significantly reduced so that doses they would normally tolerate may al-
ready have fatal effects (see ÖBIG 2006b). 
In 2005 a total of 36 fatalities were identified as indirectly related to drugs. The majority of 
these cases (18 persons) died of diseases such as myocarditis or cirrhosis. Seven persons 
died in accidents, and seven committed suicide. Two indirectly drug-related deaths were at-
tributed to HIV infections resulting from intravenous drug use, and two cases were accounted 
for by other causes. 
According to the statistics of BADO (Vienna) 59% of the patients registered said that they 
were suffering from health problems. Compared to the previous two reporting years, a 
downwards trend shows. In particular, indications of current diagnoses of hepatitis C in the 
case histories have fallen from 42% in 2002 to 30% at present (IFES 2005b). Table 6.2 gives 
a more detailed list of the relevant diseases according to age and gender. 
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Table 6.2: Current health problems by age group and gender (percentages) 
(n = 1 700), clients of the year 2004 
Age groups 
Total Men Women < 15 16–20 21–25 26–30 31–35 36–40 > 49
Current health problems 59 58 60 14 47 57 61 65 74 77 
Chronic hepatitis C 30 30 29 3 14 23 37 41 51 45 
Dental problems 19 20 16 – 13 19 21 23 23 27 
Gastrointestinal problems 11 11 11 – 9 12 11 10 12 17 
Psychiatric diseases 9 8 12 3 7 10 9 9 11 12 
Dermatological and venous prob-
lems 7 6 8 – 4 6 8 8 11 13 
AIDS, HIV infection 4 3 5 – 1 3 2 7 9 7
Spasms, epileptic seizures 5 5 6 – 6 5 7 3 4 4
Chronic hepatitis B 4 4 3 3 2 2 4 4 6 10 
Chronic ill health 1 1 1 – – 1 * 2 4 2
Gynaecological problems 2 * 8 – 4 4 2 2 3 1
STD (sexually transmitted dis-
eases) * * 1 – * * 1 * 1 1
Other health problems 9 8 12 7 9 9 8 9 7 16 
No current health problems 41 42 40 86 53 43 39 35 26 23 
* = share of less than 1% 
– = share of 0% 
Source: IFES 2005b    
In Vienna, ambulance services because of suspected overdoses were called 663 times in 
2005, thus the upwards trend of the last few years has not continued (FSW 2006b, see ÖBIG 
2005a). The low-threshold centres of Vienna report that a total number of 72 life-saving inter-
ventions, i.e., either calling ambulance services or adopting artificial respiration measures, 
were needed in the reporting year (VWS 2006b, VWS 2006c). 
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7 Responses to Health Correlates and 
Consequences 
In Austria the responses to health correlates and consequences include a wide range of in-
terventions. The relevant measures focus on drug-related infectious diseases, thus low-
threshold assistance aimed at harm reduction prevails. For instance, syringe exchange, 
hepatitis vaccinations and information on safer use/safer sex are typical services performed 
by low-threshold centres and outreach services (street social work). Treatment of health con-
sequences is primarily provided by the general health-care system (e.g. emergency physi-
cians, psychiatrists).  
In recent years the prevention of overdoses and the issue of comorbidity have played in-
creasingly important roles in this context.   
7.1 Prevention of drug-related deaths 
Measures to prevent overdoses continue to be of key importance in the field of low-threshold 
services (see ÖBIG 2004, ÖBIG 2005a). Experience has shown that drug users in a situation 
of crisis often find it very difficult even to contact a low-threshold centre. Therefore, emer-
gency services such as crisis intervention and observation as well as life-saving measures 
primarily take place in settings linked to the everyday life of clients, e.g., street social work. In 
the reporting year, the low-threshold centres of Vienna managed 284 crisis interventions, 
1 041 observations and 72 life-saving measures (see VWS 2006b, VWS 2006c). CONTACT, 
the hospital connection service for drug addicts in Vienna, was called by various hospitals 
423 times in 2005. In the context of its work in hospitals, CONTACT had 1 007 contacts to 
drug-using patients and 990 contacts to drug users after their hospital stays (FSW 2006b). 
7.2 Prevention and treatment of drug-related infectious 
diseases 
Preventing infections continues to play a central role in low-threshold centres and outreach 
work. In this context, exchanging and selling syringes is of particular relevance. In this field, 
no nationwide programmes exist in Austria, but the corresponding measures are taken at 
provincial level. Six out of Austria’s nine provinces run syringe programmes, and four of 
these provinces provide syringe exchange services in addition to operating syringe vending 
machines (see ÖBIG 2004). Since 2003, an additional syringe exchange and sales point has 
been established, and the number of mobile services has increased from one to three. The 
overall number of syringes distributed has also risen considerably in this period: from more 
than 1.7 million to over 2.4 million. Figure 7.1 gives an overview of the development regard-
ing syringe availability in 2003 and 2005, and Table 22 of Annex A lists the relevant figures 
by province. On average, the return rate is between 93% and 97%. This share has hardly 
changed in the last few years. 
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Figure 7.1: Exchange and sales of injection equipment in 2003 and 2005 
 
Sources: Standard Table 10, investigations by ÖBIG 
In 2005 the Vienna Social Projects Association (VWS) registered an enormous increase in 
contacts to clients because of the syringe exchange service provided. The number of con-
tacts rose from 161 117 in 2004 to 227 457, and the number of syringes exchanged went up 
by around 20 000 compared to the previous year (see ÖBIG 2005a). This rise is almost ex-
clusively due to increases in the Streetwork contact points of Karlsplatz square (VWS 
2006a). The above figures only relate to syringe exchange, however. The drug scene of 
Karlsplatz has not grown in numbers. New syringe exchange services have been provided by 
AIDS Hilfe of Salzburg since autumn 2005, and as of early in 2005 also at Braunau, Upper 
Austria. Data from these new services will not be available before 2006. 
In Graz, Styria, both the exchange and the sales of syringes continue to show good results. 
Compared to the previous year, the number of exchanged syringes has risen by one third 
(see ÖBIG 2005a). In addition to the syringes, also stericups and plastic storage containers 
for the injection equipment were distributed, which further raised the awareness of infection 
risks (Kontaktladen 2006). From the Tyrol, the Komfüdro low-threshold centre reports around 
6 000 syringe sales and 150 000 syringes returned in the context of the exchange pro-
gramme, and the Mentlvilla centre registered a rise in syringes exchanged in 2005 because 
of the greater number of persons living in the centre (Kern, personal communication).  
In Vienna, the Municipal Department responsible for street cleaning collected and disposed 
of 10 422 syringes in the context of its Mistmobile programme. Graz, Styria, reports that sy-
ringe disposal boxes were installed in public toilets, and the syringes found in public toilets 
are now systematically counted (Zeder, personal communication). 
Hepatitis vaccination projects at regional level or run by individual centres are another impor-
tant measure for the prevention and treatment of drug-related infectious diseases. From 
1995 to 2004, a total of 799 persons were tested for HBV markers at the outpatient clinic of 
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Vienna’s Ganslwirt low-threshold centre. For 80% of these clients hepatitis A/B vaccinations 
were recommended. 70% of them obtained basic immunisation, and almost half of these cli-
ents concluded the regular vaccination series. In order to test their immunisation status, anti-
HBs titre was determined for more than half of the person receiving vaccinations. The immu-
nological response was not as good among drug users than among the general population: 
the non-responder rate was 34% in this group. Here, the adverse effects of an unhealthy 
diet, smoking, multiple bacterial infections and HCV coinfections are likely to play a signifi-
cant role (Haltmayer 2006). The Kontaktladen centre of Graz, as a focus of its medical ser-
vices, offers cost-free vaccinations for hepatitis A and B, which are organised in cooperation 
with other organisations. In 2005, 17 clients obtained vaccinations. In the context of the vac-
cination programme it showed that as a result of this service, clients also began to think 
about the risk of infection to a greater extent. This had positive effects on safer use, and on 
the other hand, the clients’ interest in hepatitis and HIV tests increased, which is also re-
garded as a result of the vaccination programme started in 2005 (Kontaktladen 2006, see 
ÖBIG 2005a).  
According to API, only 19% of patients treated at the Institute had received HBV vaccinations 
in the past, which is a lower share compared to 2004. The clients immunised against hepati-
tis had been vaccinated either during a previous stay at API, at the Ganslwirt centre or at a 
general practitioner’s office (API 2006). 
Regarding treatment of HCV infections, API registered four successful treatments under-
taken outside the Institute; the corresponding patients had PCR negative results after three 
months or earlier (API 2006). Graz also reports that HCV infections in patients who were tak-
ing part in substitution programmes could successfully be treated at the same time (Kon-
taktladen 2006). The treatment of HCV infections was the subject of several expert papers 
and of a workshop at the second international hepatitis C conference that was held in Vienna 
in October 2005. Here it was pointed out that several aspects of the cooperation with hepa-
tological specialist outpatient departments were not optimal with regard to drug-using pa-
tients. What has shown good results is the treatment of HCV in settings where the physician 
who is in charge of substitution treatment also administers the required hepatitis medicine 
(Tanzmeister 2006, see ÖBIG 2005a). 
Safer use and safer sex are central subjects of talks that are addressed by outreach workers, 
usually in the context of syringe exchange. In the reporting period, Vienna’s low threshold 
service providers were involved in around 3 800 talks, which focused on harm reduction with 
regard to drug use. The centre Clean Feldkirch (Vorarlberg), after noticing knowledge deficits 
among clients, addressed central aspects of HCV infections in a project that took place in 
2005. General know-how both on the different types of hepatitis and risks associated with 
drug use as well as general infection risks was communicated in personal safer use talks and 
by means of an information booklet (Stiftung Maria Ebene 2006). 
In particular the low threshold centres of the Tyrol, Vorarlberg and Vienna regularly organise 
staff training courses focusing on syringe exchange and syringe sale as well as the themes 
of infection risks, safe handling of contaminated material and treatment of stab wounds with 
needles. In addition, the workers in the centres are increasingly often asked to give lectures 
on first aid and drug use as well as HIV and HCV prevention (VWS 2006c). 
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In October 2005 the second international hepatitis C conference was held in Vienna, with 
more than 100 participants primarily from the German-speaking world. It gave an overview of 
the state of the art with regard to central aspects of comorbidity of drug use and hepatitis C 
and also highlighted the subjects of epidemiology, prevention, treatment and psychosocial 
care (VWS 2006d).  
7.3 Interventions related to psychiatric comorbidity 
The fact that comorbidity in addiction contexts has played an increasingly important role has 
also had effects on the corresponding interventions. A rising number of drug help centres 
provide specific services for patients with multimorbid personality disorders or thorough clini-
cal psychology examinations are made upon admission and integrated in the treatment proc-
ess (see API 2006, Stiftung Maria Ebene 2006). Dialog (Vienna) when giving recommenda-
tions for treatment, to increasing degrees distinguishes between general medical treatment 
and psychiatric treatment, and the quality of the treatment recommendations has significantly 
improved since several professional fields are taken into account for the examinations and 
diagnoses after the first contact to a client (Dialog 2006). 
The long-term treatment department at Mödling, Lower Austria, has capacities for treating 40 
drug inpatients suffering from severe personality disorders (see ÖBIG 2005a). Its structured 
psychotherapy services include individual therapy, group therapy and large group sessions, 
combined with ergotherapy and a community-oriented structure. A total of 106 clients were 
treated in 2005, 58 of whom had newly been admitted. The average age of the female clients 
was 28, and in the case of the men, 29 years. Around half of these persons concluded the 
regular treatment process as planned (API 2006). 
In order to be able to meet to a greater extent the demands of withdrawal persons with se-
vere addiction problems and other psychiatric diseases, the Lukasfeld treatment centre has 
started to offer more flexible treatment schedules: in the context of the 8 weeks plus pro-
gramme (see ÖBIG 2005a), patients undergo trial treatment for four weeks and then decide 
whether to continue therapy for another four weeks. The perspective of long-term treatment 
is also maintained as under the 8 weeks plus programme it is easy for patients to be readmit-
ted (Stiftung Maria Ebene 2006). 
The BBZ centre of Vienna introduced weekly psychiatric outpatient services to facilitate ac-
cess to specialist examinations of and treatment recommendations for the rising number of 
addiction clients with comorbidities (Dialog 2006).  
7.4 Interventions related to other health correlates and 
consequences 
The outpatient clinic at the Ganslwirt low-threshold centre in Vienna provided medical ser-
vices for 1 315 persons in 2005. What was most often needed in this field was administration 
of medicines, followed by treatment of acute withdrawal symptoms, temporary substitution 
treatment and medical counselling talks. In Styria, the Kontaktladen centre of Graz registered 
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a rise to 820 of drug users requiring medical treatment in 2005 (2004: 686 treatments; Kon-
taktladen 2006). 
In 2005 the work of Clean Bregenz (Vorarlberg) focused on accepting care for drug-using 
women who had formerly been sex workers, often for many years. The situation of these cli-
ents is characterised by existential crises, suicidality, trauma and problems of subsistence. In 
this context, pregnancy and childbirth are frequent motivations for stopping sex work, but 
they present new problems as well (Stiftung Maria Ebene 2006). 
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8 Social Correlates and Consequences 
Homelessness, unemployment and debts continue to be the most pressing social problems 
of drug users, in particular addicted users in the street scene. This development has been 
aggravated by the tight labour market situation. For example in Vienna, according to statisti-
cal data from the Public Employment Service, in July 2005, 76 543 people were unemployed, 
which is an unemployment rate of 9.2% (diepartner.at 2005). 
The overall number of reports to the police on the basis of the Narcotic Substances Act 
(SMG) has risen only slightly. As to the situation in prisons, an estimated 25% to 50% of 
prisoners use illegal drugs. 
8.1 Social problems 
Among the clients of BADO in Vienna (see Chapter 4.2) in 2004, more than 78% of those in 
treatment were not gainfully employed or did not hold a regular occupation (n = 1 512), which 
is 10 percentage points more than inthe previous year (2003: 68%). The share of full-time 
employed clients was very low (12%), and even lower for women (8%, men: 14%). One third 
of the clients indicated that they lived alone or with their parents, while 10% were homeless 
or had a place in an institution (n = 1.792). Their incomes were primarily composed of unem-
ployment assistance, unemployment benefits or welfare assistance; in the middle and older 
age groups, the share of recipients of unemployment benefit declined and that of unemploy-
ment assistance rose steadily. The share of these persons among the age group between 36 
and 40 was 48% (n = 1.663). More women than men said they were recipients of welfare as-
sistance, whereas significantly more men said they received unemployment assistance or 
unemployment benefit. With regard to educational level, the clients of the drug help services 
in Vienna continued to be markedly below the general average. For slightly more than half of 
the people receiving assistance, their highest degree was a lower secondary school or poly-
technic school leaving certificate (IFES 2004b, IFES 2005b).  
This shows that the social situation of the clients of drug help services in Vienna is worse 
compared to the general population (as to their housing, education, employment, income and 
health situations). However, it should by no means be concluded that drug problems arise 
mainly in the group of socially disadvantaged persons. What this does signify is that this 
group will more readily turn to the drug help service system in Vienna than people who (still) 
have their own social and financial resources (see Chapter 4.2, IFES 2005b). 
8.2 Drug-related crimes 
In 2005, the number of reports to the police on the basis of the Narcotic Substances Act 
(SMG) was 25 892 (2004: 25 215; see also Table A11 in Annex A and Standard Table 11), 
which means that there was only a slight rise compared to the previous year. 
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A total of 25 041 were reports related to narcotic substances, the rest concerned psychotro-
pic substances. Regarding type of report (see Figure 8.1), the development observed since 
2003 was continued, according to which the number of reports for misdemeanours (posses-
sion and small-scale trafficking – Section 27 of the SMG) was rising and that of felonies 
(large-scale trafficking, professional trafficking – Section 28 of the SMG) was declining (see 
Chapter 1.1). 
Figure 8.1: Development of reports to the police for violation of the Narcotic Drugs Act/Narcotic 
Substances Act by misdemeanours and felonies in Austria from 1996 to 2005 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. In order to facilitate compari-
son, for the period from 1998 to 2001 only reports concerning narcotic drugs have been considered here. The difference 
to the total number of reports results from reports that are not assignable.  
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
In terms of substances involved (see Table A11 in Annex A and Standard Table 11), com-
pared to the previous year there were slight increases regarding reports related to cannabis, 
cocaine and crack as well as psychotropic substances, and also other addictive substances 
(see Figure 8.2). For the first time since 2001, reports for heroin and opiates were observed 
to decline, if only slightly. As in the previous year, the number of reports concerning ecstasy 
and LSD decreased further in 2005, as did reports for amphetamines. 
In 2005, 25 892 reports led to a total of 3 929 arrests (2004: 3 667) in connection with nar-
cotic drug investigations; no detailed indication of the type of offences, substances involved, 
etc. can be given. 
As explained in previous years and also stressed by the responsible Ministry of the Interior 
(BMI 2006), the data concerning reports to the police permit only limited conclusions as to 
the development of drug use and misuse, because they primarily reflect the intensity and fo-
cus of police measures in this field. 
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Figure 8.2: Development of reports to the police for violation of the Narcotic Drugs Act/ 
Narcotic Substances Act by type of substance, from 1996 to 2005 
 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. 
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
Although the number of convictions for violation of the SMG rose only slightly in 2005, 
namely by 7% (6 128 cases, compared to 5 706 in 2004, or 26% from 2003 to 2004), the 
number of unsuspended prison sentences (2005: 1 624) increased by 21% compared to the 
previous year. This resulted in a new peak in the total number of convictions according to the 
SMG and its share in the total number of convictions (1996: 5.2%; 2005: 13.4%), although 
they were only slightly higher than the figures of the previous year (see Table A13 in Annex 
A).
Again, there were significantly more misdemeanours (Section 27 of the SMG – possession 
and small-scale trafficking), namely 4 702 cases (2004: 4 229) compared to 1 357 cases of 
felonies (Section 28 of the SMG – trafficking; 2004: 1 441 cases; see Table A13 in Annex A). 
The number of young people among the cases of felonies and misdemeanours decreased in 
the previous year, whereas the number of adults declined only in the case of felonies, but 
rose by 17% in the case of misdemeanours (2004: 3 511, 2005: 4 115). Approximately 70%  
of all persons convicted (2004: 71%) were punished with imprisonment (see Table A15 in 
Annex A). The share of sentences that were suspended on probation in all convictions was 
41% (2003: 47%, 2004: 42%). 
In addition to convictions, the data on the provisional waiving of reports (Section 35 SMG) 
and suspensions of proceedings (Section 37 SMG) are also relevant (see Chapter 1.1 and 
Table A16 in Annex A). As yet there are no reliable data on the suspension of sentences on 
the basis of Section 39 of the SMG. In fact, such data would provide an important source of 
information on the practical implementation of the principle of therapy instead of punishment.  
As before, there are no general data on offences committed to finance drugs and drug-
related crimes. The few data that exist regarding cocaine are included in Chapter 12.4. 
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8.3 Drug use in prison 
The existing information on drug use in prison was presented in detail in the Key Issue chap-
ter on drug use in prison in 2001 (ÖBIG 2001a). At the Second European Conference on 
Health Promotion in Prisons, which took place in Vienna in spring 2006, it was indicated that 
in March 2006 there were approximately 9 000 prisoners, 2 000 of whom were drug users. In 
the prison at Josefstadt in Vienna, there were 990 places, but 1 300 inmates, 40% of whom 
had addiction diseases (multiple drug users: 30%, alcoholics: 10%; Gesundheitsförderung in 
Haft 2006).. 
8.4 Social costs 
There are still no recent studies or data on the social and economic costs of drug use avail-
able. Information on expenditure for drug-related demand reduction was presented in detail 
in the corresponding Key Issue Chapter for 2001 (ÖBIG 2002a). 
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9 Responses to Social Correlates and 
Consequences 
Measures for the social (re)integration of (former) drug addicts address both clients who 
have undergone drug-free treatment and people who are currently using drugs. In Austria, 
this type of measures has traditionally played an important role, especially with regard to 
housing, work, education and training (see Structured Questionnaire 28). Some of the perti-
nent measures are part of the chain of treatment and integrated in the corresponding care 
modules, while others are services provided by low-threshold centres in the context of ac-
cepting drug assistance (see Chapter 5). Recently, activities in this regard have also been 
promoted for recreational settings. Austria’s prisons and police detention centres have taken 
a wide range of drug-related measures for prisoners, from prevention of addiction, substitu-
tion treatment and prevention of infectious diseases to drug-free treatment.  
9.1 Social reintegration 
In previous national reports to the EMCDDA (ÖBIG 2004, ÖBIG 2005a) the Development 
Partnership drugaddicts@work was described in detail. This DP and its subprojects were 
completed in September 2005 with good results, as an evaluation carried out in mid-2005 
showed (diepartner.at 2005). The objective of drugaddicts@work had been to (re)integrate 
people (formerly) suffering from addiction into, and to reduce their exclusion from, the regular 
labour market. Within the framework of measures taken in the context of training and em-
ployment, the Development Partnership assisted over 700 clients (formerly) suffering from 
addiction and was able to double their labour market counselling activities and job offers for 
the target group. Approximately 90% (86) of the participants concluded the courses organ-
ised by @work, and another 30 people working in the socioeconomic enterprises of the De-
velopment Partnership took part in specific trainings and qualified in the field of personal em-
powerment and communication. In total, 17 people working in socioeconomic enterprises 
found a job in the regular labour market, depending on the respective occupation module in 
which they participated, the placement quota on the formal labour market was between 25 
and 50% (see EDDRA). As the actual revenues were markedly lower than expected, the 
modules did not succeed in reaching a self-financing quota of 20%. However, taking into ac-
count the indirect economic benefit, on balance the project may be regarded as successful 
from an economic point of view. 
In 2004 the Vienna Job Exchange (WBB), one of the organisations active in 
drugaddicts@work, was evaluated (Gruber et al. undated). The WBB serves as a link be-
tween addiction help services and the Public Employment Service (AMS); the necessity for 
such an organisation is reflected in the annually rising number of personal counselling talks 
(1998: 521, 2003: 3.500). Between 2001 and 2003, approximately two thirds of the clients 
were referred to the WBB by the Public Employment Service and one third by addiction help 
services and the City of Vienna. According to a comparison of the WBB data with those of 
the social insurance organisations, the employment situation improved considerably in the
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first year after counselling or assistance by the WBB. Averaged over all clients and over the 
first and second year after turning to the WBB, the employment rate was stable at 40% (see 
EDDRA). 
In cases where occupational reintegration is not possible. appropriate measures, such as 
applying for (early) retirement, enquiries etc. can be initiated for the people concerned with 
the help of WBB, on the basis of a detailed social and biographical case history. In this con-
text WBB organises information and education seminars for AMS counsellors, which has led 
to a greater awareness of this theme and a better understanding for people with addiction 
experiences. In addition, WBB counsellors offer diagnostic assistance during the counselling 
days in the regional offices of AMS, which further reduces the stress of AMS counsellors. It 
has turned out that many people with addiction problems can in fact be integrated into the la-
bour market, and that even some of the clients with acute addiction problems are able to 
work under conditions that are adapted to their needs. 
The association Dialog completed its work for the EQUAL courses (Development Partnership 
drugaddicts@work) and presented the results at various national and international events 
(Dialog 2006). The coaching group was terminated and substituted by Landebahn (landing 
runway), which makes it possible for interested clients to stay in touch with the organisation 
while waiting for a place in assistance or a course, to obtain a form of basic support in spite 
of limited counselling capacities. The group for women who want to reenter the job market, 
another new service organised by EQUAL, was transferred to WAFF (the Vienna Employees 
Promotion Fund) and is now a regular group which is developed further continually. On the 
basis of its experience, the Needles or Pins project, together with close partners, applied for 
a second  EQUAL round. However, this committed project which was presented in last year’s 
Report to the EMCDDA (ÖBIG 2005a) and designed to include case management on the 
one hand and specific activities for young people and older persons on the other, was not 
considered eligible for funding within the framework of the EQUAL programme.  
After a longer intermission the low-threshold project Training der Schlüsselqualifikationen 
(training of key qualifications) was organised again, which provides job orientation for people 
with good chances to reenter the job market and structural training for persons who will 
probably take longer to stabilise. All the Dialog courses were full, which is probably due to 
the scarcity of assistance and care for this target group and the difficulty of getting a place in 
a help service institution. Remarkably, almost all the participants of the job orientation 
courses obtained a hands-on training position where they could test their working abilities in 
practice (Dialog 2006).  
The socioeconomic enterprise fix und fertig registered that the revoking of the quota regula-
tion in autumn 2005 resulted in a noticeably better quality of applicants referred to this enter-
prise by the AMS (VWS 2006e). In order to further improve the opportunities of transitional 
workers, in 2005 fix und fertig adopted a new programme that focuses on job-specific and 
social work goals, qualification and job application plan in outplacement,  internal and exter-
nal qualification  and adaptation of all instruments of personnel development. In order to fa-
cilitate the external qualification of transitional workers, in 2005 the framework conditions, 
such as taking over employment costs, working hours etc., were regulated in a directive. 
Transitional workers who do not immediately have another job position after their employ-
ment has ended can receive single coaching for a period of three months as aftercare. 
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Grüner Kreis organised a socioeconomic employment project called Pool 7 in the field of ca-
tering and party services, event management as well as art and culture projects for people 
with addiction experience (Grüner Kreis 2006b). Here, on the one hand articles carrying the 
fair-trade label are used, and on the other, products of Grüner Kreis, some of which are 
grown in the plant nursery of the therapy unit Meierhof. As the demand for horticulture prod-
ucts has grown considerably over the past few years, bigger greenhouses were added to the 
plant nursery. In the meantime, the patients of Grüner Kreis are not only in charge of tending 
to existing gardens, but primarily with establishing new gardens, and there are always some 
clients who want to continue working as landscape gardeners after having completed ther-
apy. 
Housing is among the issues that the Streetwork Tyrol Working Group STARK is committed 
to; STARK is an umbrella organisation for all streetwork organisations in the Tyrol (Z6-
Streetwork 2006). In addition to aims like a regular trans-organisation exchange and influ-
ence on social policies, the issue of emergency housing for young people in crisis situations, 
especially girls and young women, was discussed. In all the organisations, clients occasion-
ally need a place to stay for several days, and the relevant services have no free beds, or 
young people, for various reasons, cannot or do not wish to stay there. 
In Vienna, the emergency shelter for young people a_way opened in December 2005; here 
homeless youths between 14 and 18 years find a low-threshold place to stay in an emer-
gency (Caritas der Erzdiözese Wien undated). Clients are primarily runaways from families 
or public institutions, or members of the punk scene; they are also welcome if they are ad-
dicted to alcohol and/or drugs. However, consumption and/or trafficking in and near the shel-
ter is strictly prohibited. The only prerequisite for staying there anonymously and free of 
charge is a talk with a social worker before sleeping at a_way for the first time. After that the 
young clients may stay at the shelter for up to five nights a month, and they are also referred 
to other accomodations if they wish (see Chapter 11.5).  
The major role that homelessness plays for drug users is also reflected in the demand for 
places to sleep. In this respect, the integration of homeless drug users into the system of 
general services for the homeless, which was established in April 2004, also had positive ef-
fects in 2005. The Ganslwirt centre now has the possibility to offer accomodation for several 
nights, which opens up new perspectives for assistance. Correspondingly, the number of us-
ers of the emergency housing facility increased compared to the previous year (overnight 
stays: +25%, reservations: +11%), but the service was never so overbooked as in the period 
between 2001 and 2003. In 2005, 359 persons came to sleep at Ganslwirt; 6 362 reserva-
tions and 4 460 overnight stays were registered (VWS 2006c). 
In Styria, the project Wohnen (housing) was initiated in cooperation with the Styrian housing 
platform. The project is designed to meet the needs of clients with regard to acquiring and 
maintaining living space (Drogenberatung des Landes Steiermark 2006). The aim is to pro-
vide adequate and assisted housing for adult clients with addictions for a transitional period 
and to promote the social integration of this group by giving them the support they need. For 
a two-year stay, two forms of accomodation will be available: either shared housing for three 
to four clients, or single flats with mobile housing assistance.  
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Also regarding recreational activities the Drug Counselling Centre of the Province of Styria 
presented new initiatives (Drogenberatung des Landes Steiermark 2006). In June 2005 
mountain climbing tours were organised by the Drug Counselling Centre and have since 
been established as regular groups. A total of 14 clients had their first climbing experience at 
such an occasion. In 2005, a dance and movement workshop enhancing body awareness in 
four lessons was organised for women who had already had individual contact to a drug 
counselling service. In addition, also in 2005 three drum workshops with professional drum-
mers and thirteen participants took place.  
9.2 Prevention of drug-related crime 
 
The legal and organisational framework conditions of drug-related interventions in prisons, 
which were described in great detail in the Report on the Drug Situation 2001 (ÖBIG 2001a), 
were not changed in the reporting period. As recent data and information have shown, im-
prisonment on account of felonies in violation of the SMG still play a relevant role and are 
strongly growing in importance (see Chapter 8.2). 
As mentioned in Chapter 8.3, in spring 2006 the Second European Conference on Health 
Promotion in Prisons took place in Vienna. The prison population is a vulnerable group with 
HIV and hepatitis-C prevalence rates five to ten times higher than in the general population. 
The risk of new infections during the prison term is increased due to shared use of injecting 
equipment, tatoos and unsafe sex (see also Chapter 6.2; Grüner Kreis 2006b). Whereas sy-
ringe exchange is not (yet) possible in Austrian prisons, substitution treatment can be contin-
ued or started in prison. At the time of release from prison it is essential to provide help. 
Therefore, at the prison (JA) of Simmering counselling is available before the end of the 
prison term, in the course of which a lower substitution dosage may be selected in order to 
avoid overdosing. The highest principle is that of equivalence, which guarantees that the 
same range of medical care services are available inside prisons as well as outside (Ge-
sundheitsförderung in Haft 2006).  
In order to support doctors who attend to persons in prison, the Federal Ministry of Justice 
issued guidelines for prison physicians (Pont und Wool 2006). They are an important source 
for physicians who lack further education or training in this field, leading practitioners step by 
step from general principles to a great number of recommendations regarding the various ar-
eas of work of a prison physician. A special chapter is dedicated to drug misuse and addic-
tion as a disease, describing drug strategies, therapy programmes, harm reduction measures 
etc. It is also pointed out that a prison term may be a good opportunity to undergo an anti-
addiction therapy, as the strict daily structure of life in prison may bring about physical and 
psychological stability. The outcome in cases of successful treatment may be ensured with 
the support of physicians by planning further assistance after the prison term has ended.  
The association Dialog expanded its police detention centre (PAZ). As a consequence, the 
focus of medical work there was shifted from providing mainly medical care for addicted pris-
oners to comprehensive psychiatric care and treatment of all psychiatric diseases. In 2005 
there was a significant increase in the number of persons who received counselling and care 
by Dialog at the PAZ, namely 415, so the total number rose to 1 104. Compared to 2004, this 
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is an increase by 60%. As yet, no psychosocial counselling is provided to the group of male 
administrative law offenders in the police detention centre. 
The after-care services established by Dialog in previous years, e. g., Frauensache 
(Women’s Business) offering psychosocial and medical support exclusively to women, 
yielded positive effects in the reporting year also within the PAZ. The number of clients in 
care rose considerably, not least because of the fact that the Dialog services were presented 
to all prisoners by the prison guards. Dialog succeeded in making their services an integral 
part of the PAZ, thus providing a possibility to start preparations for social integration after re-
lease already during a prison term on account of an administrative offence.  
For 2006 a major expansion of psychiatric care is planned. Also, after the reopening of the 
PAZ Rossauer Lände, the medical service of the association Dialog will be based there as 
well as at the PAZ Hernalser Gürtel (both in Vienna). Psychosocial care for women shall be 
continued. Funding options for the social work with men prisoners shall be worked out (Dia-
log 2006). 
Since the end of 2005 Dialog has expanded its services for a broader public by offering spe-
cial office hours for matters concerning the waiving of reports, as well as multiprofessional 
clearing for specific target groups (Dialog 2006). 
The principle of therapy instead of punishment continues to be an important component of all 
drug strategies and plans in Austria (ÖBIG 2002a). The related measures are implemented 
by the entire range of the drug help system rather than by specialised services (see Chapter 
1.1) 
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10 Drug Markets 
The substance most frequently seized in Austria is cannabis, followed by cocaine and heroin. 
However, quantities seized are not a good indicator for the availability of a substance in Aus-
tria, as Austria often is not the final destination of these drugs but a transit country, and be-
cause these figures also reflect the intensity of police activities. Regarding potency and con-
centration of the substances available in Austria, experience of recent years has shown that 
considerable variations occur. This applies to both substances used by the traditional street 
scene (opiates and cocaine) and also new synthetic drugs (ecstasy and amphetamines). As 
the actual ingredients and potency are often unknown, this is a considerable risk factor for 
drug use. 
10.1 Availability and supply 
No new data on the availability and supply of illicit drugs in a narrower sense are available. 
Indirect information has been provided by a nationwide representative survey of substance 
use conducted in 2004 (Uhl et al. 2005a; see Chapters 1.4, 2.1 and 12.1). The survey in-
cluded questions about a number of different psychoactive substances (see Table 10.1), for 
instance: Do you have a personal acquaintance or friend of who takes (specified type of 
drug)? It showed that, with the exception of cannabis and ecstasy, the shares of respondents 
who personally knew a user of the drug in question was below 10%. 
Table 10.1: Indications of availability and supply of psychoactive substances in 2004 (percentages) 
Substance 
Do you have a personal ac-
quaintance or friend who takes 
(specified type of drug)? Cannabis Ecstasy Amphetamines Cocaine Heroin LSD
Biogenic 
drugs 
Solvents
and 
Inhalents
Yes 33% 12% 9% 8% 5% 6% 10% 6% 
No 67% 88% 91% 92% 95% 94% 90% 94% 
Source: Uhl et al. 2005a 
10.2 Seizures 
According to the Federal Ministry of the Interior (BMI) of Austria, seizures of cannabis slightly 
declined in 2005, while seizures of the rest of illicit drugs remained at a high level similar to 
the year before (see Figure 10.1 on the following page and Table A17 in Annex A).
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Figure 10.1: Number of seizures of narcotic drugs in Austria from 1996 to 2005 
 
Source: BMI/Bundeskriminalamt  (Federal Criminal Agency) 
The amount of substances seized reflect these trends only to a limited extent, as individual 
seizures of exceptionally large quantities strongly influence the general picture (BMI 2006, 
see Table A18 in Annex A and Chapter 12.4).  
10.3 Price/purity 
In 2005 the project ChEckiT!, which tests the purity and ingredients of substances bought as 
ecstasy or speed during events of the party and clubbing scene (see Chapter 3.2) was pre-
sent at six music events (goa, techno, electronic), where 57 pills bought as ecstasy and 33 
samples purchased under the name of speed were handed in for testing (VWS 2006f). The 
percentage of pills bought as ecstasy that did not contain psychotropic substances other than 
MDMA, MDE or MDA was lower than in previous years (70%). In addition, the purity of the 
individual pills was found to be inconsistent to extreme degrees compared to the past, and in 
a number of tablets, the concentrations of MDMA, MDE or MDA were very high and consti-
tuted relevant health hazards. 
Only 33% of the substances bought as speed and analysed by ChEckiT! had amphetamines 
as their only ingredients, while 6% combined amphetamines and caffeine, and 24% con-
tained amphetamines with additions of other psychotropic substances (see Tables A19 and 
A20 in Annex A). Unknown amphetamine derivatives continue to be a problem in this regard. 
These substances may either result from inappropriate production procedures of ampheta-
mines from cheap base substances, or they may be newly developed designer drugs. The 
effects and risks of these substances are unknown and cannot be assessed (VWS 2006f). 
In 2005 both seizures and use of ecstasy pills containing the ingredient mCPP were re-
ported. Compared to MDMA, the psychoactive effect of mCPP is weaker, but very frequently, 
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it leads to unpleasant side-effects such as headache, kidney pain, nervousness, heavy 
breathing, tiredness and hangover lasting for several days. Furthermore, simultaneous use of 
MDMA may lead to convulsions. 
Information by the Ministry of the Interior on the potency and prices of various drugs sold at 
street level are given in Table 10.2. These data are based on information and fictitious pur-
chases by undercover police agents. For the individual drugs, between 60 and 218 purity 
analyses were carried out. 
Table 10.2: Purity and price (EUR per gram*/pill**) of various drugs sold on the street in 2005 
Herbal 
cannabis* 
Cannabis 
resin* 
Brown 
heroin* 
White her-
oin* Cocaine* 
Ampheta-
mines* Ecstasy** LSD** 
Minimum 0.03% 0.1% 0.2% – 0.2% 0.6% 2% – 
Maximum 20% 26% 48% – 94% 92% 100% – 
Pu
rit
y
Typical 6% 8% 8% – 38% 25% 33% – 
Minimum 3 7 45 80 65 15 10 30 
Maximum 4 8 70 90 90 25 15 35 
Pr
ic
e
Typical 3 7 55 85 80 20 11 30 
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
What is striking is the variations in potency, which are considerable in the drugs sold on the 
street. However, a further interpretation and an analysis of trends are only feasible for data 
gathered over several years. 

PART B 
Selected Issues 

63
11 Drug Use and Related Problems among 
Very Young People  
In general there are few data on drug use among people younger than 15 years in Austria, 
as most representative surveys and studies only collect data for people older than 15. The 
presented results are based on data from previous population surveys (e. g., ESPAD), on 
specific separate evaluations and on interviews in youth-specific services1. Furthermore, 
there are a number of surveys which permit conclusions on first-time use. 
11.1 Drug use and problematic drug use among 
very young people (<15 years old) 
In Austria, drug use among young people under 15 years of age is not a massive problem 
with regard to quantity, as only few young people in this age group use psychoactive sub-
stances. As in the case of young people in general (see ÖBIG 2001b, ÖBIG 2002a, ÖBIG 
2002b, ÖBIG 2005a) experts report experimental use on the one hand and massive high-risk 
poly-drug use on the other also for this age group. According to nationwide representative 
studies and local surveys illicit substances used once or repeatedly range far behind ciga-
rettes and alcohol among people younger than 15. Among the psychoactive substances 
used, cannabis and poppers predominate. According to the data, the use of poppers appears 
to be more common among this age group, and between 9% and 14% among those aged 14 
or 15 indicate to have used poppers several times, with a tendency of young men to use 
drugs more frequently than young women. Few young people aged 12 or 13 have come into 
contact with cannabis, and for those aged 14 and 15 there is a lifetime prevalence varying 
between 4% and 6% from survey to survey. It has been reported that while men and women 
tend to have their first experience of cannabis use earlier in life than before, lifetime preva-
lence in the age group under 15 has not risen noticeably (Uhl et al. 2005a, Uhl et al. 2005b). 
For all other illicit substances, a lifetime prevalence of 1% to a maximum of 2% is reported in 
the selected age group (see Gartner-Schiller et al. 2006, MA-L 2001, ÖBIG 2002b, X-Sample 
2002). In general, 11% of the young people aged between 12 and 14 have experience of at 
least one psychoactive substance, apart from alcohol and tobacco (Schönfeldinger 2002). 
The lifetime prevalence for repeated use of illicit substances discernibly rises from the age of 
approximately 15 years on (see Figure 11.1 on the next page). Among 14-year olds, canna-
bis has a maximum prevalence of 6%, which rises to a maximum of 24% in the age group 
between 15 and 16 (see ÖBIG 2002a, ÖBIG 2003). 
 
1 We are especially grateful to the following experts and services for collecting additional data: B.I.T. (Tyrol), Z6 (Tyrol), DOWAS 
Chill Out (Tyrol), Dialog (Vienna), VWS (Vienna) and Ms Andrea Gartner-Schiller (Auftrieb, Lower Austria), as well as Mr Wolf-
gang Bäcker (Drug Prevention Competence Centre), Mr Martin Haiderer, Ms Lena Hodlinka (a_way) and Mr Uwe Hincicza 
(VWS Streetwork) for extensive interviews 
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Figure 11.1: Lifetime prevalence among 14- and 15- to 16-year-olds in Vienna in percent, 2000 
 
Source: MA-L 2001 
An indirect indication of lifetime prevalence is provided by data on first use by older youths in 
the ESPAD-survey. Approximately 12% of the responding school students report to have 
used cannabis for the first time when they were younger than 15, with a share of boys that is 
by almost 13% higher than that of girls (approximately 10%). First use of poppers under 15 is 
reported by 9% (men: 8.4%, women: 9.8%) (Uhl et al. 2005b, see ÖBIG 2005a).   
The average age of the general population at first use of cannabis and poppers is approxi-
mately 15 years. All other psychoactive substances, with the exception of alcohol and to-
bacco, on average are used some years later (vgl. Haller 2005). These results are in line with 
the data from the treatment sector (see Grüner Kreis 2005, VWS 2005a; IFES 2005b, see 
also Chapter 4.2). On the whole the average age at first use among women is markedly be-
low that of men for nearly all substances (see Table A25 in Annex A). The average timespan 
between first use and regular use is relatively short. Only for alcohol is it approximately 2.5 
years, compared to a maximum of one year for most of the other substances. This means 
that when beginning regular use, young people on average are older than 15.  
As to the frequency of contacts to young people under 15, drug help services report little or 
no contacts with this age group, and if any, they occur in the context of syringe exchange 
programmes (Substanz and Neubauer, personal communications). This age group is more 
visible in the youth-specific services and counselling centres, where they constitute between 
2% and 5% of the clients. Z6-Streetwork Innsbruck reports a share of 18%, which includes 
young people aged 15 (see Table 11.1); here, drug use is frequent, but not all clients use 
drugs. As in the case of lifetime prevalence, the number of contacts is higher among young 
people over 15 (see B.I.T. 2006). Chill Out, a low-threshold centre of Youth Welfare Service 
in the Tyrol, points out that in the years from 2002 to 2005 between 20% and 30% of all 
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young clients showed harmful patterns of substance use. For the reporting years, between 
10% and 19% are younger than 15 (DOWAS Chill Out, personal communication). 
Table 11.1: Number of contacts at Z6-Streetwork, by age and gender, in 2005 
Age group Number of contacts Men Women Share of total contacts 
Younger than 12 37 9 28 1.3% 
12–13 50 26 24 1.9% 
14–15 359 178 211 14.9% 
16–17 1 101 519 582 41.3% 
18–19 686 453 233 25.7% 
Older than 19 401 275 126  15% 
Source: Z6-Streetwork 2006 
Youth-specific drug help services report that regarding substances, modes of administration 
and related problems there are two groups of young people under 15, which are fairly equal 
in size.  
One group of young people who contact drug help services are those starting to have regu-
lar, but unproblematic use of cannabis, partly also infrequent use of opiates (smoking or 
snorting heroin) as well as intermittent use of cocaine, party drugs or benzodiazepines, in 
some cases. These young people seem to come into contact with counselling centres in a 
phase when they are trying to find their place in the world. Many of them are still integrated 
into the school or education systems, and few psychological or social problems show. In 
many cases the motivation of these clients is limited to fulfilling obligations imposed by au-
thorities, e. g. because they were referred to the centre by a school, as regulated in Section 
13 (1) of the SMG. In this context, family and friends play an important role for making con-
tact to the respective service. In the course of assistance, quitting the use of drugs often 
turns out to be rather unproblematic, and it has been observed that although they have not 
turned to the drug help service of their own accord, the young people concerned develop 
new goals with regard to their use of substances in the course of the assisted process (see 
B.I.T. 2006, Dialog 10 and BBZ, personal communications). 
The other group of young people is described as showing high-risk poly-drug patterns of use 
combined with a great curiosity for experimenting with all kinds of substances. They are 
young people under 15 who have used opiates nasally and/or intravenously on a regular ba-
sis for at least one year. Many of them also indicate that they have regularly used benzodi-
azepines for a longer period of time (between six months and two years). In this group use of 
alcohol and cannabis is not significant. There are great deficits of knowledge about the effect 
of substances, dosages and safer use, which increases the risk of grave health conse-
quences and also the risk of overdosing. The services report that the members of this group 
come voluntarily, but they are hard to keep as clients and in need of very intensive treatment 
(Gartner-Schiller and Neumayr 2006, Dialog, VWS Streetwok, Z6-Streetwork, a_way, per-
sonal communications).  
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11.2 Profile of main groups of young people 
at risk of drug use and of problematic drug use 
In Austria there are no representative surveys available which focus on the relation between 
specific at-risk groups of society as well as specific psychological diagnoses and drug con-
sumers younger than 15. The general view is that it is not just the fact of being a member of 
an at-risk group that implies greater vulnerability regarding drug problems and the develop-
ment of an addiction, but that rather an accumulation of problems and interactions of individ-
ual difficulties and resources in the sense of risk and protection factors are relevant (see 
ÖBIG 2001b). 
However, youth-specific services have found that in general, young people who appear in the 
street drug scene in most cases already have psychosocial problems and contact to youth 
welfare agencies. Here a direct connection to difficulties in life, such as a family history char-
acterised by special problems, e. g., neglect, massive abuse of substances by parents and/or 
physical or psychological absence of parents becomes visible. Socioeconomic disadvan-
tages are a factor which aggravates these problems. Additionally, in many cases the young 
people concerned have experienced physical or psychological abuse, physical violence 
within the family and consequently, referral to the care system of youth welfare or child and 
youth psychiatry.  
For young people, the contact to the drug scene has strong connotations of being autono-
mous and living one’s own life and implies breaking loose from old social ties. In the scene, 
contacts and friendships are made and personal support is found quickly, so that for many, 
trying to do without all this in the context of care and treatment is an obstacle that turns out to 
be too hard to overcome.  
The current life situation of those concerned is characterised by issues like refusing to go to 
school inspite of being legally obliged to do so, running away from home or from institutions 
of youth welfare, and (in some cases) the lack of a daily structure. For girls daytime sex work 
may also play a relevant role. From a psychiatric view, the frequency of suicide attempts at a 
very young age, in some cases from 12 years onwards, and what is called a lack of orienta-
tion and perspectives are significant (a_way, Dialog, Z6-Streetwork, VWS-Streetwork, Wolf-
gang Bäcker, personal communications). 
11.3 Correlates and consequences of substance use 
among very young people 
In Austria, young people under 15 who use drugs are usually not regarded as drug addicts. 
Among other factors, this is due to the fact that the importance of psychosocial problems is 
particularly evident in this age group. Substance use is seen as one aspect of the entire 
problem situation or as a consequence of accumulated difficulties and stress. But in many 
cases substance use aggravates the situation. The intensity of use which may be excessive 
in some cases is also related to the consumption patterns of the social peer group and is less 
manifest than in older drug users. Another observation of experts is that in this age group, 
hardly any physical or psychological syndromes of dependence are noticeable, except in al-
cohol and nicotine users.  
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Those young people who practise experimental use of drugs, which can become massive in 
some cases, are trying to cope with adolescence crises; some of them show psychiatric 
symptoms that require treatment, above all psychotic symptoms and a tendency towards 
destitution. In the Vienna drug help services, 4% of the clients under 15 indicate that they 
have been in psychiatric treatment within the past twelve months (IFES 2005b). With regard 
to behaviour, aggressive acts against others and autoaggressive acts have been registered, 
with girls tending more towards autoaggressive acts such as burning or cutting themselves, 
while boys rather become aggressive against members of their social environment. Girls in 
particular are confronted with sex work in their lives in the street scene. They enter sex work 
gradually, by “doing favours” for the older members of the street scene, which leads to ex-
perience of sexual abuse, sex work to finance drugs, and also early pregnancies. Prostitution 
is certainly also an issue among boys, although it is a strong taboo which is hardly ever 
talked about (a_way, personal communication). 
In young people who regularly use cocaine and mushrooms in addition to massive cannabis 
use, problems such as sleep disorders, a heightened level of aggressiveness, and psychotic 
symptoms are registered, which are partly due to use of the substances mentioned above 
(Dialog, personal communication). Among those younger than 15 who engage in high-risk 
multiple drug use there is the danger of overdosing. In Vienna, the hospital connection ser-
vice CONTACT (see Chapter 7.1) registered seven young people under 15 among those 
admitted to a hospital. According to statistics on drug-related deaths, in 2004 there were 
three casualties of young persons under 15 as a direct consequence of drug use, and in 
2005, one casualty (ÖBIG 2006a, ÖBIG 2006b; see Chapter 6.1). The lack of knowledge 
about safer use increases the probability of drug-related infectious diseases. Youth-specific 
services have also reported lack of hygiene in young people regarding teeth and general 
body hygiene, scabies and sexually transmitted diseases (Z6-Streetwork, personal commu-
nication). 
The psychosocial consequences of early drug use are mainly due to the failure to cope with 
puberty-related development. In this context young people may find it difficult to complete 
school or traineeship. Data from Vienna care and treatment services (IFES 2005b, ÖBIG 
2005a; see Chapter 4.2) reveal that only four out of ten young people under 15 are still inte-
grated in the school system, the others live outside the world of education or work. In the 
process of disengagement from their homes many of the young people concerned cut their 
emotional ties to their parents, get thrown out or run away. In these dynamics, the transition 
from living with the family to finding one’s own job and a place to live by oneself is disrupted 
and confronts the young people concerned with long-term problematic consequences.  
The great importance of social ties and relationships in this age group has often been 
stressed. Counselling services report that especially in the case of occasional users of can-
nabis it is essential to promote the communication with the family and with education and 
training institutions, and to maintain relations with these areas of life. 
As in all age groups, massive drug use leads to a tendency towards committing petty crimes. 
Among these are theft, burglary and small-scale trafficking. In Austria, the age of criminal re-
sponsibility is 14 years, so those concerned are confronted with the justice system, and 
prison sentences are pronounced. Precisely in this setting young people are in danger of 
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meeting older drug users and obtaining substances under problematic conditions, which may 
constitute the beginning of a manifest drug career (Bäcker, personal communication). 
11.4 Policy and legal development 
According to the allocation of jurisdiction in the federal constitution, the issue of substance 
use by children and young people in Austria is regulated by youth legislation at province 
level. The consumption and purchase of tobacco and alcoholic drinks by young people under 
16 years of age is prohibited in all provinces. In addition, according to the youth protection 
laws of all provinces except the Tyrol, the use of drugs or similar substances which are not 
regulated by the Narcotic Substances Act (SMG) but may lead to narcotisation, excitement or 
stimulation if taken either by themselves or in combination with other substances is prohib-
ited for young people under 18 (see www.api.or.at/akis). 
The use of and trafficking in illicit substances is regulated in the SMG. Under Section 13 of 
the SMG, schools are obliged to offer special help to young students who are noticed in the 
context of substance abuse. In such cases the school management has to ensure that the 
young people concerned are examined by the school medical officer and school psycholo-
gist. Depending on the result, a health-related measure under Section 11 (2) may be re-
quired. If young people undergo the requested medical tests, the school is not obliged to in-
form the authorities in any way (BMBWK 2001, see ÖBIG 2004). 
11.5 Prevention and treatment 
In general, the youth-specific services in the field of prevention and treatment also apply to 
the age group of people younger than 15 (see Chapters 3 and 5, ÖBIG 2001b), as apart from 
a few specifications no differences to older youths are made. 
Young people under 15 who do not live with their (foster) family are placed in youth welfare 
institutions. Such institutions distinguish between children up to the age of 14 and young 
people over 14. Drug use is an issue in both areas, although care staff usually do not expect 
it to occur among children, so it sometimes goes unnoticed there. In cases of massive drug 
use, youth welfare institutions have made the experience that it is hard to keep the young 
drug users in the institution, so the cooperation with child and youth psychiatry services has 
been increased. In order to establish the necessary network between youth welfare agen-
cies, drug help services and psychiatrists, the City of Vienna created the Drug Prevention 
Competence Centre (see ÖBIG 2002b). The objective of this centre is to provide an early in-
tervention strategy and help the young clients to get assistance where they are, without be-
ing torn from their social environments, if possible. In addition to specific training for the 
youth welfare workers in substance use by young people, the competence centre has fo-
cused on the cooperation with drug help services and psychiatrists in order to be able to 
draw on their resources and support if necessary. Furthermore, guidelines were drawn up 
which should make it easier to assist young drug-users.  
In Vienna it has been considered to establish a youth-psychiatry emergency service for youth 
welfare institutions, which would go to the place where an emergency occurs and give further 
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instructions, as the care staff in these institutions increasingly often reach a point where they 
no longer know how to handle young people who use drugs. Also, the institutions have been 
equipped with respirators, as cases of overdosing have repeatedly occurred. For girls for 
whom assistance cannot easily be provided, a house-sharing project with twelve places was 
established as a contact point. This is a low-threshold accomodation without a daily structure 
(Bäcker, personal communication).  
The drug help services have also responsed to the growing drug use prevalence among 
young people (see ÖBIG 2001b, ÖBIG 2002a, ÖBIG 2002b). In Vienna the low-threshold 
service Dialog 10 for young people was opened in 2005 (see Chapter 5.1), which provides 
practically oriented assistance and a daily structure. In order to elucidate all the factors that 
are relevant for the work with young people, there are several cooperation structures as well 
as individual case conferences.The open service mainly focuses on meeting basic needs 
such as food, drinking and hygiene, rather than on development in the sense of social educa-
tion. Drug help services have designed special strategies for young people and children, with 
the aim of giving young clients the opportunity to perceive and accept the service as help. 
The services do not distinguish by age. It has been noticed that especially among young 
people, various issues and problems are mixed up and addressed in a spontaneous manner; 
accordingly, professional responses cannot be divided according to the usual counselling 
schemes. 
The importance of integrating relevant persons or institutions that are part of the social envi-
ronment, activating other support services in the field of child and youth work, as well as child 
and youth psychiatry treatments, also becomes evident in this setting.  
Outreach services are also faced with drug-users younger than 15, especially on the occa-
sion of syringe exchange in drug street social work. In December 2005, an emergency shel-
ter for young people between 14 and 18, which also admits alcohol users and drug users, 
was opened in Vienna (see Chapter 9.1). 
In general, the primary aim of assistance services is to stabilise young people with problem-
atic substance use and to free them from the dynamics of drug use and the related psycho-
logical patterns, at least for a certain period of time. 
The importance of specific training for professionals who work with young people using sub-
stances has been realised to some extent at the level of services and training schemes are 
implemented there. In addition to trainings for staff of the youth welfare office in Vienna, also 
the drug outpatient service at Innsbruck (Tyrol) organises further training for its care staff, 
because the care setting for children and young people with drug problems has some special 
aspects that need to be considered (Bäcker, Giacomuzzi, personal communications). 
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12 Cocaine and Crack – Situation and Responses 
As already in 2000, information and data on cocaine in Austria are relatively scarce (ÖBIG 
2000). This is partly due to the fact that the group of persons exclusively using cocaine are 
socially inconspicuous, therefore it is difficult to obtain epidemiological data for this group. 
Also, the majority of available research studies on drugs and addiction focus on opiates. 
Therefore, there is little statistical material on the extent of cocaine consumption and the 
number of cocaine users. The information used for this chapter mainly originates from sur-
veys of the drug situation in general and not of cocaine in particular. According to the few co-
caine-specific studies, crack in Austria still is insignificant, as it was six years ago. 
12.1 Prevalence, patterns and trends of cocaine 
and crack use 
For a comparison of drug experience see Tables A1 and A2 in Annex A, which combines life-
time prevalence from various surveys since 1998. For adults and school students, the preva-
lence of cocaine is in the range of 2% to 4%, which roughly corresponds to the prevalence of 
amphetamines and is markedly below cannabis prevalence, which is between 7% and 37% 
(see also Chapter 11.1). 
The representative population survey carried out in 2004 in Austria included questions on the 
use of legal and illicit substances (Uhl et al. 2005a). The results showed a lifetime prevalence 
rate of cocaine of 2.3%, and a 30-day prevalence of 0.3%. In comparison, the corresponding 
prevalence rates for amphetamines were 2.4% and 0.3%, respectively, and for heroin, 0.7% 
and 0.2%, respectively (see Chapters 1.4, 2.1, 11.1). 
The results of a survey by IFES (IFES 2005a) did not confirm reports of a strong increase in 
the availability of cocaine (see Chapters 1.4, 2.1 and Figure 2.1, S. 12). As two years before, 
a total of 2% of the respondents indicated to have used this substance before, and they were 
almost exclusively men (4%). For the years from 1993 to 2001 the share of respondents stat-
ing they had tried cocaine before was 1%. The share of cocaine users in the total population 
within the past three years and the past 30 days was below 1%. IFES did not register any 
relevant changes as to the lifetime prevalence of cocaine over the past few years, either.  
In Upper Austria, every three years a representative population survey is carried out, which 
also addresses the subject of illicit drugs. In addition, 420 young people aged between 15 
and 24 were included, so that this age group was over-represented, which permitted a de-
tailed evaluation of the corresponding data. Regarding substances in the year 2003, the 
group between 15 and 59 showed lifetime prevalence rates of 3.7% in total and 5.2% for 
men (see Table A1 in Annex A). For the group between 15 and 24, the corresponding figure 
was 6.2% (see Table A2 in Annex A). In a survey carried out in 2000 (market 2000) among 
the general population, a lifetime prevalence of cocaine of 2% was registered. A comparison 
shows that the figures for lifetime prevalence of cannabis were much higher: 23.7% in 2003 
(young people aged 15 to 24: 34.3%) and approximately 15% in 2000. Also in Upper Austria, 
the figure referring to cocaine prevalence within the past 30 days was below 1% in the group 
Chapter 12: Cocaine and Crack – Situation and Responses 
71
aged 15 to 59, while the corresponding share among young people between 15 and 24 was 
1.3% (see Tables A1, A2 in Annex A). 
In the course of the ESPAD survey in 2003, Austrian school students of the ninth and tenth 
grade were interviewed about alcohol and other drugs (Uhl et al. 2005b). Among these re-
spondents, the lifetime prevalence was 2% for cocaine, 5% for amphetamines, 3% for ec-
stasy and 1% for heroin. Regarding the age in which specific illicit substances were tried for 
the first time, for cocaine, as well as heroin, figures below 1% were registered in all respond-
ing age groups (ranging from younger than 11 up to 16 years).  
In Lower Austria, in late 2005 the counselling service Auftrieb carried out a survey at Wiener 
Neustadt and surroundings, in which 1 404 young people aged between 12 and 19 were in-
terviewed on the subject of substance use (Gartner-Schiller and Neumayr 2006). Here the 
lifetime prevalence of cocaine, as well as of speed and of LSD, was approximately 2.5%. The 
corresponding figure for cannabis was 12%. According to the authors, opiates, cocaine and 
other hard drugs hardly play a role among their target group, and also experimental use is 
found only to a minor degree. Only few young people, whose lives are influenced by several 
problematic and addiction-promoting factors at once, seem to try, and may consequently be-
come addicted to, such drugs.  
In Styria, a survey of the drug situation at vocational schools and residence halls for trainees 
based on surveys among 43 educators and 3 919 school students provided recent data 
(Hutsteiner et al. 2005). In the case of cocaine, this survey registered a lifetime prevalence of 
2% and a twelve-month prevalence of 1.2%, which is significantly below the figures previ-
ously reported for this group (see Chapters 1.4, 2.2, 3.1). 
Within the framework of the EU project Support Needs for Cocaine and Crack Users in 
Europe (COCINEU), at the Institute of Psychology of the University of Vienna a diploma the-
sis was presented which surveyed Austria’s cocaine and crack users and explored the extent 
of the problem (Primus 2005); this is one of the few cocaine-specific studies available. By 
means of interviews, this diploma theses collected data on three different groups of consum-
ers and compared them. In addition test results of urine samples from seven years were 
compared in order to check the development of cocaine consumption from 1996 to 2002.  
Between 2002 and 2003, a total of 211 persons were interviewed and split up in three 
groups: client group, scene group and party group. At the time of the interviews, members of 
the first group had to be clients of drug treatment services, while members of the scene 
group were not admitted to interviews if they currently were in drug treatment, and they had 
to be members of the open scene, whereas the party group consisted of socially integrated 
persons who were not in drug treatment and used cocaine only nasally. The criterion for in-
clusion in this survey was the use of cocaine at least once a month prior to the interviews.  
The average age of the respondents was approximately 28 years, the share of women was 
approximately one third in the client group and the scene group, and almost 50% in the party 
group. The average age at first-time experience of cocaine was 21 years, the average dura-
tion of use was 4.5 years. Only nine of the respondents said they had used crack, therefore 
no corresponding data could be presented. 
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Within the past month, cocaine had been used by members of the scene group on 22 days, 
by members of the client group on 9.5 days and on 8 days in the party group. In addition to 
other illicit substances, heroin was used in the scene group on 19 days (client group and 
party group: seven days), and cannabis on eight days (client group and party group: ten 
days). The scene group indicated to have used more than one substance on 23 days in the 
month prior to the interviews. The corresponding figures were 14 days for the client group 
and 12 days for the party group. The longest uninterrupted phase of use was 31 hours in the 
client group, twelve hours in the party group and nine hours in the scene group. The party 
group indicated nasal administration (97%) or smoking (3%) of cocaine, while the client 
group reported nasal (21%) and i.v. application (79%). The scene group used cocaine only 
intravenously. 
In addition, urine samples that patients handed in at the drug outpatient service of the Gen-
eral Hospital of Vienna (AKH) between 1996 and 2002 in the course of methadone mainte-
nance therapy were tested for cocaine. On the one hand, always two successive years were 
compared for significant changes, on the other, the entire period was investigated. It showed 
that in 2002 significantly more persons had handed in cocaine-positive urine samples than in 
1996. On the basis of the results the author of the diploma thesis comes to the conclusion 
that in Austria, as in the majority of European countries, there has been a rise in cocaine use 
over recent years.  
A 2003 survey focuses on cocaine-related problems in the street drug scene of Vienna (VWS 
2003b). Since the mid-1990s, cocaine use has played an important role in the street drug 
scene, and a special problem is its almost exclusive i.v. use. The number of persons con-
cerned was cautiously estimated at several hundred, consisting of three distinct group with 
different drug use patterns. The first group uses mainly cocaine; opiates are only used in 
connection with cocaine (mixed in “cocktails”), the main desired effect being that of cocaine. 
The second group consists of persons who follow a poly-drug use pattern and consume co-
caine in the same measure as opiates and benzodiazepines (see ÖBIG 2000, ÖBIG 2001a). 
The third group is persons who primarily use opiate and benzodiazepines, with cocaine use 
on the side.  
Silbermayr stated that in Vienna, 2 000 persons showed a daily, problem pattern of cocaine 
use(Silbermayr 2003); to the above-mentioned groups he added students who use cocaine 
for better concentration as well as representatives of the new economy who, according to 
Silbermayr, regularly use amphetamines and cocaine in small doses. The latter group did not 
perceive themselves as having drug problems, therefore they did not turn to drug help ser-
vices.  
Another group with very different characteristics from the street drug scene was the target 
group of ChEck iT!, which hardly injected cocaine, hardly showed comparable peaks of use 
and as a rule was (still) socially integrated. The prevalence of use for the ChEck iT! clients 
was 29% within the past month and 55% regarding lifetime prevalence. 23% reported com-
bined use of cocaine and ecstasy. Although these prevalence figures are relatively high, co-
caine, usually administered nasally in this group, was not the primary drug in most cases. 
Cocaine was used on special occasions or when users could afford it. Often, speed was pre-
ferred over cocaine on account of its longer effect and lower price (see Chapters 3.2, 10.3; 
VWS 2003b). 
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In the Tyrol, the drug and addiction counselling service provided a very helpful analysis of 
data from 160 persons indicating to have used cocaine at the time of admission, which led to 
the following results (B.I.T. 2006): the average age of users was 25.4 years, the share of 
women was approximately one fifth. The average age at first-time use was 18.8 years for co-
caine and 19.9 years for crack, which was used in addition to cocaine by eight persons (5%). 
Around 40% of the cocaine users indicated to have used cocaine at least once a week in the 
month before counselling started, while 3% said they used cocaine every day. Cocaine was 
administered nasally by 79% and intravenously by 14%. Additional substances used were 
cannabis, alcohol, MDMA and amphetamines.  
Within the framework of a survey drawn up in 2005 for the project QCT-Europe, differences 
between compulsory clients (persons under obligation to receive therapy) and voluntary cli-
ents of drug services were examined (Trinkl and Werdenich 2005). For 22% of the persons 
who were obliged to receive therapy, cocaine was the main problem substance, whereas the 
corresponding share was 10.4% among the voluntary group; the predominant use pattern 
was poly-drug use and no significant differences as to use were registered between the two 
groups (see Chapter 5.2).  
For more information on this issue see Chapter 13 (Developments in drug use within recrea-
tional settings) of the previous report (ÖBIG 2005a). 
12.2 Problems related to cocaine and crack use 
With regard to treatment requirements in the context of cocaine, only treatment data relating 
to all substances are available. Data from the nationwide documentation system of clients of 
drug help services (DOKLI) will not be available before 2007 (see Chapter 4.2).  
According to the Vienna BADO documentation, four out of ten clients assisted between 2002 
and 2004 indicated to have used cocaine in the previous month (see Chapter 4.2). Slightly 
more than half of the clients used cannabis and/or heroin at that time. In 2004 approximately 
half of the respondents used cocaine nasally, the other half administered it intravenously. 
More than half of the clients in 2004 had been assisted by a drug help service in Vienna be-
fore they came to BADO. There were no cocaine-specific data available in this respect (IFES 
2005b). 
Similar figures were reported by Grüner Kreis (Grüner Kreis 2005). In 2004, prior to therapy 
46% of the persons in inpatient treatment had used cocaine and 49% heroin several times 
per week. Remarkably, 63% of the persons who had to undergo therapy upon court order 
used cocaine, which is a much higher figure than that registered by Trinkl and Werdenich in 
their survey (see above), whereas only 42% of the other clients indicated use of cocaine. In 
2004, a total of 54 patients were treated in short-term therapy, one fifth of whom were 
women. The substances used most frequently by patients undergoing this type of therapy, 
apart from alcohol (70%) were cannabis (46%), cocaine (43%) and ecstasy (28%). In the 
case of cocaine there were no significant differences between patients in long-term or short-
term treatment (46% and 43%, respectively. Clients in outpatient treatment and care had 
used mainly cannabis (65%) and cocaine (57%). Outpatients used cocaine more frequently, 
while inpatients consumed alcohol, heroin, substitution substances, benzodiazepines and 
other tranquillisers to a greater extent.  
Chapter 12: Cocaine and Crack – Situation and Responses 
74
In its annual report of 2005, the Maria Ebene foundation reported that drug use trends 
among their clients had largely remained the same. Stimulating substances such as cocaine, 
but also amphetamines and ecstasy continued to be used at a generally high level. However, 
the leading cause of treatment demand still was poly-drug use of opiates (58%). While the 
share of cannabis as main drug increased from 13% to 23%, that of cocaine as primary drug 
declined from 23% to 12% (Stiftung Maria Ebene 2006).  
At the Tyrolean outpatient drug help service B.I.T. the percentage of cocaine users in the to-
tal number of clients was approximately 8.5% in 2005  (B.I.T. 2006). Contrary to the patients 
at Grüner Kreis, this group came to the service because they were recommended to do so by 
a physician or by family member, or upon their own initiative, rather than because they were 
obliged to do so upon court order. This difference is due to the modes of operation: B.I.T. is 
an outpatient service, while Grüner Kreis essentially provides inpatient treatment.  
In Styria the outpatient service b.a.s. indicated that cocaine as a main drug played a very 
marginal role (b.a.s. 2006). In 2005, cocaine had been the primary drug for six men and 
three women; the total number of persons registered that year was 1 312. Also from this ser-
vice it was reported that crack continued to be insignificant.  
The statistics on drug-related deaths show that cocaine plays an important role in this con-
text.  Over the years, cocaine was found in 30% of drug related deaths (ÖBIG 2006a, ÖBIG 
2006b, BMGF 2004). As can be seen in Table 12.1, in 37 out of 169 toxicological analyses of 
drug-related deaths carried out in 2005, cocaine was found, which made cocaine the second-
most frequent illicit substance after morphine, as in the years before. In 34 cases cocaine 
had been combined with opiates, which accounted for 83% of poly-drug intoxication with opi-
ates and another illicit substance. In three cases cocaine was the only illicit substance, in one 
of these cases it had been used in combination with a psychoactive pharmaceutical. Two 
persons had consumed cocaine with alcohol (see also Chapter 6.1). 
Table 12.1 Number of drug-related deaths with toxicological analysis  
in which cocaine was found, from 2003 to 2005 
2003 2004 2005 
Total number of drug-related deaths which were toxicologically analysed 163 175 169 
Cocaine found 49 52 37 
Cocaine in combination with opiates (and alcohol and psychoactive  
pharmaceuticals) 
43 49 34 
Cocaine as the only illicit substance 6 3 3 
of which: cocaine and alcohol 1 1 2 
of which: cocaine and a psychoactive pharmaceutical 1 – 1 
Sources: ÖBIG 2006a, ÖBIG 2006b, BMGF 2004 
Between 2003 and 2005 the majority of deaths in which cocaine was found to play a role was 
registered in the group of men between 20 and 24 years (2003: 11; 2004: 15; 2005: 14). In 
2004 there were also 11 cases in the age group between 15 and 19 years. In all surveyed 
years, the gender ratio of cocaine-related deaths corresponded to the total number of drug-
related deaths, with a share of men of approximately 80%. By far the highest percentage of 
cocaine-related deaths was registered in Vienna (between 60% and 70%). In the course of 
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collecting data on drug-related deaths, infectious diseases are recorded, but there is no 
specification of the substances that were used (see Chapter 6.2).  
The diploma thesis mentioned in Chapter 12.1 (Primus 2005) also examined the infection 
status of the respondents. Regarding hepatitis B, the majority of the respondents said they 
ere not infected. The results for hepatitis C were different. 57% of the client group indicated a 
hepatitis C infection, in the scene group the percentage was 59. With only 3%, the party 
group differed significantly here. Regarding HIV, the majority in all three groups indicated no 
infection. Regarding sexual contacts of persons in all three groups, it was registered that they 
did not differ either in the frequency of sex without a condom or in the number of partners 
with whom they had unprotected sex. Only the scene group members indicated they had 
sexual contacts with intravenous drug users more frequently than the other two groups.  
As mentioned above, the problem of intravenous cocaine use in the street scene has be-
come more dramatic over the past few years. One has to bear in mind that using cocaine up 
to 20 times per day results in enormous pressure to acquire cocaine, and in the neglect of 
safer-use rules (VWS 2003b). The use of speedballs, a mixture of heroin and cocaine, which 
is injected and was already reported in 2000, was continued. As effects of the two sub-
stances used interact their effect, this mixture should be considered particularly dangerous  
(ÖBIG 2000).  
12.3 Responses and interventions to cocaine and 
crack use 
As yet there are no cocaine-specific treatment approaches in Austria, which may partly be 
due to the fact that poly-drug use is the predominant pattern of use among the clients of the 
drug help system. Therefore cocaine users are usually treated together with users of other 
substances. As mentioned before, there are very different groups of cocaine users, so it 
would be necessary to offer a specific form of treatment for each group.  
It is especially hard to motivate users of cocaine in the street scene to undergo treatment. 
Excessive cocaine use has the effect that pain is hardly felt at all. If medical help is sought, 
compliance with regard to appointments for check-ups and prescribed pharmaceuticals is 
very low. As a  consequence, lesions may become so grave that inpatient treatment would 
be indicated. However, this type of intervention is bound to fail either because the patients ei-
ther refuse inpatient treatment altogether or they discontinue it prematurely. In order to pro-
vide some sort of remedy for this situation, at Ganslwirt outpatient service treatment is pro-
vided to cocaine users also during the night (VWS 2003a).  
At Maria Ebene hospital in Vorarlberg, cocaine-addicts may undergo inpatient treatment in 
the existing departments. The target group are especially persons consuming alcohol in 
combination with cocaine. In addition, cocaine users receive treatment in the context of the 
principle of therapy instead of punishment (Neubacher, personal communication). 
The drug outpatient service at Innsbruck in the Tyrol reports that cocaine consultation hours 
have been offered for three years and are well accepted by the clients. In addition to coun-
selling talks, a medical therapy programme is offered, in the course of which patients may 
receive treatment and care for a maximum of six months and regular urine samples are 
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taken. In exceptional cases of severe cocaine dependence, additional sleep therapy is pos-
sible to complement treatment (Kern, personal communication). 
Cocaine users in the street scene suffer from restlessness, extreme tension, even paranoia, 
but they have no possibility of being by themselves or relaxing. However, what is most alarm-
ing is that rules of safer use in the sense of harm reduction, e. g., greatest possible hygiene 
and slow use, are no longer considered relevant. In 2002, Ganslwirt responded by further re-
ducing possible thresholds and opening a rest room for this group of users. Other harm re-
duction measures include information and safer use talks, which also serve as a starting 
point for further interventions. Water, tea and soft drinks are available 24 hours a day at 
Ganslwirt; another measure is unlimited sale of syringes and needles (see also Chapter 7.2; 
VWS 2003a). Other harm reduction measures are not limited to cocaine users (see Chapter 
7.2 and Structured Questionnaire 23). 
In order to create adequate care options also for the party group of users, the Vienna Univer-
sity Hospital of Psychiatry introduced a cocaine telephone hotline. Patients from the party 
group who use cocaine (not heroin) have the possibility to call once a week and are guaran-
teed the greatest anonymity possible (Thau 2004). 
Volume Six of the publication series issued by the Maria Ebene foundation is an information 
brochure on cocaine, with the aim of drawing more attention to this so-called fashion drug 
and provide factual information. In addition the brochure includes a section on counselling 
and therapy as well as addresses and contacts (Stiftung Maria Ebene, web site). 
In addition to the establishment of user rooms and more syringe dispensing machines, ex-
perts consider it essential that an intervention model for cocaine users be drawn up (VWS 
2003b). This idea corresponds to proposals voiced by Silbermayr, who also believes that a 
network of diversified approaches and services should be developed and offered. According 
to Silbermayr, cocaine-specific programmes should also accommodate the needs of different 
ethnic groups and provide counselling in their native languages (Silbermayr 2003). 
12.4 Cocaine-related crime and cocaine and 
crack markets 
As outlined in Chapter 8.2, the total number of reports in connection with cocaine rose only 
slightly compared to the previous year, but more than doubled in comparison to the year 
2000 (see Table A11 in Annex A and Standard Table 11). The number of seizures of cocaine 
increased only slightly compared to 2004, whereas the amounts seized were three times as 
high as in 2004, reaching an all-time peak on account of three large seizures (see Tables 
A17, A18 in Annex A and Standard Table 13). 
Regarding offences committed to finance drugs, the survey presented in Chapter 12.1 (Pri-
mus 2005) states that among the user groups examined, members of the scene group most 
frequently indicated to have pursued sex work (21.4%) in the month prior to the interviews. 
The corresponding share in the party group was a mere 1.4%. Another significant difference 
between these two groups regards selling drugs, obtaining drugs for others or producing 
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drugs. The scene group indicated to have engaged in these activities on 13 days in the 
month prior to the interview, compared to five days indicated by the party group.  
Data from the BMI indicate that the purity of cocaine sold on the street in 2005 was 45% on 
average, which represents a slight rise compared to the previous years (see Table 10.2 and 
Standard Table 14). In 2002 a survey on the basis of 526 used syringes and 496 question-
naires was conducted (Haltmayer and Schmid 2004). The drugs found when analysing the 
syringes were cocaine (35%), cocaine and opiates (12.5%), morphine (24%) and opiates 
(17%). It was also found that only 17% of the samples believed to be cocaine (as indicated 
by users) actually contained pure cocaine. In the majority of the samples the cocaine was di-
luted (31%) or mixed with other substances (31%). An examination of purchasing patterns 
showed that the surveyed group mostly bought cocaine off the street rather than from private 
sources. 
According to the BMI (2006) (see Table 10.2 and Standard Table 16), the retail price for co-
caine in 2005 was EUR 80 per gram on average, which is a slight decline in comparison to   
2002 (EUR 95). Per month, the scene group interviewed by Primus (2005) spent almost EUR 
2 000 on drugs, while the party group named an amount of almost EUR 600. 
Young people who indicated that they had been offered drugs said they had been confronted 
mainly with cannabis, ecstasy and amphetamines, cocaine ranked fourth in this respect 
(BMSG 2003a). In the ESPAD survey of 2003, 8.7% of the school students who were asked 
to indicate how difficult it was to get cocaine, responded that it was “rather easy” (Vienna: 
11.9%). The corresponding figure for cannabis was 20.8% (Vienna: 23.6%), which is mark-
edly above the percentage indicated for cocaine (see Chapter 12.1 and Uhl et al. 2005b). 
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13 Drugs and Driving 
In Austria, the theme of drugs used in road traffic is a recurring issue, which has been con-
troversial at the political, expert and scientific levels. In the corresponding discussions, on the 
one hand the priority of traffic safety was stressed, and on the other, concerns about the 
constitutionality of drug tests were expressed. In the past few years, there have been some 
legislative changes in this context. In general, a distinction is made between alcohol and 
drugs, but not between individual substances (e.g., cannabis) or pharmaceuticals (e.g., ben-
zodiazepines). 
13.1 Policy 
Already in 1997/98 a survey by the Ministry of Transport was presented to the Vienna Drug 
Commission, which had the aim of assessing the driving ability by means of urinalysis and 
medical examinations. It was found that drug use can be detected through urinalysis and ex-
amining the pupils’ position and reaction, but not through saliva tests or other clinical exami-
nations. In 2001 the subject of drugs in road traffic was discussed on the basis of a  resolu-
tion by the government coalition; in this context, an expert hearing was organised by the 
Federal Drug Coordination, a symposium was held by the Vienna Social Fund and ARBÖ, 
the Automobile, Motorcycle and Bicycle Club of Austria, and expert interviews took place as 
well (ÖBIG 2001a, ÖBIG 2002a). In essence, the discussion centred on mandatory drug 
tests for drivers; strong doubts were expressed as to their usefulness because the existing 
tests on the current driving ability have little informative value. It was found that further infor-
mation and the identification methods are necessary, and that there is demand for research 
especially in the fields of substance-specific diagnosing and testing procedures.  
In June 2002 the Tyrolean Chamber of Pharmacists organised a symposium on the topic of 
the use of pharmaceuticals and drugs in road traffic (Heinrich 2002). In the course of this 
event relevant questions were discussed from scientific, legal, forensic and political perspec-
tives. One of the demands raised was that the Decree on Labelling Pharmaceuticals be 
amended in the sense that all possible side effects on the driving ability should be specified; 
another demand was to create a scientific basis through research assignments, and clarifica-
tion and information rather than surveillance and potential punishment. As a consequence, 
both the Ministry of Health and the Vienna Drug Advisory Board formed a working group on 
the issue of the use of drugs and pharmaceuticals in road traffic.  
In July 2002 an amendment to the Road Traffic Regulations (StVO) was passed by parlia-
ment, containing the introduction of mandatory blood tests if an impairment of the ability to 
drive due to drugs is suspected (Chapter 13.3). The aim was to adapt the drug regulations 
executed by the street police to the regulations regarding alcohol (Vergeiner et al. 2004). On 
1 July 2005 the 21st amendment to the StVO entered into force, according to which saliva 
tests were introduced to assess suspected impairment of the driving ability by narcotic sub-
stances (Chapter 13.3). However, the interministerial decree necessary for implementation, 
which is to regulate the exact procedure to be followed by the police, public prosecutors and 
public health officers, is still missing because there is no suitable testing equipment. 
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Apart from amendments to the StVO, possible amendments to the Driving Licence Act 
Health Decree (FSG-GV) were also repeatedly discussed. According to the FSG-GV (Fed-
eral Collection of Statutes BGBl. II No. 322/1997, as amended by BGBl. II No. 427/2002), 
persons who are dependent on alcohol or narcotic substances or are unable to limit their use 
of addictive substances in a way that their driving ability is not impaired, are not healthy 
enough to be entitled to drive. Therefore, if dependence is suspected, a psychiatric expert 
opinion must be presented to the public health officer. To (re)issue the driving licence on the 
basis of a positive opinion by a medical specialist and obligatory medical check-ups is only 
possible in the case of group 1 driving licences (motorcycles and passenger cars). Especially 
with regard to occupational re-integration of former drug addicts, it has been demanded to 
include group 2 driving licences (busses and lorries) as well (ÖBIG 1999, ÖBIG 2002a, ÖBIG 
2003). However, these plans still have not been implemented.  
In this context also Section 39 of the Driving Licence Act (BGBl. I No. 129/1997, last 
amended by BGBl. I No. 152/2005), is relevant, as it rules that in the case of an impairment 
due to alcohol or substance use the driving licence must provisionally be revoked if a car-
holder drives, operates or attempts to operate their vehicle. 
Alcohol and drugs are among the focuses of the Austrian Road Safety Programme  2002–
2010 (BMVIT 2003). The measures under this heading include special training of police offi-
cers to identify conspicuous drivers in the course of traffic controls, but also of physicians 
who are in charge of examining such drivers. Furthermore, surveillance shall be intensified. 
13.2 Prevalence and epidemiological methodology 
There are no prevalence estimates on drug use and driving available, neither for illicit drugs 
in general nor for cannabis or pharmaceuticals such as benzodiazepines. No regular data 
collections or surveys are conducted in this field. Therefore, hardly any data are available on 
the extent of drug use in road traffic, a deficit which has been deplored by experts in Austria. 
In order to ameliorate this situation it has been suggested, among other measures, that in 
cases of accidents that result in damage to persons, it should be investigated whether drugs 
were acquired by the drivers involved (e.g., Vergeiner et al. 2004). Because of the data situa-
tion no statements on trends, age groups concerned, gender differences etc., are possible. 
Still, it has shown that drugs at present play a much less significant role than alcohol. For ex-
ample, in 2003, 688 driving licenses were provisionally revoked because of impairment fol-
lowing drug use, compared to 21 188 cases of impairment after consuming alcohol (ÖBIG 
2004). In 2005, 913 persons were reported to the police on account of impairment of the abil-
ity to drive caused by clinically detected drugs confirmed by blood tests (Germ, personal 
communication). In the same year 32 708 persons were reported on account of impairment 
of the driving ability by alcohol, and another 7 000 persons on account of minor impairment 
(0.5‰). 
The annual statistics on road traffic accidents in Austria (Statistik Austria 2006) only include 
evaluations on accidents involving drivers under the influence of alcohol (a total of 2 746 ac-
cidents in 2005). Some experts assume that a high risk of accidents results especially from 
combined use of drugs and alcohol and that this is a rising trend, contrary to the exclusive 
Chapter 13: Drugs and Driving 
80
use of alcohol when driving. Others have expressed doubts whether this observation is cor-
rect, considering the use of pharmaceuticals which negatively influence the driving ability to 
be a much greater problem than the use of drugs (Heinrich 2002).  
As to age, according to an estimate by the Austrian Road Safety Board (2004), approxi-
mately 90% of all persons driving under the influence of drugs are between 18 and 33 years 
old. According to the Diagnoses Institute (ISD, Vienna) based on expert opinions in the con-
text of Section 5 StVO (FSW 2006a), in 2005 53 persons were referred to the Institute, 
whereas in the two previous years, the corresponding figures were 89 (2004) and 54 (2003). 
What the ISD regards as problematic in this connection is the lack of adequate measuring 
techniques that directly indicate an impairment relevant in road traffic. 
Regarding the prevalence ratio of benzodiazepines and alcohol in road traffic an interesting 
survey has been carried out by the University Clinic for Accident Surgery at Innsbruck. In the 
course of one year, blood samples for assessing plasma levels of alcohol and benzodiazepi-
nes were taken of 269 persons who had been admitted after a road traffic accident. 27.5% 
tested positive for alcohol, 5.2% for benzodiazepines, and 1.9% for both (Heinrich 2002). All 
plasma concentrations of benzodiazepines found were within a subtherapeutic or therapeutic 
range. The evaluation of the degree of severity of injuries showed a significantly higher share 
of polytrauma injuries in persons with positive benzodiazepine plasma level. 
At the drug outpatient department of the Vienna University Hospital for Psychiatry, a con-
trolled survey was carried out to examine the influence of the substitution substances metha-
done and buprenorphine as to potential cognitive and psycho-motor impairments that play an 
important role in road traffic (Schindler et al. 2004). 30 persons stabilised on methadone or 
buprenorphine were examined in a psycho-diagnostic test series 22 hours after taking their 
medication and were compared to a control group. For the majority of parameters examined, 
there were no significant differences. Under monotonous conditions, the number of reactions 
with a greater share of mistakes was significantly higher in the group using substitution sub-
stances. Under dynamic conditions, patients using methadone as a substitution substance 
on average took longer to decide and react. The additional use of illicit substances led to 
relatively worse results compared to the persons without additional drug use.   
13.3  Detection, measurement and law enforcement 
The procedure for drug tests in road traffic is regulated in Section 5 of the StVO 1960 (BGBl. 
I No. 159/1960, last amended in BGBl. I No. 52/2005). A distinction is made only between al-
cohol and narcotic substances (as defined in Section 2 of the SMG), and there are no spe-
cific regulations regarding pharmaceuticals like benzodiazepines. Unlike in the case of alco-
hol, for narcotic substances used in road traffic there are no threshold values, but driving is 
prohibited altogether. The decisive factor is a state of impairment which is described in Sec-
tion § 58 (1) of the StVO as follows: a vehicle may only be operated if the driving person is in 
a physical and mental state which permits them to have control over the vehicle and to ob-
serve the legal regulations that apply to driving. If the police has reason to suspect that a 
driver is physically unfit to drive on account of their behaviour, an accident or unusual physi-
cal state, and if the possibility of alcoholic intoxication has been excluded, the police have the 
right to test the driver for drugs. This also applies to pedestrians if there are grounds for sus-
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pecting that they have caused a traffic accident under the influence of narcotic substances. 
The procedure for assessing impairment by drugs follows a model in several steps:  
• First, the officers in charge of traffic control investigate the suspicion of impairment follow-
ing the use of narcotic substances and simultaneously exclude alcoholic intoxication by 
means of a drug-checking form. This form includes questions about driving behaviour, the 
accident situation or situation when the person was stopped, responses, disposition, 
manner of speaking and walking as well as the results of the alcohol test (Öffentliche Si-
cherheit 2006). 
• The second step in this model is a saliva test for narcotic substances by means of a saliva 
pre-testing device operated by specially trained road surveillance officers or a public 
health officer; however, no adequate devices are available yet (see below). 
• If the suspicion of impairment by narcotic substances has been corroborated, the degree 
of impairment is assessed through clinical examination by a health officer (e.g., measuring 
blood pressure and heart rate) according to a standardised examination sheet. 
• If the clinical examination has confirmed the impairment, the last step is a blood test for a 
narcotic substance by an authorised physician. Although the blood test cannot be per-
formed by force, Section 5 (10) provides that a blood sample must be taken and the per-
son in question shall to undergo the blood test.  
According to Section 5 (8) of the StVO the blood sample must be brought to the nearest po-
lice station without undue delay; the blood sample must not be delivered by the examined 
person themselves. The blood test is to be performed by a forensic medicine institution or a 
similar agency. The costs for the blood test (approx. EUR 500) have to be paid by the person 
in whom impairment by a narcotic substance has been detected.  
If the blood test shows a misuse of narcotic substances, the competent health authority is no-
tified (Sections 12–14 of the SMG), but no police report according to Section 27 of the SMG 
is filed. Furthermore, impairment by drugs is punished with an administrative fine of between 
EUR 581 and EUR 3 633, which is the equivalent of a fine for alcoholic intoxication between 
0.8‰ and 1.9‰ (Vergeiner et al. 2004). In addition to provisionally revoking the driving li-
cence (see Chapter 13.1) accompanying measures such as after-training or obtaining a cer-
tificate on physical fitness for driving issued by a public health officer may be required. How-
ever, there are no regulations as to the duration of the measures and who is in charge of 
monitoring that these measures are observed; also, no reporting procedure has been defined 
(FSW 2006a). Refusal to be summoned by the police and undergo clinical examination as 
well as illegal refusal to have a blood sample taken is punished with an administrative fine 
(Vergeiner et al. 2004). In case of a refusal to be summoned, the fine is between EUR 1 162 
and EUR 5 813, which corresponds to the highest level of alcoholic intoxication (more than 
1.6‰). 
The evaluation of existing saliva pre-testing devices on behalf of the BMI has not yielded re-
liable results so far. In a research project three different saliva pre-testing devices were as-
sessed in comparison to blood analyses (serum) in 100 addiction patients (Öffentliche Si-
cherheit 2006). For cannabis, the results corresponded to those of the blood analysis in only 
approx. 75% of the cases, for opiates, in 80%, and for cocaine, in 95% of the cases. How-
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ever, these results are not sufficient for a practical application of the devices, as false-
positive results are problematic and should be avoided because of the legal consequences. 
False-negative results, on the other hand, are problematic with regard to road safety, as they 
counteract the aim of barring impaired drivers from the roads. Because of the lack of ade-
quate devices, the decree on assessing these devices as provided in Section 5 (11) of the 
StVO has not been drawn up yet, either (see Chapter 13.1). Consequently, saliva tests are 
currently performed only for experimental purposes and on a voluntary basis (Germ, per-
sonal communication). The Vienna Social Fund (FSW 2006a) views such cases as problem-
atic in which impairment is found on the basis of a urinalysis in connection with an examina-
tion by a public health officer and the driving licence is revoked immediately, whereas the 
blood test result, which is only available approximately two weeks afterwards, does not con-
firm impairment. 
With the introduction of mandatory blood tests and also in the context of the saliva tests as 
planned, adequate training of the officers involved has been demanded. Traffic control offi-
cers receive training on how to recognise driving impairment in the context of traffic law edu-
cation lessons within the framework of their basic training (Germ, personal communication). 
In 2002/2003 an additional training initiative in the form of a halfday course for traffic control 
officers took place. These training lessons have since been organised by  the province police 
headquarters within the framework of personnel development. According to some experts the 
courses held for physicians on the subject of recognising potential impairment following sub-
stance use are insufficient. What is deemed necessary is the intensification of further training 
(FSW 2006a) and/or that only physicians who have had special in-depth training and relevant 
practical experience may work in this field (Dantendorfer 2005). 
13.4 Prevention 
The majority of prevention activities focus on alcohol. However, some of these measures are 
aimed at making young people consider their own consumption behaviour and the issues of 
risk and responsibility, so in general effects with regard to their use of psychoactive sub-
stances in road traffic may be expected. Typical examples include Mehr Spaß mit Maß (More 
Moderate Fun, in Vorarlberg), an initiative in the course of which 72 training units at driving 
schools were organised (Neubacher, personal communication), and the pilot project Respo-
Drive (Styria), which consists of a workshop and special driving safety training (bluemon-
day.at, 9 June 2006). 
Measures aimed directly at young people and also addressing the issue of drugs in road  
traffic are few in number. One example is project mobil & sicher (Safe Mobility) of Raiffeisen 
Club Styria which directs public attention to traffic risks at four stages (bluemonday.at, 9 June 
2006). The stage Be clean includes practical information and discussion on the issue of al-
cohol and drugs. In all vocational schools nationwide, traffic safety counselling is carried out 
by means of a lecture and a film in which the subject of alcohol and drugs is also addressed 
(Germ, personal communication). A similar programme is planned for upper secondary 
school levels, the target group being young people aged between 16 and 18. In the Tyrol, a 
pilot project is being carried out. The folder by the Austrian Association of Experts in the field 
of Drugs (ÖVDF) A Clear View from the Steering Wheel which has a special focus on legal 
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information, e.g. on traffic surveillance and suspected use of narcotic substances and poten-
tial effects on holders of a driving licence, is directed at multipliers. The meeting under the 
heading Rausch und Recht (intoxication and the law) which was organised for youth social 
workers in April 2005, also concentrated on legal aspects of the issues of drugs, youth pro-
tection and road traffic (ISP OÖ 2006). Complaints have been voiced because there is no 
adequate after-training for persons who were found to be impaired because of drug use, al-
though subsequent training measures have been scientifically proven effective (FSW 2006a). 
Even less activities which directly refer to pharmaceuticals are undertaken. One example is 
the information campaign on pharmaceuticals and drugs in road traffic carried out by the 
Tyrolean Chamber of Pharmacists in 2001. As a consequence of the campaign, greater 
awareness of the side-effects of pharmaceuticals and a higher frequency of related enquiries 
to pharmacies were registered (Heinrich 2002). Regarding the prevention of impairment by 
pharmaceuticals, labelling is relevant, among other factors. This has been regulated in the 
Austrian Medicines Act, which was amended in BGBl. I No. 152/2005 to conform to current 
EU directives. Section 17 (3) of the AMG provides that medicines which may impair the abil-
ity to react or driving ability shall have corresponding information on the outer packaging and 
on the primary packaging. Effects on the ability to drive passenger vehicles must also be in-
cluded on the enclosed information sheet (Section 15 (2) of the AMG), whereas the rules for 
use do not specifically list these effects (Section 16 (2) AMG). In Austria no relevant activities 
with regard to the classification of pharmaceuticals according to their effects have been reg-
istered. 
In the media, the issue of drugs and driving comes up again and again, but mainly in connec-
tion with alcohol use and accidents. To a much lesser extent, and also in the context of rele-
vant accidents, the use of drugs in road traffic has been addressed. Impairment of the ability 
to drive caused by pharmaceuticals such as benzodiazepines is not discussed at all. 
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Personal communications, alphabetical order  
Name and page Organisation or function 
Christine Anderwald (p. 39) Caritas Marienambulanz outpatient department, Graz 
a_way (pp. 54, 66, 70) Emergency shelter for young people, Vienna 
Wolfgang Bäcker (p. 66) MAG ELF – Department 6 – Social Education Services – Drug 
Counselling and Treatment Services, Vienna 
BBZ (p. 65) Counselling and Care Centre, association Dialog, Vienna 
B.I.T. (p. 66) Assistance, Integration, Tolerance; outpatient drug help service, 
Tyrol 
Dialog (p. 66 f.) Association Dialog, Vienna 
Dialog 10 (p. 65) Association Dialog, Vienna 
DOWAS Chill Out (p. 65) Chill Out emergency shelter for young people, Innsbruck 
Vinko Duspara (p. 39) Lukasfeld therapy department, Maria Ebene foundation, Vorarlberg 
Klaus Peter Ederer (pp. 19, 29) Drug coordinator, Styria  
Dr. Gabriele Fischer(p. 39) Clinical Department of General Psychiatry, drug outpatient depart-
ment at the General Hospital Vienna 
Colonel Martin Germ (pp. 82, 84 f) Federal Ministry of the Interior 
Dr. Salvatore M. Giacomuzzi MD (p. 70) Outpatient department of dependence diseases/drug outpatient de-
partment of the Psychiatric University Hospital of Innsbruck 
Dr. Hans Haltmayer (p. 39) Vienna Social Projects Association (VWS) 
Dr. Ursula Hörhan (pp. 9, 14, 29, 33) Addiction coordinator, Lower Austria  
Harald Kern (pp. 44, 78) Addiction coordinator, Tyrol  
Sabine Kolar (p. 17) Institute of Addiction Prevention (ISP) / Social Vienna Fund (FSW)  
Thomas Neubacher (pp. 27, 34, 77, 85) Drug coordinator, Vorarlberg  
Paul Neubauer (p. 64) Vienna Social Projects Association (VWS) 
Mag. Nicole Rögl (p. 19) Akzente addiction prevention centre, Salzburg 
Dr. Franz Schabus-Eder (p. 17) Addiction coordinator, Salzburg 
Dr. Ingrid Stolz-Gombocz (p. 39) Anton Proksch Institute, long-term therapy of drug addicts with 
personality disorders, Mödling, Lower Austria 
Dr. Ulf Zeder (pp. 27, 45) Addiction coordinator, Graz  
Z6-Streetwork (pp. 20, 54, 64 f., 66 f) Z6-Streetwork association (counselling, assistance and crisis 
intervention for adolescents) Innsbruck 
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DATA BASES 
 
EDDRA = Exchange on Drug Demand Reduction Action 
Internet data base of EBDD: http://eddra.emcdda.eu.int/eddra  
Austrian projects in the EDDRA data base:
Abrakadabra – (Re-)socialisation of drug addicts by integration in the labour market 
(Caritas der Diözese Innsbruck, Tyrol) 
Addiction information in schools supported by experts 
(kontakt+co - Suchtpräventionsstelle, Tyrol) 
Addiction prevention in early childhood: An advanced training course for kindergarten 
teachers 
(VIVID - Fachstelle für Suchtprävention, Styria) 
Addiction prevention within the apprenticeship of the Austrian Federal Railways 
(Institut für Suchtprävention, Vienna) 
Addiction prevention within the Styrian Soccer Association 
(VIVID – Fachstelle für Suchtprävention, Styria) 
Addiction programme: Promote health, prevent addiction 
(Bundesministerium für Unterricht und kulturelle Angelegenheiten, Vienna) 
Ambulance for addiction diseases at the University Hospital of Innsbruck, Department for 
Psychiatry 
(Universitätsklinik für Psychiatrie - Innsbruck, Tyrol) 
Become Independent: education programme for prevention in schools  
(SUPRO - Werkstatt für Suchtprophylaxe, Vorarlberg) 
Campaign „Empower our Children“ 
(SUPRO - Werkstatt für Suchtprophylaxe, Vorarlberg) 
Caritas Marienambulanz. Drug related street work, an outreach service in the field of 
medical care and treatment. 
(Caritas der Diözese Graz Seckau, Styria) 
CONTACT: Liaison service for hospitals 
(Fonds Soziales, Vienna) 
DAPHNE project: Addiciton as chance of survival? For women with experience of violence. 
(Verein Dialog und Verein Wiener Sozialprojekte, Vienna) 
DP drugaddicts@work. Equal ESF community initiative programme for reintegrating people 
with problematic drug use into the labour market. 
(Fonds Soziales, Vienna) 
Drug-free areas in Innsbruck prison 
(Justizanstalt Innsbruck, Tyrol) 
Drug free zone Hirtenberg prison 
(Justizanstalt Hirtenberg, Lower Austria) 
Drug Out: Innsbruck prison’s therapy unit 
(Justizanstalt Innsbruck, Tyrol) 
Early detection and intervention with regard to problematic drug use and addiction 
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(kontakt+co – Suchtpräventionsstelle, Tyrol) 
Employment Programme WALD (Forest) 
(H.I.O.B. - Anlauf- und Beratungsstelle für Drogenabhängige, Vorarlberg) 
Erlenhof: An inpatient treatment centre for addicts 
(Pro mente Upper Austria) 
European networking in addiction prevention 
(Institut Suchtprävention, Upper Austria) 
Fantasy instead of Ecstasy: Addiction prevention through peer group education in 
a vocational high school in Neumarkt in Salzburg 
(AKZENTE Salzburg - Suchtprävention, Salzburg) 
Generation E: Workshop for creative parents work 
(Institut für Suchtprävention, Fonds Soziales, Vienna) 
Grüner Kreis: A treatment facility for adolescents 
(Verein Grüner Kreis, Lower Austria) 
“Guat beinand’!”: Addiction prevention in communities and city districts 
(Akzente Salzburg – Suchtprävention, Salzburg) 
Health Promotion and Addiction Prevention in the Workplace  
(SUPRO - Werkstatt für Suchtprophylaxe, Vorarlberg) 
High enough? – Practical kit for addiction prevention in the field of youth work 
(VIVID Fachstelle für Suchtprävention, Styria) 
H.I.O.B.: Help, information, orientation and counselling for drug addicts  
(H.I.O.B. - Anlauf- und Beratungsstelle für Drogenabhängige, Vorarlberg) 
In motion: A multiplier project for addiction prevention at schools  
(Institut Suchtprävention - eine Einrichtung von pro mente, Upper Austria) 
Job assistance - subproject of the Vienna Job Exchange in the context of the Equal devel-
opment partnership 
(Wiener Berufsbörse, Vienna) 
Living together in the 2. district. Program for the prevention of addiction in schools, 
children and youth work in urban areas. 
(Institut für Suchtprävention, Vienna) 
Local Capital for Social Purposes (a pilot action of the DG V of the EU) Programme: 
“Socially Innovativ 2000” (EU regional management Eastern Styria) 
(Volkshilfe Steiermark, VIVID Fachstelle für Suchtprävention, Regionalbüro Oststeiermark, 
Styria) 
Log In: Measures for the integration and health promotion of former drug users 
(Anton Proksch Institute, Lower Austria) 
Long-term therapy, Anton Proksch-Institute, Mödling  
(Anton Proksch Institute, Lower Austria) 
Long-term therapy facility CARINA 
(Stiftung Maria Ebene, Vorarlberg) 
Long-term treatment of drug dependence Senobio, Schnifis, Vorarlberg 
(Senobio, Vorarlberg)  
Low threshold service Ganslwirt 
(Verein Wiener Sozialprojekte, Vienna) 
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Lukasfeld: A short term therapy for young illegal drug addicts 
(Stiftung Maria Ebene hospital, Vorarlberg) 
Making kids strong through Sports 
(SUPRO - Werkstatt für Suchtprophylaxe, Vorarlberg) 
MDA basecamp – mobile drug work in recreational settings 
(Jugendzentrum Z6, Tyrol) 
Medico-psycho-social Sanatorium „Schweizer Haus Hadersdorf“ 
(Evangelisches Haus Hadersdorf - WOBES, Vienna) 
Needles or Pins: Vienna: A European Project to develop innovative projects for the social 
and labour integration of people with drug related problems. 
(Beratungsstelle DIALOG, Vienna) 
Needles or Pins: A European Project to develop innovative projects for the social and 
professional rehabilitation of people with drug problems. Sub-project of Vorarlberg 
(Die Fähre, Vorarlberg) 
Needles or Pins: Occupational reintegration of (former) drug addicts. 
(Beratungsstelle DIALOG, Vienna) 
Pib – prevention in companies 
(kontakt+co - Suchtpräventionsstelle, Tyrol) 
Pilot projekt: Addiction prevention in Trofaiach 
(b.a.s. (betrifft alkohol und sucht) – steirischer Verein für Suchtkrankenhilfe, Styria) 
Probation assistance for prisoners at Vienna Favoriten prison provided by 
voluntary staff 
(Verein für Bewährungshilfe und soziale Arbeit – Bewährungshilfe, Vienna) 
SAS: Pupils searching for alternative solutions. A pupil multiplier project of primary addiction 
prevention based on the concept of peer group education. 
(VIVID - Fachstelle für Suchtprävention, Styria) 
Scientific project: ChEckiT! 
(Verein Wiener Sozialprojekte, Vienna) 
Social medicine counselling centre Ganslwirt 
(Verein Wiener Sozialprojekte, Vienna) 
Socio economical company: Fix und Fertig (“All ready”) 
(Verein Wiener Sozialprojekte, Vienna) 
Stationenmodell: Primary addiction prevention in schools 
(Fachstelle für Suchtvorbeugung, Koordination und Beratung, Lower Austria) 
Step by Step: A programme for early detection and crisis intervention at schools 
(VIVID – Fachstelle für Suchtprävention, Styria) 
Streetwork mobile youth work: “Rumtrieb” Wiener Neustadt 
(Verein für Jugend und Kultur Wr. Neustadt, Lower Austria) 
Substitution treatment in the Outpatient Clinic for Addictions in Innsbruck 
(Outpatient Clinic for Addictions Innsbruck, Tyrol) 
Supervised housing 
(Verein Wiener Sozialprojekte, Vienna) 
Supromobil: Secondary prevention of the Foundation Maria Ebene 
(Stiftung Maria Ebene, Vorarlberg) 
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The Umbrella Network Programme: Analysis of border issues with regard to HIV, AIDS 
and STD problems and the development of cooperative border crossing preventative 
measures. 
(Institut für Sozialdienste, Vorarlberg) 
Therapy for parents and children at Grüner Kreis 
(Verein Grüner Kreis, Lower Austria) 
Toy-free Kindergarten: Addiction prevention by promoting life skills  
(ISP - Informationsstelle für Suchtprävention, Vienna) 
Travelling exhibition with the aim of addiction prevention: “Have you got the hang of 
everything?“ 
(Fachstelle für Suchtprävention, Lower Austria) 
Treatment and care of addicted offenders in Vienna Favoriten prison 
(Justizanstalt Wien-Favoriten, Vienna) 
URBAN: Vienna Gürtel Plus. Secondary prevention for young people in urban areas  
(Drogenberatungsstelle Change, Vienna) 
Vienna Job Exchange 
(Wiener Berufsbörse, Vienna) 
Viennese pilot project “Pregnancy and Addiction”: Aftercare of the children. 
Comprehensive care project for substance abusing mothers and their children 
(Neuropsychiatrische Abteilung für Kinder und Jugendliche am KH Rosenhügel, Vienna) 
Viennese pilot project “Pregnancy and Addiction”: Comprehensive care for substance 
dependent mothers and their children 
(AKH, Vienna) 
Viktoria’s birthday: Primary addiction prevention for primary school pupils. 
(Fachstelle für Suchtprävention, Lower Austria) 
Way Out: Early intervention for young drug-using first offenders.  
(Kooperation der Landesstelle Suchtprävention und Neustart, Carinthia) 
Youth and addiction counselling centre “Auftrieb” 
(Verein für Jugend und Kultur Wr. Neustadt, Lower Austria)  
Youth counselling centre „Waggon” 
(TENDER – Verein für Jugendarbeit, Lower Austria) 
Youth without borders?! Mladi brez meja?! – Addiction prevention in the district of 
Radkersburg 
(blue|monday gesundheitsmanagement, Styria) 
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WEBSITES  
Please find below websites of relevant institutions and associations in the field of drugs and 
addiction in Austria.  
For a comprehensive list of European and international websites on drugs and addiction 
please consult http://www.oebig.at under Activities/ Prevention/ Illegal drugs/ Links 
Provincial Drug or Addiction Coordinators: 
Addiction Coordinators for the Province of Burgenland 
http://www.burgenland.at 
Drug Coordinators for the Province of Carinthia 
www.gesundheit-kaernten.at 
Addiction Coordinators of the Province of Lower Austria 
http://www.noel.gv.at/service/gs/gs4/noesuchtkoordination.htm 
Drug and Addiction Coordinators of the Province of Upper Austria 
http://www.land-oberoesterreich.gv.at/cps/rde/xchg/SID-3DCFCFC3-
8C8F5206/ooe/hs.xsl/554_DEU_HTML.htm  
Drug Coordinators of the Province of Salzburg 
http://www.salzburg.gv.at/themen/gs/soziales/leistungen_und_angebote/abhaengigkeit/a
bhaengigkeit_drogenkoordination.htm   
Addiction Coordinators of the Province of Styria 
http://www.drogenberatung-stmk.at/ 
Addiction Coordinators of the Province of the Tyrol 
http://www.jugendweb.at/drogen/drogen_ein_det.asp?ID=19  
Addiction Coordinators of the Province of Vorarlberg 
http://www.vorarlberg.at/vorarlberg/gesellschaft_soziales/gesellschaft/suchtkoordination/
start.htm  
Addiction and Drug Coordinators Vienna (gemeinnützige GmbH - SDW), 
http://www.drogenhilfe.at  
Provincial Addiction Prevention Units: 
Burgenland: Fachstelle für Suchtprävention Burgenland 
http://www.psd-bgld.at  
Carinthia: Landesstelle für Suchtprävention Kärnten 
http://www.gesundheit-kaernten.at/gesundheitsserverhtml/page.asp?MEN_ID=77  
Lower Austria: Fachstelle für Suchtvorbeugung, Koordination und Beratung, NÖ 
http://www.suchtvorbeugung.at 
Upper Austria: Institut Suchtprävention, OÖ 
http://www.praevention.at  
Salzburg: AKZENTE Suchtprävention – Fachstelle für Suchtvorbeugung Salzburg 
http://www.akzente.net/Suchtpraevention.7.0.html  
Styria: VIVID – Fachstelle für Suchtprävention, Steiermark 
http://www.vivid.at  
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Tyrol: Kontakt&co – Suchtprävention. Jugendrotkreuz, Tirol 
http://www.kontaktco.at 
Vorarlberg: SUPRO – Werkstatt für Suchtprophylaxe, Vorarlberg 
http://www.supro.at   
Federal Ministries: 
Federal Ministry of Health and Women 
http://www.bmgf.gv.at  
Federal Ministry of the Interior 
 http://www.bmi.gv.at   
Federal Ministry of Justice 
http://www.bmj.gv.at 
Federal Ministry of Education, Science and Culture  
http://www.bmbwk.gv.at  
Federal Ministry for Social Security, Generations and Consumer Protection  
http://www.bmsg.gv.at 
Federal Ministry of Transport, Innovation and Technology 
http://www.bmvit.gv.at  
Monitoring and research: 
EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) 
http://www.emcdda.eu.int 
Institut für Suchtforschung der Universität Innsbruck mit Sitz am Krankenhaus Maria Ebene  
(Institute of Addiction Research of the University of Innsbruck, based at the hospital 
Maria Ebene) 
http://www.suchtforschung.at 
Ludwig Boltzmann Institute of Addiction Research at Anton Proksch Institute 
http://www.api.or.at/lbi/index.htm 
ÖBIG – Österreichischer Suchthilfekompass/Austrian Addiction Help Compass 
http://suchthilfekompass.oebig.at  
ÖBIG – Einheitliches Dokumentationssystem der Klienten und Klientinnen der Drogenhilfe  
(Uniform documentation and reporting system of clients of Austrian drug help centres) 
http://tdi.oebig.at  
Other websites: 
AIDS assistance 
http://www.aidshilfen.at 
Allgemeines Krankenhaus in Wien (General Hospital Vienna) 
http://www.meduniwien.ac.at 
ARGE Suchtvorbeugung (Working Group for Addiction Prevention) 
http://www.suchtvorbeugung.net 
Anton Proksch Institute 
http://www.api.or.at  
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b.a.s. – Styrian society for addiction issues 
http://www.bas.at 
Blue Monday Gesundheitsmanagement (health management) 
http://www.bluemonday.at  
Carina – Therapiestation (treatment centre) 
http://www.mariaebene.at/carina/  
Caritas Innsbruck 
http://www.caritas-innsbruck.at  
Caritas Graz – Kontaktladen (contact point) 
http://caritas-graz.at  
ChEck iT! – Vienna Social Projects Association 
http://checkyourdrugs.com    
CONTACT – hospital connection service 
http://www.drogenhilfe.at/rathilfe/skh/r-s-contact.htm 
dialog – counselling and care centre 
http://www.dialog-on.at  
Do it yourself – low-threshold centre for drug users 
http://www.doit.at  
Drogenberatung des Landes Steiermark (Drug Counselling Centre of the Province of Styria) 
http://www.drogenberatung-stmk.at 
drugaddicts@work 
http://www.work.at  
ENCARE Austria 
http://www.api.or.at/akis/encare/encare.htm  
Ex und Hopp – drug counselling 
http://www.exundhopp.at  
Fachzeitschrift für Online-Beratung und computervermittelte Kommunikation (Magazine for 
online counselling and computer-aided communication) 
http://www.e-beratungsjournal.net  
Ganslwirt – Verein Wiener Sozialprojekte (low-threshold centre; Vienna Social Projects 
Association) 
http://www.vws.or.at/ganslwirt/index.html 
Grüner Kreis 
http://www.gruenerkreis.at 
Haus am Seespitz (short-term therapy centre for drug patients) 
http://sogis.i-med.ac.at/ich-brauche-hilfe/einrichtungsdaten.cfm?eid=47 
H.I.O.B. – (drug counselling centre) 
http://www.caritas-vorarlberg.at  
Jugendstreetwork Graz (youth street work) 
http://caritas-
graz.at/home.php?cakt=einr&id=2&einrakt=&narchiv=&armonat=&arjahr=&suche=&einri
d=&ibhid=&mitid 
Klinische Abteilung für Allgemeine Psychiatrie; Universitätsklinik für Psychiatrie in Wien 
(Clinical department of general psychiatry, Vienna University Hospital of Psychiatry) 
http://www.medizin-medien.info/dynasite.cfm?dssid=4263 
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Komfüdro – communication centre for drug users 
http://www.caritas-innsbruck.at/einrichtungen.cfm?mode=showseite1&e_id=15 
Krankenhaus Rosenhügel (hospital) 
http://www.wienkav.at/kav/nkr/ 
Verein LOG IN Association 
http://www.login-info.at  
Lukasfeld – (treatment centre) 
http://www.mariaebene.at  
Marienambulanz (outpatient centre) 
http://www.caritas-graz.at/home.php?cakt=einr&id=68 
MDA basecamp – (mobile drug prevention in the Tyrol) 
http://www.mdabasecamp.com  
MDA basecamp – (online counselling) 
http://www.onlinedrogenberatung.at 
Needles or Pins – dialog 
http://www.dialog-on.at/article_69.html 
Neustart – Bewährungshilfe, Konfliktregelung, Soziale Arbeit (probation assistance, 
conflict management, social work) 
 http://www.neustart.at/ 
Otto-Wagner-Spital – drug institute 
http://www.wienkav.at/kav/ows/medstellen_anzeigen.asp?suchstring=912 
Österreichische Caritaszentrale – (Caritas social integration enterprise) 
http://www.esf.at/projekte/arbeitslose/projekte_ida.html 
Österreichischer Verein für Drogenfachleute (Austrian Association of Experts in the Field 
of Drugs) 
http://www.oevdf.at  
Österreichisches Netzwerk Gesundheitsfördernde Schulen (Austrian Network of Health-
Promoting Schools) 
http://www.schule.at/gesundheit  
Plattform Drogentherapien – information on opiate addiction 
http://www.drogensubstitution.at  
pro mente Oberösterreich 
http://www.promenteooe.at 
Schultüte (FSW/ISP Vienna; school project)  
http://schultuete.at  
Schweizer Haus Hadersdorf (counselling and treatment centre) 
http://www.shh.at  
Stadt Wien - City of Vienna 
http://www.magwien.gv.at 
Stiftung Maria Ebene (foundation, hospital) 
http://www.mariaebene.at  
Streetwork Graz (social work) 
http://caritas-
graz.at/home.php?cakt=einr&id=11&einrakt=&narchiv=&armonat=&arjahr=&suche=&einr
id=&ibhid=&mitid= 
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Substanz – Verein für suchtbegleitende Hilfe (association for accepting drug assistance) 
http://www.substanz.at 
Sucht- und Drogenkoordination Wien gemeinnützige GmbH –SDW (Addiction and Drug 
Coordinators Vienna) 
http://www.drogenhilfe.at 
Supromobil (secondary prevention) 
http://www.supromobil.at 
Therapiestation Erlenhof (treatment centre) 
http://www.therapiestation-erlenhof.at  
Tiroler JugendWeb – Drogen, Sucht, Hilfe (Tyrolean youth network for drug assistance) 
http://www.jugendweb.at/drogen/ 
Verein für eine Legalisierung von Cannabis (legalise cannabis association) 
http://www.legalisieren.at  
VIVA (drug counselling centre) 
http://www.gesundheit-
kaernten.at/gesundheitsserverhtml/page.asp?MEN_ID=109&SEI_ID=99&LST_ID=48 
Vorarlberger Drogenhilfe (drug help services) 
www.suchthaufen.at  
VWS (Vienna Social Projects Association) 
http://www.vws.or.at  
Verein Jugend & Kultur Wiener Neustadt (youth and culture association) 
http://www.jugendundkultur.at  
Wiener BerufsBörse (Vienna Job Exchange) 
http://www.berufsboerse.at   
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Table A1: Overview of selected general population surveys on drug experience among the Austrian 
population from 1998 to 2005 
Study 
(author(s), year of 
publication) 
Area covered
Year of data 
collection 
(period covered)
Target group
(sample) 
Drug types surveyed Percentage of 
respondents with 
drug experience 
Age group %
Linzer Suchtmittelstudie / 
drug survey, Linz 
(Institut für Soziologie der  
Universität Linz, undated) 
Linz 
1998 
(lifetime) 
General 
population 
aged 15 and 
older  
(n = 394) 
Cannabis 
Cannabis 
Cannabis 
Cannabis 
Cannabis 
15–19 
20–29 
30–39 
40–49 
50 + 
28 
37 
19 
7
5
Wiener Suchtmittelstudie / 
drug survey, Vienna 
(Wiener Drogenkoordination 
and IFES 2000) 
Vienna 
1999 
(lifetime) 
General 
population 
aged 15 and 
older 
(n = 623) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Other illicit drugs (e. g., LSD) 
16 +
16 + 
16 + 
16 + 
16 + 
16 + 
11
1
1
1–2 
1
1–2 
Bevölkerungsbefragung OÖ /
drug survey, Upper Austria 
(market 2000) 
Upper Austria
2000 
(lifetime) 
General 
population 
aged 15 and 
older 
(n = 1 011) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Morphine 
LSD 
Smart drugs 
15 + 
15 + 
15 + 
15 + 
15 +
15 + 
15 + 
21 
4
1
4
1
3
1
Wiener Suchtmittelstudie / 
drug survey, Vienna 
(FSW and IFES 2002) 
Vienna 
2001 
(lifetime) 
General 
population 
aged 15 and 
older 
(n = 650) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Other illicit drugs (e. g., LSD) 
15 + 
15 + 
15 + 
15 + 
15 + 
15 + 
14 
1
1
1
1
2
Suchtmittelstudie Steiermark /
drug survey, Styria 
(IFES 2002) 
Styria 
2002 
(lifetime) 
General 
population 
from 14 to 60 
(n = 1 000) 
Illicit drugs (total) 
Cannabis  
Other illicit drugs 
14–60 
14–60 
14–60 
14 
13 
2
Bevölkerungsbefragung OÖ /
drug survey, Upper Austria 
(Seyer 2005) 
Upper Austria
2003 
(lifetime) 
General 
population 
aged 15 and 
older 
(n = 1 018) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Heroin 
Morphine  
LSD 
Solvents and inhalants 
Biogenic drugs 
15–59 
15–59 
15–59 
15–59 
15–59 
15–59 
15–59 
15–59 
15–59 
23.7 
3.9 
3.6 
3.7 
2.0 
2.1 
3.3 
5.8 
3.9 
Wiener Suchtmittelstudie / 
drug survey, Vienna 
(IFES 2004a)   
 
Vienna 
2003 
(lifetime) 
General 
population 
aged 15 and 
older 
(n = 750) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Biogenic drugs 
Other illicit drugs  (e. g., LSD) 
15 + 
15 + 
15 + 
15 + 
15 + 
15 + 
15 + 
16 
2
2
3
1
3
2
Bevölkerungsbefragung 
Österreich / 
drug survey Austria 
(Uhl et al. 2005a) 
Austria 
2004 
(lifetime) 
General 
population 
aged 14 and 
older 
(n = 4 547) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Biogenic drugs 
LSD 
Solvents and inhalants 
14 + 
14 + 
14 + 
14 + 
14 + 
14 + 
14 + 
14 + 
20.1 
3.0 
2.4 
2.3  
0.7 
2.7 
1.7 
2.4 
Wiener Suchtmittelstudie / 
drug survey, Vienna 
(IFES 2005a) 
Vienna 
2005 
(lifetime) 
General 
population 
aged 15 and 
older 
(n = 600) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Biogenic drugs 
Other illicit drugs  (e. g., LSD) 
15 + 
15 + 
15 + 
15 + 
15 + 
15 + 
15 + 
17 
2
2
2
2
3
2
Summarised by ÖBIG 
108
Table A2: Overview of selected school youth surveys on drug experience among young people 
in Austria from  1996 to 2005  
Study 
(author(s), 
year of publication) 
Area covered 
Year of data 
collection 
(period covered) 
Target group 
(sample) 
Drug types surveyed Percentage of 
respondents with 
drug experience 
Age group              % 
Schulstudie Kärnten / 
school survey, Carinthia 
(Bohrn and Bohrn 1996) 
Carinthia 
1996 
(lifetime) 
Students in their 
7th to 12th/13th school 
years 
(n = 1 234) 
Hashish 
Ecstasy 
LSD 
Cocaine 
Heroin 
13–19 
13–19 
13–19 
13–19 
13–19 
7.7
3.2
1.0
0.3
0.3 
NÖ Jugendstudie / 
youth survey, Lower Austria 
(Brunmayr 1997) 
Lower Austria 
1996/97 
(lifetime) 
Students in their 
9th to 12th/13th school 
years 
(n = 1 300) 
Hashish 
Ecstasy 
Hallucinogens 
Cocaine 
Heroin 
15–19 
15–19 
15–19 
15–19 
15–19 
20 
4
> 1
> 1
>1 
Schulstudie NÖ / 
school survey, Lower Austria
(Institut für Sozial- und 
Gesundheitspsychologie 
1999) 
Lower Austria 
1997 
(lifetime) 
Students in their 
7th to 12th school years
(n = 1 899) 
Cannabis 
Ecstasy 
LSD 
Cocaine 
Heroin 
13–18 
13–18 
13–18 
13–18 
13–18 
13.6
3.8
1.7
1.3
0.6 
Jugendstudie Tirol / 
youth survey, Tyrol 
(Schüßler et al. 2000) 
Innsbruck 
1999 
(lifetime) 
Young people from 
 14 to 19 
(n = 493) 
Hashish 
Other illicit drugs 
14–19 
14–19 
22 
3
Schulstudie Burgenland / 
school survey, Burgenland 
(Schönfeldinger 2002) 
Burgenland 
2001 
(lifetime) 
Students in their 
7th to 13th school years
(n = 1 899) 
Cannabis 
Ecstasy 
Cocaine 
Heroin 
Speed 
Hallucinogens 
Solvents and inhalants 
Biogenic drugs 
12–19 
12–19 
12–19 
12–19 
12–19 
12–19 
12–19 
12–19 
20 
 4
2
1
3
3
20 
 8
HBSC-Studie  / 
HBSC study 
(Dür and Mravlag 2002) 
Austria 
2001 
(lifetime) 
Students aged 15 
(n = 1 292) 
Cannabis 15 14 
Berufsschulstudie Salzburg /
vocational school survey, 
Salzburg 
(Klopf and Weinlich 2004) 
Salzburg 
2003 
(lifetime) 
Trainees at vocational 
school  
from 15 to 25 
(n = 609) 
Cannabis 
Ecstasy 
Cocaine 
LSD  
Hallucinogenic mush-
rooms 
Solvents and inhalants 
15–25 
15–25 
15–25 
15–25 
15–25 
15–25 
 31 
 7
5
5
9
15 
Bevölkerungsbefragung OÖ /
general population survey, 
Upper Austria  
(Seyer 2005) 
Upper Austria 
2003 
(lifetime) 
Adolescents and young 
adults from 16 to 24 
(n = 567) 
Cannabis 
Ecstasy 
Heroin 
Amphetamines 
Cocaine 
LSD 
Solvents and inhalants 
Biogenic drugs 
15–24 
15–24 
15–24 
15–24 
15–24 
15–24 
15–24 
15–24 
34.3 
8.3 
4.7 
8.9 
6.2 
5.7 
12.5 
10.0 
ESPAD Österreich / 
ESPAD Austria 
(Uhl et al. 2005b) 
 
Austria 
2003 
(lifetime) 
Students from 14 to 17 
(n = 5 281) 
Cannabis 
Ecstasy  
Cocaine 
Crack 
Heroin 
Amphetamines 
GHB 
LSD 
Solvents and inhalants 
Magic Mushrooms 
14–17 
14–17 
14–17 
14–17 
14–17 
14–17 
14–17 
14–17 
14–17 
14–17 
22 
3
2
2
1
5
1
2
15 
4
Berufsschulstudie 
Steiermark /  
vocational school survey, 
Styria 
(Hutsteiner, Seebauer, 
Auferbauer 2005) 
Styria 
2005 
(lifetime) 
Trainees at vocational 
school 
from 15 to 19 
(n = 3 919) 
Cannabis 
Party drugs 
Cocaine 
Crack 
Opiates 
Amphetamines 
Hallucinogens 
Solvents and inhalants 
Magic Mushrooms 
15–20 
15–20 
15–20 
15–20 
15–20 
15–20 
15–20 
15–20 
15–20 
27.1 
4.8 
2.0 
1.1 
1.4 
3.1 
1.8 
11.4 
8.9 
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Table A3: Number of directly drug-related deaths in Austria by cause of death from 1996 to 2005  
Cause of death 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Intoxication by opiate(s) 69 39 27 25 18 17 17 40 38 31 
Poly-drug intoxication with opiate(s) 115 92 81 101 147 119 119 115 133 134 
Poly-drug intoxication by narcotic drug(s) without 
opiates 
6 5 1 2 2 3 3 8 4 4
Psychoactive medicines 4 5 8 8 * * * * * *
Intoxication of unknown type 1 0 0 0 0 0 0 0 10 22 
Directly drug-related deaths/total 195 141 117 136 167 139 139 163 185 191 
* = as of 2000 no longer taken into account  
Source: BMGF, calculations by ÖBIG 
Table A4: Number of directly drug-related deaths in Austria by province from 1996 to 2005 
Province 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 1996–2005 
Burgenland 2 2 2 0 0 0 0 2 5 3 16 
Carinthia 3 3 3 7 2 5 7 6 4 6 46 
Lower Austria 18 12 9 8 11 14 12 13 31 29 157 
Upper Austria 6 6 6 2 11 8 6 13 15 13 86 
Salzburg 6 11 11 7 6 7 7 5 7 8 75 
Styria 9 13 5 6 11 9 13 14 12 17 109 
Tyrol 12 8 12 14 11 16 13 13 15 17 131 
Vorarlberg 14 5 6 5 5 11 6 5 8 6 71 
Vienna 125 81 63 87 110 69 75 92 88 92 882 
Total 195 141 117 136 167 139 139 163 185 191 1573 
Source: BMGF, calculations by ÖBIG 
Table A5: Number of directly drug-related deaths in Austria by age group and total by gender from  
1996 to 2005  
Age group 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
abs. % abs. % abs. % abs. %. abs. % abs. % abs. % abs. % abs. % abs. %
19 and younger 24 1.3 18 12.8 7 6.0 16 11.8 19 11.4 20 15.1 18 12.9 20 12.3 40 21.6 28 14.7
20–24 45 23.1 32 22.7 35 29.9 23 16.9 33 19.8 21 14.4 20 14.4 37 22.7 40 21.6 48 25.1
25–29 34 17.4 25 17.7 20 17.1 23 16.9 31 18.6 19 13.7 24 17.3 28 17.2 30 16.2 36 18.8
30–34 47 24.1 30 21.3 20 17.1 27 19.9 27 16.2 27 19.4 23 16.5 24 14.7 19 10.2 25 13.1
35–39 31 15.9 23 16.3 16 13.7 28 20.6 27 16.8 25 18.0 24 17.3 29 17.8 23 12.4 19 9.9
40 and older 14 7.2 13 9.2 19 16.2 19 14.0 30 17.4 27 19.4 30 21.6 25 15.3 33 17.8 35 18.3
Total 195 100 141 100 117 100 136 100 167 100 139 100 139 100 163 100 185 100 191 100
Women 27 13.8 23 16.3 16 13.7 38 27.9 35 21.0 22 15.8 25 18.0 30 18.4 38 20.5 43 22.5
Men 168 86.2 118 83.7 101 86.3 98 72.1 132 79.0 117 84.2 114 82.0 133 81.6 147 79.5 148 77.4
abs. = absolute figures 
Source: BMGF, calculations by ÖBIG 
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Table A6: Distribution of directly drug-related deaths in Austria by cause of death and age in 2005  
Age group 
Cause of death 
< 15 15–19 20–24 25–29 30–34 35–39 40–44 45–49 > 49 Total
One opiate 0 7 5 6 2 4 0 0 0 24 
Several opiates 0 1 0 1 1 2 0 0 2 7
+ alcohol 0 2 2 4 3 1 0 2 0 14 
+ psychoactive 
medicines 1 8 13 11 6 5 4 1 2 51 
Opiates 
+ alcohol + psychoactive 
medicines 0 3 5 2 3 3 8 2 2 28 
Narcotic drug(s) only 0 1 3 3 2 1 0 1 1 12 
ND + alcohol 0 0 6 1 1 0 1 0 0 9
ND + psychoactive 
medicines 0 2 5 3 2 2 0 0 0 14 
Opiates and
other narcotic 
drugs 
ND + alcohol + 
psychoactive medicines 0 1 2 1 0 1 1 0 0 6
Narcotic drug(s) only 0 0 0 0 0 0 0 0 0 0
ND + alcohol 0 1 0 0 2 0 0 0 0 3
ND + psychoactive 
medicines 0 0 0 0 0 0 0 0 1 1
Narcotic drugs
without opiates
ND + alcohol + 
psychoactive medicines 0 0 0 0 0 0 0 0 0 0
Intoxication of unknown type 0 1 7 4 3 0 1 6 0 22 
In
to
xi
ca
tio
ns
Directly drug-related deaths/total 1 27 48 36 25 19 15 12 8 191 
of these: men 0 18 35 32 22 14 11 9 7 148 
ND = narcotic drug(s) 
Source: BMGF, calculations by ÖBIG 
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Table A7: Distribution of directly drug-related deaths in Austria by cause of death and province 
in 2005  
Province 
Cause of death 
B C LA UA S ST T VB V A 
One opiate 2 1 5 1 1 4 1 0 9 24 
Several opiates 0 0 1 2 0 0 0 0 4 7
+ alcohol 0 1 0 0 0 3 1 2 7 14 
+ psychoactive medicines 1 2 9 5 1 6 3 0 24 51 
Opiates 
+ alcohol + psychoactive
medicines 0 1 2 2 2 3 8 2 8 28 
Narcotic drug(s) only 0 0 2 0 0 0 2 1 7 12 
ND + alcohol 0 0 2 0 1 0 0 0 6 9
ND + psychoactive 
medicines 0 1 3 1 1 1 0 1 6 14 
Opiates and 
other narcotic 
drugs 
 
ND + alcohol + 
psychoactive medicines 0 0 1 1 1 0 1 0 2 6
Narcotic drug(s) only 0 0 0 0 0 0 0 0 0 0
ND + alcohol 0 0 0 0 1 0 0 0 2 3
ND + psychoactive 
medicines 0 0 0 0 0 0 0 0 1 1
Narcotic drugs 
without opiates
ND + alcohol + 
psychoactive medicines 0 0 0 0 0 0 0 0 0 0
Intoxication of unknown type 0 0 4 1 0 0 1 0 16 22 
In
to
xi
ca
tio
ns
Directly drug-related deaths/total 3 6 29 13 8 17 17 6 92 191 
Direct drug-related deaths 
per 100 000 inhabitants 
aged 15 to 64 years 
1.6 1.6 2.7 1.4 2.2 2.1 3.6 2.4 8.2 3.4 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, ST = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
ND = narcotic drug(s) 
Source: BMGF, calculations by ÖBIG 
Table A8: Development of AIDS cases in Austria by risk situation from 1996 to 2005 
Risk situation 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
Homo-/bisexual contact 60 26 28 27 12 21 19 7 14 13 
Intravenous drug use 26 23 25 28 22 26 20 12 13 13 
Heterosexual contact 21 18 25 31 28 33 39 21 28 15 
Other cause/unknown 33 35 21 15 23 11 15 10 12 12 
Total 140 102 99 101 85 91 93 50 67 53 
Source: BMGF, calculations by ÖBIG 
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Table A9: Distribution of reports to the police for violation of the Narcotic Drugs Act/Narcotic 
Substances Act in Austria by first offenders and repeat offenders, development  
from 1996 to 2005 
Reports 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
Total number of reports 16 196 17 868 17 141 17 597 18 125 21 862 22 422 22 245 25 215 25 892 
First offenders 8 322 9 278 8 672 9 868 9 343 11 033 11 269 12 117 14 346 15 569 
Repeat offenders 7 511 8 325 8 228 7 463 8 296 10 052 10 380 9 288 9 990 9 520 
Difference between sum of individual figures and total figure = unknown offenders 
Since 1998: all reports, not only narcotic drugs but also psychotropic substances 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act 
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
Table A10: Distribution of reports to the police for violation of the Narcotic Drugs Act/Narcotic 
Substances Act (narcotic substances only) in Austria from 1996 to 2005 
Province 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
Burgenland 694 759 707 603 843 712 805 984 967 923 
Carinthia 1 280 961 1 076 1 208 1 088 1 758 1 676 1 659 1 464 1 529 
Lower Austria 1 550 2 686 2 519 2 389 2 624 2 975 3 319 3 017 3 531 3 632 
Upper Austria 1 941 2 256 2 334 1 946 1 887 2 677 3 054 2 782 3 521 3 769 
Salzburg 962 855 1 053 840 718 1 471 1 384 868 1 077 1 092 
Styria 1 093 1 125 973 1 367 1 305 1 601 1 910 1 570 1 705 1 516 
Tyrol 2 268 2 204 2 212 2 152 2 687 2 449 2 229 2 102 2 695 2 775 
Vorarlberg 1 040 933 1 144 1 848 1 183 1 447 1 265 1 146 1 044 1 008 
Vienna 5 368 6 089 4 606 4 858 5 233 6 212 6 210 7 652 8 524 8 797 
Total 16 196 17 868 16 624 17 211 17 568 21 302 21 852 21 780 24 528 25 041 
Difference between sum of individual province figures and total figure = reports not attributable to province 
Note: On 1 January 1998 the Narcotic Drug Act was replaced by the Narcotic Substances Act, which also includes psychotropic 
substances. For the purpose of comparison only reports related to narcotic drugs have been considered for the period 
after 1998. 
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
Table A11: Distribution of reports to the police for violation of the Narcotic Drugs Act/Narcotic 
Substances Act in Austria by drug type from 1996 to 2005 
Drug type 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
Cannabis 14 456 16 124 16 376 17 236 17 001 19 760 19 939 17 706 20 252 20 900 
Heroin and opiates 3 727 3 434 2 850 2 524 2 413 3 802 3 954 4 717 4 770 4 720 
Cocaine + crack 1 912 2 764 2 103 2 608 2 494 3 416 3 762 4 785 5 365 5 491 
LSD 640 893 736 532 477 506 327 214 196 160 
Ecstasy 1 375 1 942 1 411 1 517 2 337 2 940 2 998 2 473 2 362 2 106 
Amphetamines 342 1 068 – – 1 041 1 215 1 357 1 619 1 741 1 664 
Psychotropic substances –- – 802 750 780 822 736 603 903 1 085 
Other drugs 430 850 – –- – 1 288 1 524 1 311 1 826 2 471 
– = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. Because of data broken down 
by type of drug one report to the police may have been listed under several headings, therefore the added figures may dif-
fer from the total number of reports. 
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
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Table A12: Distribution of reports to the police for violation of the Narcotic Substances Act in Austria 
by drug type and province in 2005 
Drug type B C LA UA S ST T VB V Total 
Cannabis 897 1 759 3 042 4 182 1 145 1 828 3 145 958 3 944 20 900 
Heroin and opiates 99 31 742 417 48 173 150 194 2 866 4 720 
Cocaine + crack 122 141 801 459 179 160 451 230 2 948 5 491 
LSD 10 1 43 42 2 19 24 7 12 160 
Ecstasy 89 140 527 531 193 105 242 103 176 2 106 
Amphetamines 78 17 440 621 75 111 97 26 199 1 664 
Psychotropic substances 7 14 65 21 9 12 38 1 918 1 085 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, ST = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna 
Note: Because of data broken down by type of drug one report to the police may have been listed under several headings, 
therefore the added figures may differ from the total number of reports.  
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
 
Table A13: Convictions under the Narcotic Drugs Act/Narcotic Substances Act and total number 
of convictions in Austria from 1996 to 2005 
Year Total number of Convictions under Convictions under Convictions in Austria 
convictions 
under the SGG/SMG 
Section 12 SGG/
Section 28 SMG 
Section 16 SGG/
Section 27 SMG 
Total number Under the SGG/SMG
(percentages) 
1996 3 454 1 027 2 382 66 980 5.2 
1997 3 797 1 036 2 717 65 040 5.8 
1998 3 327 1 041 2 207 63 864 5.2 
1999 3 359 1 022 2 230 61 954 5.4 
2000 3 240 933 2 245 41 624 7.8 
2001 3 862 1 141 2 671 38 763 10.0 
2002 4 394 1 108 3 243 41 078 10.7 
2003 4 532 1 161 3 318 41 749 10.9 
2004 5 706 1 441 4 229 45 185 12.6 
2005 6 128 1 357 4 702 45 691 13.4 
SGG = Narcotic Drugs Act 
SMG = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Section 12 SGG / Section 28 SMG = trafficking, possession etc. of large quantities of narcotic drugs (commercial trafficking) 
Section 16 SGG / Section 27 SMG = trafficking, possession etc. of small quantities of narcotic drugs 
Note: These figures only refer to the leading offence, i.e., the offence with the highest range of punishment, so not all convic-
tions under the SGG, or the SMG, respectively, are covered. 
Source: Statistics Austria (Criminal Court Statistics) 
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Table A14: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act in Austria by age, 
gender and basis of conviction in 2005  
Basis of conviction 14–19 years 20–24 years 25–29 years 30–34 years > 34 years Total 
SGG/SMG total men 1 401 1 907 929 524 804 5.565 
women 130 192 89 55 97 563 
Section 12 SGG / Section 28 SMG men 186 352 226 160 304 1 228 
women 20 41 27 13 28 129 
Section 16 SGG / Section 27 SMG men 1 214 1 552 697 355 469 4 287 
women 110 148 60 38 59 415 
SGG = Narcotic Drugs Act 
SMG = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act 
Section 12 SGG / Section 28 SMG = trafficking, possession etc. of large quantities of narcotic drugs (commercial trafficking) 
Section 16 SGG / Section 27 SMG = trafficking, possession etc. of small quantities of narcotic drugs 
Note: These figures only refer to the leading offence i.e., the offence with the highest range of punishment, so not all convictions 
under the SGG, or the SMG, respectively, are covered.  
Source: Statistics Austria (Criminal Court Statistics) 
Table A15: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act, young people 
and adults, basis of conviction and type of punishment in 2005 
Prison sentence Basis of conviction Fine 
Probation No probation Partial probation
Other 
punishment1
Total 
SGG/SMG total young people 171 222 112 78 73 656 
adults 1 487 1 544 1 512 859 70 5 472 
Section 12 SGG / Section 28 SMG young people 1 21 22 24 1 69 
(felonies) adults 16 280 648 344 0 1 288 
Section 16 SGG / Section 27 SMG young people 170 201 90 54 72 587 
(misdemeanours) adults 1 451 1 234 849 512 69 4 115 
Young people = person younger than 19 at the time of the offence 
SGG = Narcotic Drugs Act 
SMG = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act 
Section 12 SGG / Section 28 SMG = trafficking, possession etc. of large quantities of narcotic drugs (commercial trafficking) 
Section 16 SGG / Section 27 SMG = trafficking, possession etc. of small quantities of narcotic drugs 
1Other Punishment: partial probation (Section 43 A (2) StGB), referrals to institutions (Sections 21 (1), 21 (2), 22 and 23 StGB), 
no additional punishment (Section 40 StGB) and, only in the case of young people, conviction with 
punishment reserved (Section 13 JGG) and conviction without punishment (Section 12 JGG) 
Note: These figures only refer to the leading offence i.e., the offence with the highest range of punishment, so not all convictions 
under the SGG, or the SMG, respectively, are covered.  
Source: Statistics Austria (Criminal Court Statistics) 
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Table A16: Development of alternatives to punishment applied in Austria from 1996 to 2005  
Waiving of reports/ 
suspension of proceedings 
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
Total 5 248 5 817 7 468 6 989 8 049 8 145 8 974 9 023 9 666 11 660
Section 35 SMG (waiving of report) – – 6 557 5 979 6 924 7 346 7 817 7 902 8 599 10 668
Of these: Section 35(4) SMG 
(cannabis) 
– – 1 380 1 330 1 410 1 570 1 876 1 499 2 016 2 697
Section 37 SMG (suspension of  
proceedings) 
– – 911 1 010 1 125 799 1 157 1 121 1 067 992
Section 35 SMG = provisional waiving of reports to the police by the public prosecutor  
Section 35(4) SMG = waiving of reports to the police in the case of small quantities of cannabis for personal use 
Section 37 SMG = provisional suspension of proceedings by the court 
 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. A specification of the kind of al-
ternative to punishment can be given only for the period since 1998. Data on Section 39 of the SMG (stay of execution – 
therapy instead of punishment) is not available at present. 
Source: BMGF, calculations by ÖBIG 
Table A17: Number of seizures of narcotic drugs/substances in Austria from 1996 to 2005 
Narcotic drug/substance 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
Cannabis 4 838 4 957 4 683 5 079 4 833 5 249 5 294 5 422 6 202 6 012 
Heroin 1 110 861 654 452 478 895 836 1 263 1 383 1 371 
Cocaine 525 651 531 519 554 768 863 1 271 1 475 1 507 
Amphetamines 136 221 – – 141 161 202 294 324 312 
LSD 102 113 61 56 42 32 20 33 29 20 
Ecstasy 254 253 135 215 330 352 308 276 286 295 
Psychotropic substances – – 14 74 65 1 0 6 5 2 
Psychotropic medicines – – 521 517 501 566 515 432 678 823 
– = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, which also includes psychotro-
pic substances. 
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
Table A18: Seizures of narcotic drugs/substances in Austria by quantity from 1996 to 2005 
Narcotic rugs/substance 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 
Cannabis (kg) 517 912 1 336 451 1 806 456 743.1 925.9 1 680.9 819.9
Heroin (kg) 81.3 102 118 78 230 288 59.5 42.8 235.0 282.2
Cocaine (kg) 72.7 87 99 63 20 108 36.9 58.3 75.5 244.9
Amphetamines (kg) 3.7 7.9 – – 1 3 9.4 54.2 25.7 8.9
LSD (no. of trips) 4 166 5 243 2 494 2 811 865 572 851 298 2 227.5 2 108.5
Ecstasy (no. of pills) 25 118 23 522 114 677 31 129 162 093 256 299 383 451 422 103 122 663 114 103.5
Psychotropic substances 
(kg) 
– – 0.128 4.004 1.294 0.002 0 0.2 0.1 0.002
Psychotropic medicines  
(units) 
– – 82 018 36 437 38 507 31 377 20 081 15 649 21 119 27 104
– = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, which also includes psychotro-
pic substances. 
Source: BMI/Bundeskriminalamt (Federal Criminal Agency) 
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Table A19: Ingredients of samples bought as ecstasy and analysed by the ChEckiT! Project at parties 
and clubbings from 1999 to 2005 
Samples bought as ecstasy 
(percentages) Ingredients 
1999 
(n = 155) 
2000 
(n = 326) 
2001 
(n = 271) 
2002 
(n = 269) 
2003 
(n = 95) 
2004 
(n = 95) 
2005 
(n = 57) 
MDMA 85.81 81.90 77.12 68.03 83.45 71.58 70.2  
MDMA + MDE 0.00 3.07 2.21 14.13 7.59 9.47 0.0 
MDMA + MDA 0.00 0.92 1.48 6.69 0.00 0.00 0.0 
MDE and/or MDA 0.65 1.23 7.01 0.37 0.00 7.37 0.0 
MDMA + caffeine 1.29 1.53 0.00 0.74 0.69 1.05 5.3 
MDMA + amphetamines 0.65 0.61 0.37 0.00 0.69 0.00 1.8 
MDMA + various combinations* 3.87 2.15 0.37 0.00 3.45 1.05 12.3 
PMA/PMMA 0.00 1.23 0.37 0.00 0.69 0.00 0.0 
Amphetamines 3.87 1.53 0.00 1.86 1.38 0.00 1.8 
Methamphetamine 0.00 0.61 2.58 1.49 0.00 0.00 0.0 
Caffeine 0.00 0.92 0.00 1.49 0.00 1.05 0.0 
Chinine/quinidine 0.00 0.61 1.11 0.00 0.00 0.00 0.0 
Various combinations* 3.87 3.68 7.38 5.20 2.07 8.42 8.8 
* Various combinations: Combinations of more than two amphetamine derivatives and/or other substances and/or unknown 
substances 
Source: Vienna Social Projects Association (VWS) 
Table A20: Ingredients of samples bought as speed and analysed by the ChEckiT! Project at parties 
and clubbings from 1999 to 2005 
Samples bought as speed 
(percentages) 
Ingredients 
1999 
(n = 67) 
2000 
(n = 93) 
2001 
(n = 51) 
2002 
(n = 87) 
2003 
(n = 57) 
2004 
(n = 41) 
2005 
(n = 33) 
Amphetamines 53.73 56.99 60.78 45.98 35.09 21.95 33.3
Amphetamines + caffeine 4.48 9.68 9.80 8.05 15.79 19.51 6.1
Amphetamines + methamphetamine  1.49 0.00 0.00 0.00 0.00 0.00 0.0
Amphetamines + various combinations* 20.90 7.53 3.92 17.24 29.82 39.02 24.2
Methamphetamine 7.46 3.23 1.96 3.45 1.75 2.44 3.0
Caffeine 1.49 3.23 11.76 8.05 0.00 4.88 9.1
MDMA 2.99 3.23 0.00 1.15 0.00 0.00 6.1
Ephedrine total 0.00 0.00 0.00 0.00 0.00 0.00 0.0
Various combinations* 7.46 16.13 11.76 16.09 17.54 12.20 18.2
* Various combinations: Combinations of more than two amphetamine derivatives and/or other substances and/or unknown 
substances 
Source: Vienna Social Projects Association (VWS) 
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Table A21: Number of persons currently registered for substitution treatment in Austria in the 
BMGF monitoring system by treatment/continued treatment and province in 2005 
Treatment B C LA UA S ST T VB V
Continued treatment 67 177 751 499 382 767 268 420 3 343 
First treatment 12 62 161 77 53 112 19 73 303 
Total* 79 239 912 576 435 879 287 493 3 646 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, ST = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna 
Note: Continued treatment means treatment started before the respective year, or repeated treatment of persons who have 
undergone substitution treatment in the past. First treatment means treatment of persons who have never undergone 
substitution treatment before. The figures relate to treatments reported to the BMGF, which partly differ considerable from 
the figures collected at provincial level. 
* The total number of substitution treatments in Austria is higher than the sum of substitution treatments by province since re-
cords of the provinces are incomplete in some cases. 
Source: BMGF, calculations by ÖBIG 
Table A22: Exchange and sale of syringes by province in 2005 
Province Number of 
syringe provision points
Number of 
vending machines 
Number of syringes provided 
(exchanged or sold) 
Burgenland 0 0 0 
Carinthia 3 0 1421
Lower Austria 0 0 0 
Upper Austria 1 0 69 200 
Salzburg 1 2 22 2062
Styria3 1 1 287 767  
Tyrol 2 3 202 657  
Vorarlberg 7 6 167 370 
Vienna 8 0 1 667 845 
Total 23 12 2 417 187 
1 Syringe exchange mainly in the context of personal contacts; data not complete 
2 Data not complete 
3 Syringes are only available in Graz, the capital of Styria 
Source: ÖBIG - Standard Table 10: Syringe Availability 2006, calculations by ÖBIG 
Table A23: Prevention projects in kindergartens, 2005/6
Name Province Target group Implemented by
Connected to
family inter-
vention
No. of participating
kindergartens +
other childcare cen-
tres
No. of
participating
kindergarten
staff
Hours of
training
for fami-
lies
Evaluation
Elterncafé (parent cafe) Styria Children between 3 and 10 Parents Yes 0 3 Processevaluation
KIGAFO Styria Children between 1and 6 Kindergarten teachers No 28 59 0
Weinen, Wüten, Lachen
(Weeping, Raging, Laughing) Lower Austria Children between 3 and 6
Kindergarten teachers and
assistants No 25 25 No
Süchten Grenzen setzen –
von Anfang an (Setting Bounds to
Addiction – From the Very Start)
Lower Austria Children between 3 and 6 Parents Yes 72 parents 12 Processevaluation
Spielzeugfreier Kindergarten
(Toy-Free Kindergarten) Vienna Children between 3 and 6 Kindergarten teachers Yes
Outcome
evaluation
Training course: Addiction Preven-
tion in Kindergarten, for staff of the
Viennese municipal kindergartens
Vienna Children between 1 and 6 Kindergarten teachers Yes New course will startin autumn 2006
Note: This table gives only a selection of early childhood prevention projects in Austria.
Source: investigations by ÖBIG, spring 2006
Table A24: Prevention projects in schools, 2005/6
Name Province Target group Implementedby
Connected to
school policies
No. of participating
schools
No. of students
reached
No. of
participating
teachers
Hours of
training multipliers
Integration in
school community Evaluation
Step by Step Styria Students
between 11 and 18
Teachers,
tutors
Yes Approx. 10
per year
11 16 School medical
officers, head masters/
head mistresses,
parents, school
psychologists
Outcome
and process
evaluations
Eigenständig
werden
(Becoming
Independent)
Styria Students
between 6 and 10
Teachers Yes Approx. 41 so far Approx. 50
classes
50 24 Parents, head masters/
head mistresses
Implementation
of a project
already evalu-
ated before
Study course at
Teacher Training
Academy
Styria Students Teachers No 12 32 No No
Workshops Styria Students
between 13 and 18
Experts Yes 10 per year Approx. 230 3 6 Parents (recommended) Outcome
evaluation
Station Model Lower
Austria
Students
between 10 and 16
Experts
and
teachers
Yes 35 2 809 160 8 hours +
reflection hour
Parents, head masters/
head mistresses, in some
cases also school medi-
cal officers
Outcome and
process evalua-
tion
Traust du dich?
(Do You Dare?)
Lower
Austria
Students
between 6 and 10
Experts No 25 2 823 91 2 hours parent
meeting,
2 hours educational
conference
Parents and head
masters/head mistresses
Process evalua-
tion
Eigenständig
werden
(Becoming
Independent)
Lower
Austria
Students
between 6- and 10
Teachers No 43 74 24 hours +
8 hours reflection
Parents and head-
masters/head mistresses
Implementation
of a project
already evalu-
ated before
Step by Step Lower
Austria
Students
between 11 and 18
Teachers Yes 78 27 School medical officers
and head masters/ head
mistresses
No evaluation
planned
Amstettner
Modell
(Amstetten
Model)
Lower
Austria
Students Experts and
teachers
Yes 11 250 30 5 Head masters, head
mistresses, parents
Outcome
evaluation
Feel ok Lower
Austria
Students between
10 and 18
Teachers No 5 78 2 No Implementation
of a project al-
ready evaluated
before
Addiction preven- Lower Students Teachers Yes 12 20 98 Head masters/head No
Name Province Target group Implementedby
Connected to
school policies
No. of participating
schools
No. of students
reached
No. of
participating
teachers
Hours of
training multipliers
Integration in
school community Evaluation
tion training of
Education
Institute for Upper
Secondary
Schools
Austria mistresses, school
medical officers
Peer Education Lower
Austria
Students
between 14 and 18
Peers Yes 5 72 peers 15 24 hours
teachers,
44 hours peers
Head masters/head
mistresses, school com-
munity
Outcome
evaluation
Helfen statt
Strafen (Help
Instead of
Punishment)
Lower
Austria
Students Teachers Yes 2 128 36 2–8 hours Parents, head
masters/head mistresses
No
Eigenständig
werden
(Becoming
Independent)
Vienna Students
between 6 and 10
Teachers Partly Approx. 103 so far Approx. 14 000 517 teachers
and afternoon
education
tutors
24 lessons Parents Outcome
and process
evaluation
Step by Step Vienna Students
between 14 and 21
Teachers and
school medical
officers
None so far None so far None so far 8 lessons School medical officers
Move in der
Schule
(Move at School)
Vienna Students
between 14 and
Specialist
teachers pro-
viding coun-
selling ser-
vices
Implementation
starts in autumn
2006
None so far None so far 24
Feel ok Vienna Students
between 12 and 18
Teachers Implementation
started in May 2006
None so far None so far 3 lessons
Note: This table gives only a selection of prevention projects implemented in schools in Austria
Source: investigations by ÖBIG, spring 2006
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Table A25: Average age of first use and of start of regular use of psychoactive substances 
among clients drug help centres in Vienna, in 2004 
Total Men Women 
First use Regular use First use Regular use First use Regular use
Alcohol (n = 676) 14.1 16.7 14.1 16.7 14.0 16.7 
Nicotine (n = 1 229) 13.9 14.9 14.1 15.1 13.4 14.4 
Cannabis (n = 1 139) 15.3 16.2 15.4 16.4 14.9 15.9 
Heroin (n = 1 282) 18.9 19.8 19.2 20.3 18.0 18.8 
Other opiates and substitution drugs (n = 708) 22.0 22.7 22.4 23.0 21.1 21.9 
Ecstasy (n = 424) 17.0 17.3 17.2 17.6 16.3 16.7 
LSD / hallucinogens (n = 220) 16.8 17.0 17.0 17.3 16.2 16.4 
Cocaine (n = 877) 19.8 20.9 20.3 21.5 18.7 19.6 
Benzodiazepines (n = 817) 19.8 21.2 20.4 21.9 18.5 19.6 
Other tranquilizers and sleeping pills (n = 172) 20.3 20.8 20.7 21.3 18.9 19.5 
Stimulants, amphetamines, speed (n = 292) 17.5 18.0 17.8 18.3 16.7 17.0 
Solvents and inhalants (n = 29) 15.1 15.5 15.2 15.6 15.0 15.3 
Other substances (n = 104) 17.7 19.5 18.0 20.0 16.6 17.0 
Basis: Regular users of the respective substance 
Source: IFES 2005b 
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Table A26: Austrian population statistics by age group and gender in 2004 
Age group Men Women Total 
0 to under 5 years 203 917 192 902 396 819 
5 to under 10 years 225 702 215 320 441 022 
10 to under 15 years 250 315 237 841 488 156 
15 to under 20 years 248 797 236 364 485 161 
20 to under 25 years 261 296 255 440 516 736 
25 to under 30 years 255 860 253 033 508 893 
30 to under 35 years 299 969 301 944 601 913 
35 to under 40 years 357 340 347 619 704 959 
40 to under 45 years 349 426 339 657 689 083 
45 to under 50 years 293 317 293 045 586 362 
50 to under 55 years 247 947 252 409 500 356 
55 to under 60 years 228 773 237 484 466 257 
60 to under 65 years 241 164 260 749 501 913 
65 to under 70 years 163 541 186 608 350 149 
70 to under 75 years 138 904 176 946 315 850 
75 to under 80 years 106 971 173 796 280 767 
80 to under 85 years 64 654 150 899 215 553 
85 and older 31 297 93 487 124 784 
Total 15148 14738 17898 
0 to under 15 years 679 934 646 063 1 325 997 
15 to under 30 years 765 953 744 837 1 510 790 
30 to under 45 years 1 006 735 989 220 1 995 955 
45 to under 60 years 770 037 782 938 1 552 975 
60 to under 75 years 543 609 624 303 1 167 912 
75 and older 202 922 418 182 621 104 
Total 3 969 190 4 205 543 8 174 733 
Source: Statistics Austria, calculations by ÖBIG 
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AC Addiction Coordinator 
AIDS acquired immune deficiency syndrome 
AKH Vienna General Hospital 
AMG Austrian Pharmaceuticals Act 
AMS Public Employment Service 
API Anton Proksch Institute 
AR Addiction Representative 
ARBÖ Automobile, Motorcycle and Bicycle Club of Austria 
BADO (Vienna) Basic Documentation 
BBZ treatment and care centre (association Dialog) 
BGBl. Federal Collection of Statutes 
BMaA Federal Ministry for Foreign Affairs 
BMBWK Federal Ministry for Education, Science and Culture 
BMF Federal Ministry of Finance 
BMGF Federal Ministry of Health and Women 
BMI Federal Ministry of the Interior 
BMJ Federal Ministry of Justice 
BMLFUW Federal Ministry of Agriculture, Forestry Environment and Water 
Management 
BMLV Federal Ministry of Defence 
BMSG Federal Ministry for Social Security, Generations and Consumer Protection 
BMVIT Federal Ministry for Transport, Innovation and Technology 
CND Commission on Narcotic Drugs 
CRC capture-recapture 
DOKLI nation-wide treatment documentation system of clients 
of drug help centres in Austria 
DSM IV Diagnostic and Statistical Manual of Mental Disorders 
EDDRA Exchange on Drug Demand Reduction Action 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
ENCARE European Network for Children Affected by Risky Environments 
within the Family 
ESPAD European School Survey Project on Alcohol and other Drugs 
EU European Union 
FSG-GV Driving Licence Act Health Decree 
FSW Vienna Social Fund 
HAV hepatitis A virus 
HBV hepatitis B virus 
HCV hepatitis C virus 
HCV-Ab HCV antibodies 
HDG Horizontal Drugs Group 
HIV human immunodeficiency virus 
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ICD-10 International Classification of Diseases and Related Health Problems 
IFES Institute for Empirical Research 
ISD Diagnoses Institute 
ISP Addiction Prevention Institute 
i. v. intravenous 
JGG  Juvenile Court Act 
LSD d-lysergic acid diethylamide  
MA-L Municipal Department of Provincial Public Health Affairs 
mCPP meta-chlorophenyl piperazine 
MDA 3,4-methylenedioxyamphetamine 
MDE 3,4-methylenedioxy-N-ethylamphetamine 
MDMA 3,4-methylenedioxy-methylamphetamine 
ND narcotic drug 
ÖBIG Austrian Health Institute 
ÖVDF Austrian Drug Experts Association 
PAZ police detention centre 
PCR polymerase chain reaction 
PMA paramethoxyamphetamine 
PMMA 4-metoxy-paramethoxymethamphetamine 
PSD Psychosocial Services 
QCT quasi-compulsory treatment 
REITOX European Information Network on Drugs and Drug Addiction 
(Réseau Européen d’Information sur les Drogues et les Toxicomanies) 
SGG Narcotic Drugs Act 
SMG Narcotic Substances Act 
STARK Streetwork Tyrol Working Group  
STD Sexual transmitted diseases 
StGB Criminal Code 
StVO Road Traffic Regulations 
TB tuberculosis 
TMA-2 2,4,5-trimethoxyamphetamine 
UN United Nations 
VWS Vienna Social Projects Association 
WBB Vienna Job Exchange Association 
WAFF Vienna Employees Promotion Fund 
2C-B 4-bromo-2,5-dimethoxyphenetylamine  
2C-I 2,5-dimethoxy-4-iodophenethylamine 
2C-T-2 2,5-dimethoxy-4-ethyliophenethylamine 
2C-T-7 2,5-dimethoxy-4-(n)-propylthiophenethylamine 
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List of Austrian Standard Tables and Structured Questionnaires 
of 2006 
The following list gives an overview of all Standard Tables and Structured Questionnaires 
drawn up for Austria in 2006 and submitted to the EMCDDA. If you are interested in obtaining 
any table or questionnaire please contact Ms Monika Löbau loebau@oebig.at.
STANDARD TABLE 01: BASIC RESULTS AND METHODOLOGY OF POPULATION SURVEYS ON 
DRUG USE (Drug survey, Vienna) 
STANDARD TABLE 02: METHODOLOGY AND RESULTS OF SCHOOL SURVEYS ON DRUG USE 
(Vocational school survey, Styria) 
STANDARD TABLE 03: CHARACTERISTICS OF PERSONS STARTING TREATMENT FOR DRUGS  
STANDARD TABLE 05: ACUTE/DIRECT DRUG-RELATED DEATHS 
STANDARD TABLE 06: EVOLUTION OF ACUTE/DIRECT DRUG-RELATED DEATHS  
STANDARD TABLE 07: NATIONAL PREVALENCE ESTIMATES ON PROBLEM DRUG USE 
(2001, 2002, 2003, 2004)  
STANDARD TABLES 09: PREVALENCE OF HEPATITIS B/C AND HIV INFECTION AMONG 
INJECTING DRUG USERS (Anton Proksch Institute: HBV, HCV, HIV) 
STANDARD TABLES 09: PREVALENCE OF HEPATITIS B/C AND HIV INFECTION AMONG 
INJECTING DRUG USERS (Lukasfeld short-term therapy department: 
HBV, HCV, HIV) 
STANDARD TABLES 09: PREVALENCE OF HEPATITIS B/C AND HIV INFECTION AMONG 
INJECTING DRUG USERS (Marienambulanz Graz: HBV, HCV, HIV) 
STANDARD TABLES 09: PREVALENCE OF HEPATITIS B/C AND HIV INFECTION AMONG 
INJECTING DRUG USERS (Vienna Social Projects Association (VWS) - 
Ganslwirt: HBV, HCV, HIV) 
STANDARD TABLES 09: PREVALENCE OF HEPATITIS B/C AND HIV INFECTION AMONG 
INJECTING DRUG USERS (drug outpatient department, General Hospital 
Vienna: HCV, HIV) 
STANDARD TABLES 09: PREVALENCE OF HEPATITIS B/C AND HIV INFECTION AMONG 
INJECTING DRUG USERS (drug-related deaths: HCV, HIV) 
STANDARD TABLES 10: SYRINGE AVAILABILITY 
STANDARD TABLE 11: ARRESTS/REPORTS FOR DRUG LAW OFFENCES 
STANDARD TABLE 13: NUMBER AND QUANTITY OF SEIZURES OF ILLICIT DRUGS 
STANDARD TABLE 14: PURITY AT STREET LEVEL OF ILLICIT DRUGS 
STANDARD TABLE 16: PRICE IN EUROS AT STREET LEVEL OF ILLICIT DRUGS 
STANDARD TABLE 24: DRUG RELATED TREATMENT AVAILABILITY 
STRUCTURED QUESTIONNAIRE 22: UNIVERSAL SCHOOL-BASED PREVENTION 
STRUCTURED QUESTIONNAIRE 23: HARM REDUCTION MEASURES TO PREVENT INFECTIOUS 
DISEASES IN INJECTING DRUG USERS 
STRUCTURED QUESTIONNAIRE 28: SOCIAL REINTEGRATION 
STRUCTURED QUESTIONNAIRE 31: TREATMENT AS AN ALTERNATIVE TO IMPRISONMENT 
APPLICABLE FOR DRUG USING OFFENDERS IN THE 
EUROPEAN UNION 
STRUCTURED QUESTIONNAIRE 32: POLICY AND INSTITUTIONAL FRAMEWORK 
SELECTED ISSUE 36: COCAINE_ORIENTATIVE_FREQUENCY 
 
